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ABSTRACT 
 
Stem cells are responsible for tissue turnover throughout lifespan. Only highly controlled 
specific environment, “the stem cell niche”, can sustain undifferentiated stem cell-pool. 
The balance between maintenance and differentiation is crucial for individual’s health: 
uncontrolled stem cell self-renewal or proliferation can lead to hyperplasia and mutations 
that further provoke malignant transformation of the cells. On the other hand, uninhibited 
differentiation may result in diminished stem cell population, which is unable to maintain 
tissue turnover. The mechanisms that control the switch from maintenance to 
differentiation in stem cells are not well known. The same mechanisms that direct the 
self-renewal and proliferation in normal stem cells are likely to be also involved in 
maintenance of “cancer stem cell”. Cancer stem cells exhibit stem cell like properties 
such as self-renewal- and differentiation capacity and they can also regenerate the tumor 
tissue.  
 
In this thesis, I have investigated the effect of classical oncogenes E6/E7 and c-Myc, 
tumor suppressors p53 and retinoblastoma (pRb) family, and vascular endothelial growth 
factor (VEGF) subfamily and glial cell line-derived neurothropic factor (GDNF) family 
ligands on behavior of neural stem cells (NSCs) and progenitors. The study includes also 
the characterization of cytoskeletal tumor suppressor neurofibromatosis 2 (NF2) protein 
merlin and ezrin-radixin-moesin (ERM) protein ezrin expression in neural progenitors 
cells and their progeny.  
 
This study reveals some potential mechanisms regarding to NSCs maintenance. In 
summary, the studied molecules are able to shift the balance either towards stem cell 
maintenance or differentiation; tumor suppressor p53 represses whereas E6/E7 oncogenes 
and c-Myc increase the proportion of self-renewing and proliferating NSCs or 
progenitors. The data suggests that active MEK-ERK signaling is critical for self-renewal 
of normal and oncogene expressing NSCs. In addition, the results indicate that expression 
of cytoskeletal tumor suppressor merlin and ERM protein ezrin in central nervous system 
(CNS) tissue and progenitors indicates their role in cell differentiation. Furthermore, the 
data suggests that VEGF-C a factor involved in lymphatic system development, 
angiogenesis, neovascularization and metastasis but also in maintenance of some neural 
populations in brain is a novel thropic factor for progenitors in early sympathetic nervous 
system (SNS). It seems that VEGF-C dose dependently through ERK-pathway supports 
the proliferation and survival of early sympathetic progenitor cells, and the effect is 
comparable to that of GDNF family ligands.  
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1 REVIEW OF THE LITERATURE 
 
1.1 INTRODUCTION 
 
NSCs and neural progenitor cells (NPCs) differentiate into new neural cells both during 
embryonic development and adulthood. The differentiation process involves the cell 
proliferation, but also capacity to respond to microenvironmental signals, exit the cell 
cycle and remain quiescent. The path from self-renewing NSC to committed progeny is 
thought to be initiated when cell divisions are switched from symmetric to asymmetric. 
The decision between self-renewal and differentiation is controlled by several cell 
intrinsic and extrinsic factors but the mechanisms are still poorly understood. Intrinsic 
modulators such as length of the cell cycle, orientation of the mitotic spindle, 
asymmetrically distributed molecules and tumor suppressors together with the epigenetic 
chromatin modifiers regulate the gene expression in NSCs. These signals either compete 
or collaborate with the cell extrinsic factors such as different growth factors and signals 
derived from surrounding microenvironment, extracellular matrix and neighboring 
tissues.  
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1.2 NERVOUS SYSTEM DEVELOPMENT 
1.2.1 Development of central nervous system (CNS)  
Early events of the neural tube development 
 
CNS that includes the brain and spinal cord is one of the first organ systems formed 
during vertebrate embryo development (reviewed in Gilbert, 2008). CNS development 
and its intricate connections occur in several steps. First step is neural induction that 
results in formation of neural plate. In mammalian species, induction of the neural tissue 
is likely linked to patterning of the entire early embryo (reviewed in Levine and 
Brivanlou, 2007). This is followed by neurulation wherein increased cell proliferation 
makes the neural plate fold, elevate and bend to form a tube like structure (Figure 1).  
 
 
 
Figure 1. Left panel: Folding of the neural plate and the neural tube formation (Modified 
from Kandel et al. 2000). Right panel: Early events in brain development: formation of 
the primary vesicles (Modified from Gilbert 2008). 
 
 
Neural tube formation and maturation in anterior-posterior axis is not concurrent. The 
most anterior part of the neural tube is already undergoing changes that will eventually 
lead to the development of the brain while the posterior end is still closing. At this stage, 
the early neural tube consists of rapidly dividing neuroepithelial cells (Schoenwolf, 
1991). Brain development is initiated by formation of three primary vesicles: 
prosencephalon (forebrain), mesencephalon (midbrain) and rhombencephalon (hindbrain) 
(Figure 1B). Next the forebrain subdivides into two hemispheres and forms telencephalon 
(cerebrum) and diencephalon (interbrain). The cerebrum forms olfactory lobes, 
hippocampus, cerebral hemispheres and basal ganglia while the interbrain differentiates 
into thalamic and hypothalamic brain regions. The midbrain does not divide but the 
hindbrain subdivides into metencephalon (cerebellum) and myelencephalon (medulla 
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oblongata). The hindbrain forms also segmental pattern called rhombomeres that later 
specify the locations where certain cranial nerves originate (reviewed in Kandel et al., 
2000).
Molecular control of CNS patterning 
 
CNS patterning and cell differentiation is guided in both anterior-posterior-, and ventral-
dorsal–axis. The major signaling pathways that are involved in the anterior-posterior 
patterning are transforming growth factor β (TGF-β) family members, especially bone 
morphogenic proteins (BMPs) (Liem et al., 1997), fibroblast growth factor (FGF) family, 
Wingless (Wnt) and retinoid acid (RA) (Pierani et al., 1999) (Figure 2).  
 
Forebrain characteristics are guided by follistatin, noggin and chordin that antagonize 
BMP signaling. Antagonization of BMP and Wnt signaling seems to be the most critical 
steps for the development of early anterior CNS (Gilbert, 2008). FGFs, Wnts and RA are 
involved in the induction of the posterior neural tissues (Gilbert, 2008) and they activate 
homeodomain protein family, the group of transcription factors that are encoded by 
homeobox genes (Hox-genes) (Houle et al., 2003). The highly conserved Hox-genes are 
also expressed in overlapping domains along the hindbrain and spinal cord axis (Gilbert, 
2008). In the hindbrain, the Hox-genes control identity of cell boundaries in 
rhombomeres (Akin and Nazarali, 2008). One of the most studied signaling centers in the 
brain, the isthmus organizer, localizes between the midbrain and hindbrain and secretes 
molecules such as FGFs and Wnts that guide cell patterning in the midbrain and 
hindbrain area (Partanen, 2007).  
 
Although, the signals that define forebrain development are not as well known one 
important signaling center in forebrain patterning is anterior neural ridge (ARN) that 
localizes at junction between anterior neural plate and ectoderm and secretes signaling 
molecules such as FGF (Martinez-Barbera et al., 2001; Shimamura and Rubenstein, 
1997). Gene expression studies indicate that the embryonic forebrain is subdivided along 
its anterior-posterior axis into transversal prosomeres. These boundaries coincide with the 
expression patterns of certain transcription factors and inductive signals. For example, 
Shh is expressed in the cell boundary between prosomeres 2 and 3, and the signals from 
this area are thought to control cell differentiation in the forebrain similarly as the 
isthmus organizer controls patterning in the mid- and hindbrain (reviewed in Kandel et 
al., 2000; Akin and Nazarali, 2008). 
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Figure 2. Patterning of early neural tube in anterior-posterior-axis. In anterior neural tube, 
BMP antagonists chordin, noggin and follistatin to establish the forebrain characteristics. 
Hindbrain and the posterior neural tube are patterned by RA, Wnts and FGFs, which 
activate Hox-genes. (Modified from Kandel et al., 2000) 
  
 
In the spinal cord and brain, the cell differentiation is also guided in ventral-dorsal-axis 
(Figure 3). Dorsal ectoderm secretes signals such as BMPs, which commits the roof plate 
cells in dorsal neural tube to secrete BMP-4, and this induces expression cascade of TGF-
β family proteins such as dorsalin and activin in the adjacent cells (Liem et al., 1997). 
Whereas, the ventral neural tube is exposed to signals such as Sonic hedgehog (Shh) and 
RA derived from notocord and somites, respectively (Pierani et al., 1999). Shh induction 
commits the floor plate cells in ventral neural tube to initiate additional Shh expression 
(Briscoe et al., 1999; Roelink et al., 1995). The gradient of the roof- and floor plate 
secreted proteins together with their down-stream targets commit interneurons in the 
spinal cord (Lumsden and Krumlauf, 1996). The same dorsal-ventral signals are also 
involved in patterning of the hindbrain, midbrain and much of the forebrain (Kandel et 
al., 2000).  
From neural stem cells to precursors Review of the Literature
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Figure 3. Dorsal-ventral patterning of the neural tube is guided by gradient of BMPs and 
Shh. (Modified from Gilbert, 2008)
1.2.2 Development of peripheral nervous system (PNS)
The PNS consists of the somatic and autonomic nervous systems, and the latter can be 
divided to sympathetic-, parasympathetic- and enteric nervous systems. Unlike CNS, 
PNS is derived from the neural crest (Le Douarin et al., 2004).
Neural crest
In mammals, neural crest is a transient cell lineage that holds an extensive plasticity and 
high migration capacity. The neural crest is formed from the dorsal neuroectoderm in the 
area where ectoderm and neural tube connect. During neural tube formation, BMPs, 
Wnts, and FGFs induce expression of transcription factors, the neural plate border 
specifiers, such as Distalless-5 and Pax-3, which prevent the neural crest becoming either 
epidermis or neural plate (Huber, 2006). Consequently, this induces expression of another 
set of transcription factors, the neural crest specifiers, such as Snail, FoxD3 and RhoB. 
FoxD3 is critical for specification of ectodermal cells into neural crest cells (NCCs), and 
Snail and RhoB are required for neural crest migration (reviewed in Sauka-Spengler and 
Bronner-Fraser, 2006). Prior to the migration, the NCCs undergo epithelial-to-
mesenchymal transformation and loose their attachment. RhoB is thought to be involved 
in cytoskeletal modifications needed for the migration, whereas Snail affects the cell-to-
cell attachment (reviewed in Cheung et al., 2005). 
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Figure 4. Left panel: Neural crest regions in chicken embryo. Right panel: Neural crest 
migratory pathways: A) ventrolateral and B) dorsolateral routes. (Modified from Gilbert, 
2008). 
 
The neural crest can be divided into four regions that have their own derivatives: cranial, 
trunk, vagal/sacral, and cardiac neural crests (Figure 4). In mammals, the cranial neural 
crest starts to migrate while the neural tube is still folding whereas in the trunk area the 
migration is initiated when the neural tube is closing (reviewed in Gilbert, 2008). The 
cranial NCCs migrate dorsolaterally and form the facial and neck structures including a 
proportion of cranial neurons and glial cells. Also NCCs that differentiate into 
melanocytes migrate dorsolaterally (Figure 4) into embryonic ectoderm and towards 
ventral midline (Gilbert, 2008). In addition to pigment cell formation, this NCC 
population can also differentiate into neurons, cartilage and connective tissue. Contrary to 
cranial NCCs, the cells in trunk, vagal, sacral and cardiac regions migrate along the 
ventral migration route (Figure 4) (Gilbert, 2008). The cardiac neural crest, which is 
located between the cranial and trunk area, contributes to formation of the septum and the 
walls of large arteries in heart. Whereas, sensory (dorsal root ganglia) and sympathetic 
ganglia are derived from the trunk neural crest, and parasympathetic and enteric ganglia 
from vagal and sacral regions (Gilbert, 2008). The epinephrine secreting chromaffin cells 
in adrenal medulla are also derived from trunk neural crest.  
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Sympathetic nervous system development 
 
The sympathetic nervous system (SNS) is derived from trunk NCCs that migrate through 
the ventrolateral migratory pathway (Fraser and Bronner-Fraser, 1991). During the 
migration, the NCCs are surrounded by extracellular matrix proteins, such as laminin, 
fibronectin, tenascin, different types of collagen and proteoglycans that promote the 
migration (Testaz and Duband, 2001). The extracellular matrix protein trombospondin is 
expressed in the anterior but not in the posterior part of the somites and is important in 
guiding the migration as well (Tucker et al., 1999). Permissive signals as well as 
repulsive signals are essential to NCC migration. EphrinB1 is one of the inhibitory 
transmembrane proteins that localizes in the cells in posterior part of the somite (Wang 
and Anderson, 1997). Blocking of either EphrinB1 or its receptor EphB2 leads to 
disrupted formation of the sympathetic ganglia (Kasemeier-Kulesa et al., 2006). Class 3 
secreted semaphorin Sema3F is also expressed in the posterior somite while the migrating 
NCCs express its receptor Neuropilin 2 (Nrp2) (Chen et al., 2000; Giger et al., 2000). 
Nrp-2-deficiency results in loss of segmental NCC migration pattern while the cells 
migrate through both anterior and posterior part of the somite (Gammill et al., 2006). In 
addition, Sema3F is also involved in the repulsive guidance of the axons (Chen et al., 
2000; Giger et al., 2000). Also Sema3A and its receptor Nrp1 play role in sympathetic 
ganglia chain migration since both Sema3A and Nrp1-deficient mice show dislocation of 
in sympathetic neurons and their progenitors (Kawasaki et al., 2002).  
 
After the migration, these pre-sympathetic progenitors aggregate laterally to dorsal aorta, 
form immature sympathetic ganglia chain and undergo neuronal and catecholaminergic 
differentiation. The early sympathetic progenitors initiate expression of neuronal class β 
tubulin, neurofilament (NF), SCG10 and other neuronal markers. Also the expression of 
enzymes needed for the synthesis of noradrenaline such as tyrosine hydroxylase (TH) and 
dopamine beta-hydroxylase (DβH) is initiated (reviewed in Huber, 2006; LaBonne and 
Bronner-Fraser, 1999). Cell adhesion molecule N-cadherin is transmembrane protein 
needed for the patterning of the sympathetic ganglia (Kasemeier-Kulesa et al., 2006). 
Sympathetic progenitors start express N-cadherin prior to aggregation of the ganglia (Pla 
et al., 2001), and a dominant negative form of N-cadherin has been shown to disturb the 
normal ganglia compaction (Kasemeier-Kulesa et al., 2006).  
 
Also several growth factors such as GDNF family members GDNF and artemin (ARTN), 
neurothropins nerve growth factor (NGF) and Neurothropin-3 (NT-3) and their receptors 
and are needed for normal SNS development (Figure 5). BMPs are known to promote 
differentiation of sympathetic neurons and bHLH transcription factors such as Mash-1, 
Phox2a and Phox2b, and zinc finger transcription factors GATA3 are required for 
initiation and maintenance of noradrenergic phenotype in sympathetic cells (Figure 5). 
These factors and their role in SNS development will be discussed in differentiation of 
sympathetic lineage cells and growth and survival factors of GDNF-family chapters. 
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Figure 5. Factors that regulate development of sympathetic nervous system. GDNF 
family growth factors GDNF and ARTN and their receptors are important for migration, 
proliferation and survival of early sympathetic progenitors. Migration and aggregation of 
the cells) is guided by Sema3A and Sema3B, EphrinB1 and their receptors Nrp1, Nrp2 
and EphB2, respectively. N-cadherin is needed for aggregation of early SGC. Dorsal 
aorta (DA) derived BMPs and neuregulins promote SPC differentiation and transcription 
factors such as Mash-1, Phox2a, Phox2b and GATA3 are required for initiation and 
maintenance of noradrenergic phenotype in sympathetic cells. Later, while SGC matures, 
the GFLs switch to promote survival and target innervation of mature sympathetic 
neurons and NGF and NT-3 function as target-derived survival or differentiation factors. 
NCCs = neural crest cells, SGC = sympathetic ganglia chain, NT = neural tube. 
 
1.3 NEURAL STEM CELLS  
 
Neural stem cell (NSC) can be defined as a cell 1) that is nervous system derived or can 
generate neural tissue, 2) it has proliferation- and self-renewal capacity, 3) and 
multipotency to differentiate into three different neural cell lineages: neurons, astrocytes 
and oligodendrocytes (Gage, 2000; McKay, 1997). NSCs can be derived not only from 
nervous system but also from pluripotent embryonic stem cells (ES cells) or 
reprogrammed fibroblasts (Brustle et al., 1999; Thomson et al., 1998; Wernig et al., 
2008).  
 
NSCs and neural progenitors (NPCs) are commonly cultured as neurospheres that are a 
heterogenous population of undifferentiated NSCs, NPCs and cells at the various stages 
of differentiation (reviewed in Jensen and Parmar, 2006, Kornblum, 2007). The 
neurosphere culture system was the first in vitro system to demonstrate that the adult 
brain contains cells that have characteristics of true NSCs (Reynolds et al., 1992, 
Reynolds and Weiss, 1996). The system is still a useful tool to analyze proliferation, self-
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renewal capacity and multipotency of NSCs and NPCs (Jensen and Parmar, 2006). 
However, the major problems of neurosphere assay are that it is sensitive to culture 
methods used. Different concentration of factors in the medium, method and frequency of 
passasing, sphere size, number of passages after isolation lead to different cell properties 
within the spheres (Jensen and Parmar, 2006). Moreover, variations in cell density alter 
the microenvironment and this may affect cell proliferation for instance (reviewed in 
Jensen and Parmar, 2006). This sensitivity may lead to difficulties to compare the data 
between different research groups or even to interpret the results within the same study 
(reviewed in Jensen and Parmar, 2006). 
 
Regardless of these weaknesses the neurosphere culture system is valuable tool to study 
neurogenesis and neural development in vitro. With this system, it is possible to assess 
intrinsic cell specification at various developmental timepoints without interference of the 
extrinsic cues provided by an in vivo environment. Moreover, the intrinsic cell properties 
can be easily modulated, for example by using viral vectors, and the extrinsic cues can be 
changed by modifying the culture condition. In addition, NSCs and NPCs cultured in 
neurospheres have shown to behave as their temporal and spatial in vivo correlates in 
fetal brain and maintain expression of many developmental genes by region specific 
manner after several passages depending on the area of collection. However, as is the 
case for any other cell, culturing NSCs changes their properties so it cannot be assumed 
that the studies necessarily imply similar mechanisms in vivo (Kornblum, 2007). 
 
1.3.1 NSC niche 
 
In the nervous system, NSCs and progenitors occupy a tissue specific niche. In the adult 
CNS, the majority of NSCs are located in the subventricular zone (SVZ) of 
thetelencephalic lateral ventricles next to ependymal cells that separate SVZ from lateral 
ventricles and cerebrospinal fluid secreted by endothelial cells in choroid plexus. In SVZ, 
NSCs are closely associated with microvessels (Palmer et al., 2000; Ward and Lamanna, 
2004) and the endothelial cells have shown to promote maintenance of NSCs (Mompeo 
et al., 2003; Shen et al., 2004). Neurons and endothelial cells can communicate with each 
other via VEGF-A, neurotrophins and their cognate receptors (Chow et al., 2001; Kim et 
al., 2004a). Therefore, the neurovascular niche may play important role in adult stem cell 
maintenance. 
 
1.3.2 CNS stem cells and progenitors  
Stem cells during CNS development 
 
In embryos, NSCs are found in several regions such as cerebellum, hippocampus, 
cerebral cortex, basal forebrain and spinal cord (reviewed in Temple, 2001). Primary 
sphere-formation assays indicate that the stem cells are prevalent at early developmental 
stages but the number of CNS NSCs declines rapidly during embryonic development 
(Mayer-Proschel et al., 1997; Qian et al., 2000). In rats, 50% of spinal cord cells are able 
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to form neurospheres at embryonic day (E) 8 (Kalyani et al., 1998; Mayer-Proschel et al., 
1997). However, by E12 the number sphere-forming cells had decreased to 10%, and at 
first postnatal day (P1) only 1% of the cells showed sphere formation (Kalyani et al., 
1998; Mayer-Proschel et al., 1997).  
 
During early development, the neuroepithelial cells express markers such as 
transmembrane protein prominin 1 (CD133) (Weigmann et al., 1997) and intermediate 
filament protein nestin (Hartfuss et al., 2001). In mouse, the neuroepithelial cells give 
raise to radial glia that replace most of the neuroepithelial cells by E12 (Hartfuss et al., 
2001; Kriegstein and Gotz, 2003; Noctor et al., 2002). Radial glia express markers such 
as CD133, astrocyte specific glutamate transporter (GLAST), Ca2+-binding protein 
S100β, glial fibrillary acidic protein (GFAP), vimentin, and brain-lipid-binding protein 
(BLBP) (Kriegstein and Gotz, 2003). Most of the radial glial cells form neurons during 
neurogenesis and later either astrocytes or oligodendocytes (Malatesta et al., 2000; 
Noctor et al., 2002; Noctor et al., 2004). Therefore, the majority of neurons are derived 
either directly or indirectly from radial glial cells (Anthony et al., 2004; Malatesta et al., 
2003). In developing CNS, a third cell type appears at the onset of neurogenesis and it is 
called as basal progenitor or neuroblast. Basal progenitors originate from the 
neuroepithelial and radial glial, and they form SVZ and contribute to neurogenesis 
(Haubensak et al., 2004; Noctor et al., 2004). Basal progenitors differ from 
neuroepithelial and radial glial cells by the expression of specific transcription factors 
such as TRB2 (Englund et al., 2005), Cux1 and Cux2 (Nieto et al., 2004).  
Stem cells in adult CNS 
 
In the adult CNS, NSCs are found only in certain locations such as SVZ of telencephalic 
lateral ventricles and subgranular zone (SGZ) of hippocampal dentate gyrus (Cassidy and 
Frisen, 2001; Doetsch et al., 1999). Some other regions contain also NSC-like cells that 
show lower differentiation potential than NSCs (Kornblum, 2007; Jensen and Parmar, 
2006; Temple, 2001; Gage, 2000; McKay, 1997). Four cell types are found in adult SVZ: 
ependymal cells that are located in ventricle wall, slowly proliferating astrocytes that 
show radial glia-like features (type B cells), fast-proliferating intermediate cell type C, 
and neuroblasts or neural progenitors (type A cells) (Sohur et al. 2006; Alvarez-Buylla et 
al., 2001; Doetsch et al., 1999) (Figure 6).  
 
SVZ astrocytes express markers such as GFAP, nestin and vimentin (Jankovski and 
Sotelo, 1996; Peretto et al., 1999). Both astrocytes and neural progenitors (B and A cells) 
form neurospheres in vitro (Sohur et al. 2006; Alvarez-Buylla et al., 2001; Doetsch et al., 
1999). Since radial glia function as NSCs in the developing CNS, it as been hypothesized 
that perhaps also SVZ astrocytes could function as stem cells or progenitors in adult CNS 
(for review see Yadrigi and Marino, 2009; Sohur et al. 2006; Temple, 2001).  
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Figure 6. Frontal schematic of adult mouse brain and the cell types in SVZ. E= 
ependymal cells, A = neural progenitors, B = astrocytes, C = intermediate cells, LV = 
lateral ventricle (Modified from Doetsch et al., 1999)  
 
1.3.3 PNS stem cells and progenitors 
 
Prior the migration NCCs can be considered pluripotent cells. However, only certain 
areas of the neural crest can contribute to formation of the PNS (reviewed in Le Douarin 
et al., 2004). In chicken, the vagal neural crest located between somites 1 and 7 gives rise 
to the enteric ganglia, and the thoracic neural crest located between somites 18 and 24 
gives rise to the sympathetic ganglia chain and adrenal medulla (Le Douarin et al., 2004). 
Several chicken-quail grafting experiments have shown that NCC fate is determined by 
the environmental signals during the migration and at the final destination (Le Douarin et 
al., 2004).  
 
During embryogenesis, both sensory and autonomic ganglia contain undifferentiated non-
neural cells that can be considered as putative neural crest stem cells since they 
proliferate, remigrate and differentiate when transplanted into environment of the 
younger host (Duff et al., 1991; Hagedorn et al., 1999; Hagedorn et al., 2000; Le Douarin 
et al., 2004). Peripheral nerves and enteric plexuses (Bixby et al., 2002; Kruger et al., 
2002; Morrison et al., 1999; Nataf and Le Douarin, 2000) also contain these 
undifferentiated pluripotent cells. The progenitors can be found in these areas until late in 
development, and even during postnatal and adult life (Kruger et al., 2002). At least, the 
cells isolated from enteric-, and sciatic nerves and DRG boundary caps show capacity for 
self-renewal (Bixby et al., 2002; Kruger et al., 2002; Morrison et al., 1999). Also 
epidermal melanocytes and peripheral Schwann cells show reciprocal 
transdifferentitation (Dupin et al., 2000; Dupin et al., 2003). Endothelin-3 treatment of 
melanocytes or Schwann cells induces cell proliferation and gives rise of clonal progeny 
that contains both melanocytes and Schwann cells indicating that these cells can reverse 
their fate to bipotent glia and melanocyte producing progenitors (Dupin et al., 2000; 
Trentin et al., 2004). Adult mouse Schwann cells can also generate melanocytes after 
severe peripheral nerve injury (Rizvi et al., 2002).  
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1.4 DIFFERENTIATION 
 
Differentiation of nervous system cells is a multi-step process that includes proliferation, 
migration and terminal cell cycle exit. The formation of new neurons (neurogenesis) 
involves also neurite outgrowth, synapse formation and apoptosis. It has been estimated 
that the human nervous system contains hundreds of different types of neurons, but glial 
cells such as astrocytes and myelinating oligodendrocytes or Schwann cells in PNS are 
still most predominant cells in adult nervous system.  
 
1.4.1 NSC progeny in CNS 
Neurogenesis 
 
During embryo development, neuroepithelial cells that are connected to the lumen of the 
neural tube (ventricular germinal zone) start to differentiate and migrate “inside-out” in 
CNS (Chenn and McConnell, 1995). In mouse CNS, most of the neurons are formed 
between embryonic stage E10 and E13. After the onset of neurogenesis, the 
neuroepithelial cells give rise to radial glia that show residual neuroepithelial and 
astroglial properties and replace the neuroepithelial cells (Kriegstein and Gotz, 2003). 
Generic neural fate is promoted by certain basic helix-loop-helix (bHLH) transcription 
factors that activate the cascade of neuronal genes, which support the cell cycle exit and 
inhibit gliogenesis.  
 
One essential transcription factor in neural differentiation in both CNS and PNS is Mash1 
(Porteus et al., 1994, Guillemot et al., 1993). In CNS, Mash1-deficient mice show severe 
brain defects in basal ganglia, cerebral cortex and olfactory bulb due to loss of neuronal 
progenitor cells (Casarosa et al., 1999; Cau et al., 2002). Another group of neuronal 
bHLH transcription factors are neurogenins (Ngns), Ngn1 and Ngn2, which define 
distinct progenitor populations and are highly expressed in dorsal ventricular zone in the 
developing nervous system (Sommer et al., 1996). Transient expression of Mash1 and 
Ngns is sufficient to initiate neuronal differentiation also in mouse embryonic carcinoma 
cells (Farah et al., 2000). Mash1 and Ngns not only activate the expression of neuronal 
bHLH genes such as NeuroD and Math3 (Cau et al., 2002; Ma et al., 1998), but they also 
promote cell cycle exit. All of these factors can inhibit the cell cycle by inducing the 
expression of cyclin dependent kinase inhibitors, including p27 (Farah et al., 2000). 
Mash1 and Ngns are also involved in inhibition of gliogenesis since Mash1/Ngn2-
deficient mice show compensatory premature generation of astrocytic progenitors both in 
vivo and in vitro (Nieto et al., 2001). Ngn1 has been shown to suppress leukemia 
inhibitory factor (LIF)-induced gliogenesis through Smad1-p300 complex in cultured 
progenitors (Sun et al., 2001).  
 
In several cell types including the brain cells, differentiation is also regulated by 
CCAAT/enhancer-binding protein (C/EBP) transcription factor family (Cao et al., 1991; 
Yeh et al., 1995, Sterneck and Johnson, 1998). Activation of C/EBPs results in enhanced 
neural differentiation in cortical progenitors (Davis, 1995). Moreover, overexpression of 
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active C/EBP has been shown to enhance neurogenesis by directly activating neuronal 
genes such as neuronal class β tubulin and by preventing ciliary neurotrophic factor 
(CNTF) induced gliogenesis (Menard et al., 2002). 
 
Astrocyte differentiation  
 
Most of the astrocytes are produced in a second wave of neural differentiation that takes 
place at E12-P0 in mouse. Both astrocytes and oligodendrocytes are originated from the 
same progenitors, which become progressively more restricted. Tripotential glial-
restricted progenitors (GRP) arise directly from NSCs and can generate two different 
types of astrocytes and oligodendrocytes (Herrera et al., 2001). GRPs differentiate further 
into more restricted progenitors, which differentiate into one type of astrocytes and 
oligodendrocytes (Skoff and Knapp, 1991).  
 
In CNS, factors such as Notch, CNTF, LIF and BMP-2 influence glial fate decisions 
(Morrison et al., 2000; Morrow et al., 2001). Notch promotes both NSC maintenance and 
gliogenesis by activating transcription of Hes genes (Corbin et al., 2008; Morrison et al., 
2000), and BMP-2 and LIF induce astrocyte differentiation in synenergy by activating 
respectively Smad1/4 and STAT1/3 transcription factors in telencephalic NPCs 
(Nakashima et al., 2001). Also CREB-binding protein (CBP)/p300 transcriptional co-
activator, the adaptor molecule of STAT-Smad interaction, can directly activate glial 
factors such as GFAP (Nakashima et al., 1999). BMP-Smad pathway induces expression 
of bHLH transcription factors Hes5 and inhibitor of differentiation (Id)-family that can 
interfere the action of proneural transcription factors (Nakashima et al., 2001). Ids have 
been shown to prevent premature differentiation of neurons and oligodendrocytes but not 
astrocyte differentiation (Ross et al., 2003).  
 
Generation of oligodendrocytes 
 
Formation of oligodendrocytes occurs later in development starting at E16 in mouse and 
ending postnatally, when the synaptic connections have been established and neurons are 
surrounded by supportive glia. However, oligodendrocyte progenitors (OPs) can be found 
as early in development as at E11 in mouse (Thomas et al., 2000). In rodents, OPs are 
first found in the ventral part of the developing neural tube and brainstem and have been 
found to express platelet derived growth factor receptor α (PDGFRα) (reviewed in 
Nishiyama et al., 2009). The PDGFRα positive OPs are derived from a subset of ventral 
neuroepithelial cells (Tekki-Kessaris et al., 2001) under influence of notochord derived 
Shh that is required for oligodendrocyte differentiation (Lu et al., 2000). Soon after OPs 
start show NG2 expression followed by Olig-2 and immature oligodendrocyte antigen O4 
expression (reviewed in Nishiyama et al., 2009). These immature oligodendrocytes 
downregulate NG2 and O4, and initiate galactocerebrocide expression as the cells 
differentiate further into premyelinating oligodendrocytes. Mature myelinating 
oligodendrocytes express markers such as galactocerebrocide and myelin basic protein 
(MBP) but Olig-2 expression is downregulated (Nishiyama et al., 2009). Transcription 
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factor Sox10 have been implicated in oligodendrocyte differentiation and its expressed in 
OPs and throughout the oligodendrocyte development (Nishiyama et al., 2009; Stolt et 
al., 2002) 
 
1.4.2 Differentiation of sympathetic lineage cells in PNS 
 
Differentiation of sympathetic neurons is promoted by BMPs derived from dorsal aorta 
whereas neuregulin directs the cells into glial fates (Reissmann et al., 1996; Shah et al., 
1996). In sympathetic cells, BMPs activate bHLH transcription factors including Mash1 
(Lo et al., 1991), eHand (Cserjesi et al., 1995), dHand, paired homeodomain transcription 
factors Phox2a and Phox2b (Pattyn et al., 1997), and zinc finger transcription factors 
GATA2 and GATA3 (Groves et al., 1995). According to previous studies, Mash1 is not 
required for neuronal fate decision in sympathetic cells but it may promote the 
development of already committed cells. In Mash1-deficient mouse embryos, the early 
sympathetic cells migrate and aggregate to dorsal aorta normally and undergo at least part 
of their normal differentiation program before becoming apoptotic (Guillemot et al., 
1993). Mash1-deficiency leads to a loss of PNS neuronal markers such as SCG10 and 
peripherin (Sommer et al., 1995). Moreover, Mash1 has been shown to activate Phox2a 
that positively regulates noradrenergic characteristics and is required for TH and DβH 
expression (Hirsch et al., 1998). However, Mash-1-deficiency does not affect the 
expression of early sympathetic markers like Phox2b, receptor tyrosine kinase c-Ret, NF 
and Tuj-1 (Howard et al., 2000; Huber et al., 2002; Huber, 2006). Phox2b is expressed in 
all peripheral and CNS noradrenergic neurons and in the majority of neurons that are 
integrated in autonomic reflex pathways (Pattyn et al., 1997). Phox2b-deficient mouse 
embryos die at midgestation, and they have abolished neurogenesis (Huber, 2006). 
Phox2b has shown to regulate Hand2 expression, which is needed for the maintenance of 
noradrenergic phenotype in sympathetic cells (Howard et al., 2000; Huber et al., 2002). 
Mouse sympathetic cells express also both GATA2 and GATA3, and in GATA3-deficient 
mouse embryos, the primary sympathetic chain seems to be largely intact but in later 
stages the neurons loose TH expression and cells show increased apoptosis (Takahashi et 
al., 2000; Tsarovina et al., 2004). 
 
Development and maintenance of the sympathetic cells are also dependent on certain 
growth factors. NGF is important for differentiation of sympathetic cells and NGF-
mutant mice suffer dramatic loss of both sensory- and sympathetic cells (Crowley et al., 
1994). Lack of NGF high affinity receptor TrkA (Meakin and Shooter, 1992) leads to 
similar phenotype in sensory and sympathetic neurons (Smeyne et al., 1994). NT-3 is also 
one of survival or differentiation factors essential for maintenance of mature sympathetic 
neurons during later development (Kuruvilla et al. 2004). GDNF family members such as 
ARTN and GDNF are involved in sympathetic ganglia chain development and 
maintenance (reviewed in Francis and Landis, 1999). 
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1.5 SELF-RENEWAL 
 
Self-renewal is clonal proliferation that generates one or two daughter cells that acquire 
the same cell fate as the dividing cell. Self-renewing cells are important for replenishing 
specialized cells in tissue repair but also maintain the normal turnover of regenerative 
organs. Sphere-forming capacity is commonly used to analyze NSC or NPC self-renewal 
(reviewed in Jensen and Parmar, 2006). Due to lack of specific markers it is difficult to 
precisely determine that NSC has produced a true copy of itself and therefore self-
renewal is often operationally defined as the degree of to which NSC can raise to 
colonies e.g. neurospheres (reviewed in Kornblum, 2007). The neurosphere forming 
assay is the best available functional assay for NSC self-renewal as long as it is carefully 
performed, tested over serial clonal passaging and followed by in vitro differentiation to 
show multipotency of the individual spheres (reviewed in Jensen and Parmar, 2006).  
 
It is known that only small percentage of cells within the neurosphere has the capacity for 
self-renewal (Reynolds and Weiss, 1992) and even a smaller percentage of the cells meet 
the definitions of true NSC. Ensuring the clonality is sometimes difficult because the 
culture conditions to generate individual cells are quite harsh and floating cells tend to 
aggregate especially if plated in too high density (reviewed in Kornblum, 2007). Several 
groups have shown sorting of NSCs based on such as cell size or on LeX antigen in 
murine samples (Rietze et al. 2001, Capela and Temple, 2002), or prominin (CD133) 
expression in fetal human samples (Uchida et al. 2000). These methods are frequently 
used to enrich self-renewing NSCs (Kornblum, 2007). Unfortunately, these techniques 
still can lead to cell loss and therefore may diminish the yield of NSCs (Kornblum, 
2007). To date there is no set of markers that precisely identifies a NSC from more 
limited progenitors (Kornblum, 2007). 
 
1.5.1 Symmetric and asymmetric cell division 
 
In vertebrate cortical differentiation, symmetric and asymmetric cell divisions are 
distinguished by orientation of mitotic spindle towards the cell cleavage plane (Chenn 
and McConnell, 1995) (Figure 7). In developing neural tube, the number of 
neuroepithelial cells is first increased by the proliferative symmetric cell divisions. In 
symmetric cell division, the mitotic spindle and cleavage plane are vertical to respect of 
apical (ventricle side) plasma membrane (Gotz and Huttner, 2005). Later during 
differentiation, the cells begin to show also asymmetric cell divisions that occur in 
horizontal cleavage plane and result in one mother-cell-like cell and a second more 
differentiated cell, such as a progenitor or neuron. In spinal cord, symmetric cell divisions 
have shown more regularly to be related to production of two identical daughter cells, 
either progenitors or neurons (Wilcock et al., 2007) (Figure 7). 
 
 Stem cell self-renewal capacity is unlikely limited to only one certain cleavage plane 
orientation even though the symmetrically dividing cells show higher tendency for self-
renewal. The different orientation of mitotic spindle allows different partition of the cell 
fate determinants into daughter cells (Haydar et al., 2003). The asymmetrically 
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distributed molecules play important role in cell fate determination and some of these 
factors will be discussed in the next chapter. It has been hypothesized that also the cell 
cycle length is involved in cell fate determination (Gotz and Huttner, 2005). If the cell 
cycle length is short, the cell fate determinants may not have enough time to induce 
differentiation, and both daughter cells adopt the stem cell or progenitor fate and continue 
proliferation. Consequently, in longer cell cycle, the cell fate determinants have more 
time to affect, which leads to differentiation and asymmetric or symmetric cell division 
depending on the cell cycle length (Gotz and Huttner, 2005). The mechanisms that 
determine spindle orientation, and transition from symmetric to asymmetric divisions are 
still poorly understood. 
 
 
Figure 7. A) Symmetric and asymmetric cell divisions. B) When NSCs differentiation 
starts the asymmetric cell divisions take place producing progenitors and neurons. C) 
Symmetric cell divisions more regularly occur in production of two identical cells: for 
example two self-renewing progenitors or two neurons (Modified from Huttner and 
Kosodo, 2005, and Gotz and Huttner, 2005). 
 
From neural stem cells to precursors   Review of the Literature 
 
 25 
1.5.2 Control of NSC self-renewal  
1.5.2.1  Transcription related factors  
Notch 
 
Notch signaling pathway and its downstream targets play important role in NSC fate 
decision. In Drosophila, lateral inhibition mediated by Notch receptor controls the 
production of all neuronal cells (Artavanis-Tsakonas et al., 1999). In mammals, during 
CNS development Notch1 is expressed in SVZ and ventricular zone (VZ) cells, and 
cultured neurospheres and its ligands delta and jagged are expressed in differentiating 
cells (Corbin et al. 2008; Irvin et al., 2001). Inhibition of Notch pathway causes 
premature neurogenesis, whereas expression of active form of Notch suppresses 
differentiation (Hitoshi et al., 2002). Moreover, Notch signaling also induces glial 
differentiation (Gaiano et al., 2000).  
 
The mechanism how Notch inhibits neural differentiation and maintains undifferentiated 
cell fate is understood in some detail. Binding of Notch ligands and activation of Notch 
receptor leads to transcriptional activation of its target genes such as Hes genes (Iso et al., 
2003). Both Hes1 and Hes5 are expressed in SVZ and in cultured NPCs, and they have 
been shown to be required for Notch signaling and the maintenance of NSC pool 
(Ohtsuka et al., 2001). Hes-transcription factors can repress the activity of genes such as 
proneural Mash1 by binging to N and E box regulatory region of the target genes (Iso et 
al., 2003). Notch pathway is also important in other tissues: in mouse intestine Notch 
amplifies progenitor pool and inhibits differentiation (Fre et al., 2005), and in muscle 
Notch is a key determinant of muscle regenerative potential that declines with age 
(Conboy et al., 2003). Notch signaling is also important for angiogenesis and vascular 
development (see VEGF subfamily chapter) during normal development and in tumors 
(Rehman and Wang, 2006). Moreover, Notch signaling is implicated at least in T-cell 
leukemia, breast and colon adenocarcinomas, and cervical cancer and it also has a 
potential role in brain tumorigenesis (Rehman and Wang, 2006). Recently it was shown 
that Notch gradient in apical-basal interkinetic nuclear migration regulates neurogenesis 
in retina (Del Bene et al., 2008). 
 
Numb 
 
Numb and Numb-like (Numbl) proteins are asymmetrically distributed in the daughter 
cells and are thought to play a key role in NSC fate decisions (Cayouette and Raff, 2002). 
In mammals, Numb localizes at the ventricular surface especially near adherens junctions 
and after asymmetric division it is segregated to the cell that remains as progenitor (Kim 
and Walsh, 2007; Petersen et al., 2002). Numb-deficient mouse embryos die at E11 
showing premature neurogenesis in forebrain (Zhong et al., 2000). In mouse, conditional 
knockout of Numb in Numb-like-deficient background results in transient over-production 
of neurons and severe loss of progenitors at E10, which indicates that Numb is required 
for self-renewal (Petersen et al., 2002). It has also been suggested that Numb has 
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different functions during nervous system development. In early development, it has a 
role in maintaining progenitors (Petersen et al., 2002) but later it also promotes neuronal 
differentiation (Zilian et al., 2001). In Drosophila, Numb is shown to antagonize Notch 
signaling in formation of interneurons (Spana and Doe, 1996). 
 
Bmi-1 
 
Bmi-1 is one of the polycomb group proteins (PcGs) that are known as epigenetic 
chromatin modifiers. PcGs silence genes by means of deacetylation, methylation and 
possibly also by inhibiting the transcription initiation machinery itself (Valk-Lingbeek et 
al., 2004, Dellino et al., 2004). PcGs play role in both self-renewal and cancer 
development. Bmi-1 is needed for self-renewal and proliferation of several stem cell 
types including cerebellar NPCs. Bmi-1 effects on self-renewal are mediated through the 
inhibition of certain tumor suppressor proteins in adults (Molofsky et al., 2003). Bmi-1 is 
also expressed in several cancers and cancer stem cells (Bea et al., 2001; Hemmati et al., 
2003; Kim et al., 2004b). In cerebellum, Bmi-1 is extracellularly regulated by Shh 
(Leung et al., 2004). Moreover, Bmi-1 regulates three Hox genes in NSCs: Hoxd8, 
Hoxd9 and Hoxc9 (Molofsky et al., 2003).  
 
1.5.2.2 Cell cycle 
 
Cell cycle is the period from cell division to another and it has four phases: G1, S, G2 and 
M. During G1 the cell grows and prepares for DNA replication. This is followed by S-
phase when DNA is synthesized and centrosomes are duplicated. In G2-phase, the cell 
prepares for mitosis and during M-phase the cell divides. The cell cycle of post mitotic, 
differentiated cells is arrested from G1 to G0, the quiescent stage (Figure 8). 
 
In eukaryotic cells, the cell cycle is regulated by a small number of heterodimeric protein 
kinases that contain regulatory subunits cyclins and catalytic subunits cyclin-dependent 
kinases (CDKs). Cyclin concentrations vary depending on cell cycle phase and their 
association with CDKs leads to activation of several cell cycle related proteins and 
transcription of multiple genes (Galderisi et al., 2003) (Figure 10). One group of activated 
genes is E2F transcription factors that are required for G1-S transition and expression of 
several important genes, such as CDK2, cyclins A and E (Stiegler et al., 1998).  
 
Cell division and DNA replication are monitored at four key checkpoints. Cyclin kinase 
inhibitors (CKIs) and tumor suppressors p53 and pRb molecules can silence the cell cycle 
in G1/G0 for example due to DNA damage. Unlike other cells, NSCs and progenitors 
undergo interkinetic nuclear migration between apical (ventricle) and basal cell surface 
so that M-phase always occurs at the apical surface and S-phase in more basal locations 
(Murciano et al., 2002). The relevance of the interkinetic nuclear migration is currently 
unknown. 
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Figure 8. Cell cycle and its regulation. Cyclin concentrations vary depending on phase of 
the cell cycle and their association with CDKs leads to activation of several cell cycle 
related proteins and transcription of multiple genes. p16INK4a inhibits the activity of cyclin 
D-CDK4/6 and keeps pRb hypophosphorylated, which prevents E2F activation and 
blocks the cells from exiting the G1 phase. p19Arf blocks the cell cycle by inhibiting 
Mdm2 (Sherr and Weber, 2000), the inhibitor of tumor suppressor p53. p53 promotes cell 
cycle arrest predominantly by transcriptionally activating p21Cip1, which subsequently 
inhibits CDK activity and blocks the cell cycle at G1 or G2. 
 
Cyclin kinase inhibitors (CKIs) 
 
INK4/Arf tumor suppressor proteins p16INK4a, p15INK4b, p18INK4c and p19Arf can arrest the 
cells at G1 phase. Tumor suppressor p16INK4a inhibits the activity of cyclin D-CDK4/6 
and keeps pRb hypophosphorylated, which prevents E2F activation and blocks the cells 
from exiting the G1 phase. p19Arf blocks the cell cycle by inhibiting Mdm2 (Sherr and 
Weber, 2000), the inhibitor of tumor suppressor p53 (Bates et al., 1998; Xiao et al., 
1995). Loss-of-function mutations in Ink4a/Arf locus are common in cancers, especially 
in glioblastoma (Ekstrand et al., 1991; Hayashi et al., 1997). Increased expression of 
p16INK4a and p19Arf is associated with Bmi-1-deficiency, and loss of p16 INK4a partially 
rescues the self-renewal capacity in Bmi-1-deficient NSCs, which suggests that p16 INK4a 
controls also NSC self-renewal (Bruggeman et al., 2005; Molofsky et al., 2003). 
 
In mammals, the cell cycle arrest can also be initiated by CDK inhibitor proteins (CIPs) 
p21Cip1, p27Kip1 and p57Kip2 that inhibit CDK1-, CDK2, CDK4 and CDK6-cyclin 
complexes. p21Cip1 is one of the best studied CIPs which responses to DNA damage by 
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inhibiting CDK2 and arresting the cell cycle at G1 or G2 (Galderisi et al., 2003). p21Cip1 
plays an important role in cell cycle arrest, differentiation, DNA repair, cell senescence 
and apoptosis (reviewed in Sherr and Roberts, 1999), and its expression is regulated by 
several transcription factors, such as p53, C/EBP, STATs and Smads (reviewed in Gartel 
and Tyner, 1999) 
 
Tumor suppressor p53 
 
The p53 transcription factor and tumorsuppressor responds to multiple cellular stresses to 
regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or 
changes in metabolism. Also the other p53 family proteins, p63 and p73, can 
transactivate p53-responsive genes due to similar DNA binding domain and cause cell 
cycle arrest or apoptosis (reviewed in Murray-Zmijewski et al., 2006). However, p53, 
p63 and p73 not entirely functionally redundant, and genetic knockout models suggest 
that these proteins have their own roles in development and growth (Murray-Zmijewski 
et al., 2006). p53 activity is modulated by several posttranslational modifications such as 
phosphorylation and aceylation. In unstressed conditions, p53 is kept inactive essentially 
by ubiquitin ligase Mdm2 that inhibits transcription of p53 and promotes the protein 
degradation (Bourdon et al., 2007). All p53 family proteins have several isoforms due to 
multiple splicing and alternative promoters. p53 promotes cell cycle arrest predominantly 
by transcriptionally activating p21Cip1, which subsequently inhibits CDK activity (el-
Deiry et al., 1993).  
 
Besides controlling cell proliferation p53 also affects the cell differentiation.Several in 
vivo and in vitro studies have shown that addition of exogenous p53 promotes 
differentiation of different cell types (Almog and Rotter, 1997). In mouse, p53-deficiency 
frequently leads to spontaneous tumors, decreased fertility and neural tube closure defect 
in fore- and midbrain area that is called an excencephaly (Armstrong et al., 1995). 
Terminal differentiation of several cells including neurons involves changes such as cell 
cycle arrest, which is considered an irreversible step in differentiation (Miller et al., 
2003). Arguably the most important function of p53 in neurons is to prevent cell cycle re-
entry (Miller et al., 2003). Moreover, nuclear p53 can activate transcription of 
proapoptotic genes whereas cytoplasmic p53 directly activates proapoptotic proteins and 
induces apoptosis (Chipuk et al., 2005). p53 is mutated in approximately 50% of all the 
cancers and loss of p53 activity is considered to be universal to all cancers (Murray-
Zmijewski et al., 2006). The function of p53 is more complicated than has been thought 
since human p53 gene has been found to encode at least nine different isoforms (Bourdon 
et al., 2005). p53 variants are expressed in tissue dependent manner in several normal 
tissues and they seem to have distinct biochemical activities. Preliminary studies indicate 
that the balance between p53 and its different isoforms regulates cell fate in response to 
p53 activation (Bourdon et al., 2005). p53 also seems to accelerate the ageing of several 
tissues (Tyner et al., 2002). 
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Rb family proteins 
 
Rb family tumor suppressor proteins, pRb, p107 and p130, repress the cell cycle and their 
function is mainly accomplished by binding to E2F family members (Stiegler et al., 
1998). Rb family members are posttranslational regulated proteins and the 
phosphorylation leads to their functional inactivation. Phosphorylation of Rb family 
proteins is cell cycle related phenomenon and dependent on CDK4, CDK6 and CDK2 
(Sherr et al., 1996). pRb amino acid sequence is approximately 35% identical to p107 and 
p130, whereas p107 and p130 share 50% amino acid identity to each other (Claudio et al., 
2002). Rb family proteins can compensate each other at some level but they have distinct 
binding preferences to E2Fs and have tissue specific expression patterns (reviewed in 
Giacinti and Giordano, 2006). pRb preferentially binds to E2F1, E2F2, and E2F3, 
whereas p107 and p130 bind to E2F4 and E2F5 (Galderisi et al., 2003). Moreover, pRb 
represses gene transcription required for G1 to S phase transition (Wang et al., 2001). 
pRb also affects transcription by remodeling chromatin structure through interactions 
with factors such as histone deacetylase (Luo et al., 1998), methyltransferase (Robertson 
et al., 2003) and PcG proteins (Dahiya et al., 2001).  
 
Several human tumors show mutations or functional inactivation of pRb gene (Giacinti 
and Giordano, 2006), and pRb has a central role in various differentiation processes 
including CNS and PNS neurons, epidermal-, hair-, and muscle cells, melanocytes and in 
hepatocytes (Giacinti and Giordano, 2006). In developing brain, pRb is expressed in 
dividing progenitors and post mitotic cells (Lipinski and Jacks, 1999). pRb-deficient 
mouse embryos show severe defects in the CNS and hematopoietic system, and the 
phenotype is embryonic lethal at E14 (Lee et al., 1992; Macleod et al., 1996; Slack et al., 
1998). In neurons, pRb play a role at least in processes related to cell cycle (cell-
autonomous) and differentiation (non-cell-autonomous) (Liu et al., 2004).  
 
Both p107 and p130 have also role in neural differentiation. p107 expression is restricted 
to brain ventricular zone and subependyma, and it becomes downregulated at the onset of 
neurogenesis (Vanderluit et al., 2004). p107-deficient adult mice show increased self-
renewal and proliferation of neural progenitors but the tissue homeostasis is maintained 
by increased apoptosis (Vanderluit et al., 2004). In neural cells, highest p130 expression 
is found during and after terminal mitosis (Jiang et al., 1997; Yoshikawa, 2000). In some 
mouse strains p130-deficiency leads to no obvious defects (Cobrinik et al., 1996) but in 
others the phenotype is embryonic lethal at E11-E13 (LeCouter et al., 1998). The p130-
deficient mouse embryos display arrested growth, disorganization of the neural tissues, 
increased proliferation and apoptosis in CNS, reduced numbers of the neurons in the 
neural tube and in dorsal root ganglia (LeCouter et al., 1998).  
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Cytoskeleton, cytoskeletal tumor suppressor protein merlin and ERM protein ezrin 
 
The cytoplasm of eukaryotic cells contains a complex, dynamic network of filamentous 
proteins that form a structure called cytoskeleton. Actin is one of the three types of 
protein filaments found in the cytoskeleton, and it is essential for several cellular 
functions including in cell migration, morphogenesis, cytokinesis, establishment of 
cellular polarity, vesicle trafficking and intracellular signal transduction (reviewed in 
Ramaekers and Bosman, 2004). Such diverse roles are possible due to spatial and 
temporal control of actin filament assembly by several actin binding proteins (reviewed 
in Ayscough, 1998). In a variety of diseases, interactions between the actin cytoskeleton 
and cell membrane components are deregulated (reviewed in Ramaekers and Bosman, 
2004). In tumor cells, changes in actin expression, in actin associated proteins and in cell 
membrane-actin linker proteins are also involved in abnormal growth, metastasis and 
tissue adhesion (reviewed in Jordan and Wilson, 1998).  
 
Merlin and ezrin serve as linker proteins between the actin cytoskeleton and cell 
membrane components. They are involved in cell adhesion, cell movement, cell growth, 
cell membrane trafficking and signaling. Merlin, a cytoskeletal tumor suppressor protein 
(reviewed in Sun et al., 2002) is encoded by NF2 gene (Rouleau et al., 1993; Trofatter et 
al., 1993) and it belongs to BAND 4.1 protein superfamily. Lack of functional merlin is 
involved in tumorigenesis in dominantly inherited neurofibromatosis (NF2) disease 
(Louis et al., 1995). Merlin is a cytoskeleton-associated membrane organizing protein and 
therefore a unique type of tumor suppressor. In primary schwannoma cells, merlin 
overexpression reduces cell proliferation and promotes G0/G1 arrest (Schulze et al., 
2002). Respectively, suppression of merlin induces proliferation in schwannoma cells 
(Huynh and Pulst, 1996). In vitro, merlin is localized underneath the plasma membrane 
and it is mainly seen in membrane ruffles and filopodia (Gonzalez-Agosti et al., 1996; 
Sainio et al., 1997). In tissues, merlin is widely expressed but the expression levels are 
low especially in adults. The cell type distribution and subcellular localization are not 
well known.  
 
During mouse embryogenesis, merlin is highly expressed in heart, nervous system, 
extraembryonic tissue and skeleton (Huynh et al., 1996). In adult mouse and human 
merlin is expressed in lung, muscle, intestine, CNS, lens, spleen and kidney (Claudio et 
al., 1995; den Bakker et al., 1999). Nf2-deficient mouse embryos die at E7 due to 
collapsed extraembryonic region and absence of organized extraembryonic ectoderm 
(McClatchey et al., 1997). Heterozygous Nf2-mutants spontaneously develop several 
tumors such as osteosarcomas and hepatocellular carcinomas that show a loss of the wild 
type allele (McClatchey et al., 1997). In mice, conditional deletion of Nf2 in Schwann- 
and arachnoidal cells leads to schwannomas and meningeal neoplasias, respectively 
(Giovannini et al., 2000; Kalamarides et al., 2002). The mechanism by which merlin 
functions as tumor suppressor is not fully understood but it has been shown that merlin 
undergoes cycle-dependent nucleo-cytoplasmic shuttling (Muranen et al., 2005) and 
binds to cyclin B binding protein and cell cycle regulator HEI10 (Gronholm et al., 2006). 
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Ezrin (Gould et al., 1989; Turunen et al., 1989) is another member of BAND 4.1 protein 
superfamily and structurally related to merlin. Similarly to merlin also ezrin, the ERM 
(ezrin, radixin, moesin) family protein, is a linker protein between the actin cytoskeleton 
and cell membrane components (Bretscher et al., 2002). Ezrin has shown to have partial 
functional homology and able to form interactions with merlin (Gronholm et al., 1999). 
However, ezrin has the opposite effect on cell proliferation than merlin. Ezrin has been 
related to enhanced cell growth and metastasis and its expression is altered in several 
tumors (Bohling et al., 1996; Geiger et al., 2000; Yu et al., 2004). Overexpression of 
ezrin in fibroblasts increases the cell proliferation through loss of contact inhibition (Kaul 
et al., 1996). Ezrin has been shown also to participate in cell survival signaling through 
PI3K/Akt pathway (Gautreau et al., 1999). 
 
1.6 CLASSICAL ONCOGENES 
1.6.1 Human Papilloma Virus 16 E6/E7 oncogenes 
 
Traces of viral DNA are regularly found in human tumors, and some viruses and their 
oncogenes are directly implicated in cancer development (Lowe et al., 2007; Nevels et 
al., 2001; Tognon et al., 2003). Human papilloma viruses (HPVs) are double stranded 
nonlytic DNA viruses and their life cycle is tightly linked to differentiation program of 
the infected epithelial cells. HPVs are designated in high or low risk types according to 
malignant progression of the epithelial lesions derived after the viral infection. HPV 16 is 
the most prevalent high risk HPV type (reviewed in Munger et al., 2004). 
 
 HPVs infect the basal epithelial cells that form the actively proliferating cell layer in the 
epithelium. When the cells differentiate and migrate towards surface of the epithelium, 
the viruses replicate to high copy numbers and new viruses are released into surrounding 
environment. One of the key events in HPV induced transformation is the integration of 
viral DNA into host genome. This leads to constantly maintained expression of viral E6 
and E7 genes (Fehrmann and Laimins, 2003) whereas the other viral DNA is often 
deleted or its expression repressed (reviewed in Munger et al., 2004). DNA from different 
HPVs has been found approximately in 99% of the cervical and in 20% of the 
oropharyngeal cancers (Longworth and Laimins, 2004).  
 
E6 and E7 oncogenes degrade tumor suppressor p53 and pRb/p107/p130, respectively 
(Boyer et al., 1996; Davies et al., 1993; Scheffner et al., 1990). E7 expression and its 
interaction with pRb are critical in formation of the microenvironment that promotes viral 
genome replication. The epithelial cells that have integrated E6/E7 in their genome show 
selective growth advantage over normal cells or cells that express episomal HPV genes 
(Jeon et al., 1995). E6/E7 oncogenes immortalize and transform at least keratinocytes, 
epithelial and endothelial cells (Coursen et al., 1997; Hawley-Nelson et al., 1989). The 
constant expression of E6/E7 oncogenes is necessary for maintenance of the transformed 
phenotype in cervical cancers (Goodwin and DiMaio, 2000).  
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Besides the degradation of the tumor suppressor, E6 and E7 oncogenes have also other 
cellular functions: E6 activates human telomerase transcription (Veldman et al., 2001) 
and increases mitogen-activated protein kinase (MAPK) signaling in epithelial cells 
(Chakrabarti et al., 2004). Whereas, E7 overrides growth inhibitory activity of CDK 
inhibitors p21CIP1 and p27KIP1 (Funk et al., 1997; Jones et al., 1997) and also associates 
with chromatin modifying enzymes, particularly with histone deacetylases and histone 
acetyl transferases (Brehm et al., 1999). In addition, E7 is can integrate with transcription 
factors, cell cycle regulators and metabolic enzymes (reviewed in Munger et al., 2004), 
but the biological relevance of these interactions is still unclear. E7 has been also 
reported to interact with transcriptional co-activators p300, CBP and pCAF (Bernat et al., 
2003). Both E6 and E7 oncogenes can independently induce genomic instability in 
normal human cells (reviewed in Munger et al., 2004). E6 and E7 have also been shown 
to directly activate Notch signaling by upregulating expression of both Jagged-1 and its 
receptor Notch-1 in cervical carcinoma cells (Veeraraghavalu et al., 2004; Weijzen et al., 
2003).  
 
1.6.2 Myc -family 
 
Myc family members, c-Myc, n-Myc and l-Myc, are proto-oncogenes that belong to 
bHLH leucine zipper transcription factors. The Myc proteins are active during the 
embryo development and they show high functional redundancy for each other (Hirvonen 
et al., 1990, Murphy et al., 2005). c-Myc-deficient mouse embryos show hematopoietic, 
vascular and placental defects and the phenotype is embryonic lethal before E10 (Trumpp 
et al., 2001). Lack of n-Myc leads to dramatic abnormalities in heart, liver, kidney, limb 
bud, lungs, CNS and PNS, and the phenotype is embryonic lethal (Sawai et al., 1991; 
Sawai et al., 1993). l-myc-deficient mice are viable and show no obvious defects (Hatton 
et al., 1996).  
 
c-Myc together with its partner Max regulates transcription through several mechanisms, 
including recruitment of chromatin modifiers and remodeling factors, and interaction 
with transcriptional factors and functions that are involved in at least cell cycle control, 
growth, cell adhesion, differentiation and apoptosis (Coller et al., 2000; Dang et al., 2006; 
Grandori et al., 2000). c-Myc interacts also with Myc-interacting zinc finger protein-1 
(Miz-1) (Bouchard et al., 1999; Coller et al., 2000), which represses transcription of the 
cell cycle inhibitors p21CIP1, p15INK4b and p57Kip2 (Adhikary et al., 2003; Seoane et al., 
2002; Staller et al., 2001). Moreover, Myc represses proteins also involved in 
cytoskeleton and cell adhesion (Coller et al., 2000, Gebhardt et al., 2006).  
 
All Myc family members are expressed during fetal brain development (Hirvonen et al., 
1990). Targeted loss of n-Myc in nestin positive NPCs severely disrupts their ability to 
expand, differentiate and populate the brain even though the mice survive to adulthood 
(Knoepfler et al., 2002). Whereas, in mouse CNS c-Myc overexpression has been shown 
to increase NPC proliferation (Fults et al., 2002). Furthermore, c-Myc is also expressed at 
the neural plate border and have been shown to be important in neural crest development 
(Bellmeyer et al., 2003). In Xenopus, c-Myc downregulation by using morpholinos has 
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revealed that it is required for induction of the neural crest markers and formation of the 
neural crest derivatives (Bellmeyer et al., 2003). Overexpression of c-Myc causes 
genomic instability in several cell types (Wade and Wahl, 2006), andF amplification of 
Myc can be detected in several human and animal cancers (Grandori et al., 2000). In 
nervous system derived tumors, both c-Myc and n-Myc overexpression are implicated in 
pathogenesis of medulloblastoma, glioma and neuroblastoma (Eberhart et al., 2004; 
Schwab, 2004; Su et al., 2006).  
 
Biological functions of c-Myc are pleiotrophic and highly cell-type specific (Murphy et 
al., 2005). In fibroblasts, exogenous Myc promotes short G1-S transition (Leone et al., 
2001, Karn et al., 1989). Activation of Myc has also shown to permit prolonged 
expression of cyclin E/CDK2 by upregulation of cyclin D and CDK4, by increasing pRb 
phosphorylation and by repressing CDK inhibitors (Bouchard et al., 1999; Coller et al., 
2000). In skin, c-Myc is expressed in the basal layer that contains proliferating epithelial 
stem cells or progenitors and transient amplifying (TA) cells and it is needed for self-
renewal (Bull et al., 2001, Zanet et al., 2005).  
 
Also in ES-cells, c-Myc maintains self-renewal through LIF/STAT3 pathway (Cartwright 
et al., 2005). Ectopic c-Myc expression together with three other factors Oct4, Sox-2 and 
Klf4 can dedifferentiate adult fibroblasts into pluripotent ES-cell-like cells (Takahashi et al., 
2006), and therefore it is considered one of the factors driving “stem cell properties”. c-
myc-deficient ES-cells show severely inhibited formation of both embryoid bodies and 
secondary erythroid colony-forming units, which outlines its importance for 
hematopoiesis and vasculogenesis (Baudino et al., 2002; Knies-Bamforth et al., 2004; 
von Rahden et al., 2006). In addition, c-myc-deficient ES-cells show downregulated 
VEGF-A levels and c-Myc is able to upregulate VEGF-A in several tissues, which 
indicates that VEGF-A is one of its transcriptional targets (Baudino et al., 2002; Knies-
Bamforth et al., 2004; von Rahden et al., 2006).  
 
In skin and bone marrow, c-Myc has been proposed to indirectly affect the differentiation 
by altering the interactions between the stem cells and the niche (Murphy et al., 2005). In 
adults, Cre–loxP induced lack of c-Myc forced the expanding hematopoietic progenitors 
into quiescent G0-phase, whereas the long-term HSCs accumulated in the bone marrow 
(Wilson et al., 2004). c-myc-deficient HSCs overexpress N-cadherin and several integrin 
αL, α5 and β2 adhesion receptors that have been previously implicated in HSC homing 
and mobilization (Murphy et al., 2005). It has been suggested that increased adhesion or 
altered cell migration preserves the c-myc-deficient HSCs in the stem cell niche, which 
leads to differentiation defect (Wilson et al., 2004). c-Myc may also control the first 
differentiation step of HSCs since c-Myc overexpression results in loss of these cells 
likely due to premature differentiation (Wilson et al., 2004).  
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1.7 GROWTH- AND SURVIVAL FACTORS OF GDNF AND VEGF-C-FAMILY 
GDNF family  
 
GDNF family ligands (GFLs): GDNF (Pichel et al., 1996), ARTN (Baloh et al., 1998), 
neurturin (NRTN) (Kotzbauer et al., 1996) and persephin (PSPN) (Milbrandt et al., 1998) 
belong to the TGF β superfamily. They are secreted proteins, which are first produced as 
preproteins and then cleaved to their active forms that show approximately 40% 
similarity to each other (reviewed in Airaksinen and Saarma, 2002). In general, GLFs 
have important role in neurogenesis of the several neural subtypes.  
 
In CNS, GDNF promotes growth of the dopaminergic neurons, spinal motoneurons and 
noradrenergic neurons (Airaksinen and Saarma, 2002). Whereas, in PNS GDNF regulates 
survival and growth of other neural subpopulations including sympathetic-, 
parasympathetic and enteric neurons (Airaksinen et al., 1999; Airaksinen and Saarma, 
2002). Gdnf-deficient phenotype in mouse is embryonic lethal and the embryos lack 
enteric neurons and kidneys, and show defects in sensory neurons (reviewed in 
Airaksinen and Saarma, 2002). GDNF has role also in maintaining the spermatogonia 
stem cells in testis (Meng et al., 2000).  
 
During embryo development, ARTN is expressed in smooth muscle cells of the central 
and peripheral blood vessels. Artn-deficient mouse embryos have defects in axonal 
outgrowth of sympathetic neurons and approximately 30% decrease in the size of 
sympathetic ganglia chain (Baloh et al., 1998; Nishino et al., 1999). Recently, ARTN was 
shown to support growth of Peyer’s Patches, the major components of gut associated 
lymphoid tissue (Veiga-Fernandes et al., 2007).  
 
The third family member, NRTN has been shown to be important in development and 
maintenance of the enteric-, sensory- and parasympathetic neurons (Heuckeroth et al., 
1999), and Nrtn-deficiency leads to defects in enteric, parasympathetic nervous systems 
and innervation defects of the cholinergic sympathetic neurons (Hiltunen and Airaksinen, 
2004; Rossi et al., 1999). PSPN promotes survival of several types of neurons including 
midbrain dopamine neurons and motoneurons (Sariola and Saarma, 2003). 
 
GDNF family receptors 
 
GFLs bind to the non-kinase glycosylphosphatidylinositol-linked (GPI) GDNF family 
receptors (GFRs) GFRα1, GFRα2, GFRα3 and GFRα4 and signal through c-Ret (Ret) 
(reviewed in Sariola and Saarma, 2003) (Figure 9). GLFs have their preference in GFR 
binding: GDNF binds to GFRα1, and ARTN, NRTN and PSPN bind to GFRα3, GFRα2 
and GFRα4, respectively. However, in vitro GFRα1, GFRα2 and GFRα3 have shown 
weak redundancy according their ligands (reviewed in Sariola and Saarma, 2003). GFRs 
are normally bound to plasma membrane but at least GFRα1 is biologically active in 
soluble form (Worley et al., 2000). GFL-GFR interaction activates Ret and its 
downstream signaling pathway (reviewed in Airaksinen et al., 1999).  
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Ret is a proto-oncogene and transmembrane receptor, which has three domains: an 
extracellural domain with four cadherin-like repeats and a cystein rich domain and a 
cytoplasmic tyrosine kinase domain (Anders et al., 2001). Ret has three alternatively 
spliced isoforms, 51, 43 and 9, (Myers et al., 1995; Tahira et al., 1990). Ret isoforms 51 
and 9 are the most predominant and they have distinct functions (de Graaff et al., 2001; 
Tsui-Pierchala et al., 2002). Ret-deficient mouse embryos and newborns show mislocated 
superior cervical ganglia and defects in sympathetic ganglia chain, and the phenotype is 
lethal at P1 (Enomoto et al., 2001). Ret-deficient sympathetic neurons show retarded 
differentiation, defects in target innervation and increased neuronal death during 
embryonic development (Pichel et al., 1996; Enomoto et al., 2001). Ret-deficient mice 
have also defects in the migration of enteric neurons (Pichel et al., 1996). Similarly to 
GFLs, Ret also has role outside of the nervous system such as in kidney development 
(Pichel et al., 1996; Sariola and Saarma, 2003) and in testis (Meng et al., 2000).  
 
GDNF can signal Ret-independently through GFRα1 and Src-family kinase or neural cell 
adhesion molecule (NCAM) (Paratcha et al., 2003; Popsueva et al., 2003). Gfrα1-
deficient mouse embryos have defects in sensory neurons and they lack both the enteric 
neurons and kidneys, and the phenotype is embryonic lethal (reviewed in Airaksinen and 
Saarma, 2002). While, a lack of GFRα2 results in defects in both the enteric and 
parasympathetic nervous systems, the mutant mice show also innervation defects of the 
cholinergic sympathetic neurons (Hiltunen and Airaksinen, 2004; Rossi et al., 1999). 
Gfrα3-deficiency leads to approximately to a 30% decrease in size of the sympathetic 
ganglia chain (Nishino et al., 1999), and the mutant mice also show decreased numbers of 
cells in gut associated lymphoid tissue (Veiga-Fernandes et al., 2007). Gfrα4-deficient 
mice have no other defects than reduced production of thyroid calcitonin (Lindfors et al., 
2006). 
 
 
 
Figure 9. GFLs and interaction with their receptors. (Modified from Sariola and Saarma, 
2003) 
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VEGF subfamily 
 
Platelet derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family 
members are predominantly secreted glycoproteins, which form either disulfide-linked or 
non-covalently bound homo- and heterodimers with anti-parallel arranged subunits 
(Muller et al., 1997; Stacker and Achen, 1999). VEGF subfamily consists of VEGF-A, 
VEGF-B, VEGF-C, VEGF-D, VEGF-E, VEGF-F and PLGF, and they all share VEGF 
homology domain (VHD). In general, all VEGF subfamily members are essential for 
vascular development (vasculogenesis) and blood vessel sprouting (angiogenesis) in both 
embryo and adult, but they have also been implicated in vascular permeability and 
metastasis (reviewed in Tammela et al., 2005).  
 
VEGF-A (Jin et al., 2000; Maurer et al., 2003; Schratzberger et al., 2000; Sondell et al., 
1999) promotes proliferation and survival of endothelial cells, and increases 
microvascular permeability. Moreover, VEGF-A is involved in several biological 
processes such as mobilization of intracellular calsium, plasminogen synthesis, monocyte 
migration, expression of cell adhesion molecules, and induction of nitric oxide mediated 
vasodilation and hypotension (Ferrara, 1999; Neufeld et al., 1999; Zachary, 1998). In 
humans, VEGF-A has five isoforms encoded by distinct mRNA splice variants and 
named by their amino acid length; 121, 145, 165, 189 and 206. All isoforms promote 
mitogenic activation in endothelial cells, however the biological activity, receptor 
specificity and affinity for the low affinity receptor cell surface- and extracellular matrix- 
associated heparin sulfate proteoglycans between the isoforms is different. VEGF121 and 
VEGF165 are the predominant forms of VEGF-A even though most of the tissues express 
several VEGF-A isoforms simultaneously (Ferrara, 1999). Both VEGF121 and VEGF165 
are soluble but VEGF165 is mostly confined to the cell surface and extracellular matrix 
proteoglycans.  
 
In embryonic tissues, VEGF-A expression is associated with the vascular system, but it is 
also found in several tumors and tumor cell lines (Eggert et al., 2000; Fakhari et al., 2002; 
Komuro et al., 2001; Meister et al., 1999). Lack of a single allele of Vegf-a in mice leads 
to embryonic death at E11-E12, and the embryos showed several anomalies and defects 
in cardiovascular development (Ferrara et al., 1996). The phenotype of VEGF-A targeted 
gene disruption knockout mice also indicates that the protein is critical for the survival 
and development of the cardiovascular system and angiogenesis (Raab et al., 2004, Haigh 
et al, 2000). Recently, VEGF-A was shown to be one of the factors required for 
expansion of the ES-cell derived blood cell precursors (Pick et al., 2007). VEGF-A and 
BMP increased frequency of ES-cell derived hematopoietic progenitors and the numbers 
of immature and mature hematopoietic cells.  
 
Postnatally, VEGF-A is required for the growth, organ development, growth plate 
morphogenesis and endochordal bone formation. In adults, VEGF-A is involved in 
wound healing and the development of corpus luteum (Ferrara, 1999; Neufeld et al., 
1999). VEGF-A expression is regulated transcriptionally and post-transcriptionally. and 
Hypoxia, several hormones, interleukins and cytokines such as EGF and TGF-β can 
enhance VEGF-A expression (Ferrara, 1999). Besides of the role in endothelial cells, 
From neural stem cells to precursors   Review of the Literature 
 
 37 
VEGF-A also attracts and guides developing neurons (Carmeliet et al., 2005). In CNS, 
VEGF-A signal is mediated by VEGFR-2 and it leads to expansion of the neural 
progenitors in the hippocampus (Jin et al., 2002). In retinal progenitors, VEGF-A 
increases proliferation and decreases neurogenesis by stimulating bHLH factor Hes1 
(Hashimoto et al., 2006). In ES-derived neural progenitors, VEGF-A promotes survival 
and proliferation of the FGF and EGF-dependent definitive progenitors instead of the 
primitive LIF-dependent progenitors (Wada et al., 2006). 
 
VEGF-B (Silvestre et al., 2003) has two alternatively spliced isoforms, 167 and 186, 
which share approximately 44% amino acid sequence homology with VEGF-A (Olofsson 
et al., 1996a; Olofsson et al., 1996b). Both isoforms can form heterodimers or 
homodimers with VEGF-A. VEGF-B is primarily expressed in cardiac and skeletal 
tissues in embryos and adults (Joukov et al., 1997; Stacker and Achen, 1999), and Vegf-b-
deficient mice show dysfunction of the coronary vasculature, reduced size of the heart 
and impaired recovery after cardiac ischemia (Bellomo et al., 2000). VEGF-B is also 
expressed in the brain especially after brain injury (Nag et al., 2002), and it can reduce 
hypoxic death of cultured cerebral cortical neurons in vitro (Sun et al., 2004) and increase 
proliferation of neural progenitors in adult CNS (Sun et al., 2006). 
 
VEGF-C (Joukov et al. 1996) is produced as pre-protein that undergoes extensive 
proteolytic modifications, which result in a mature VEGF-C that shows approximately 
30% identical amino acid sequence with VEGF-A. The mature VEGF-C can bind to both 
VEGFR-3 and VEGFR-2 and promote either lymphangiogenesis or angiogenesis 
respectively depending on the receptor (Joukov et al., 1997; Makinen et al., 2001; 
Mandriota et al., 2001; Marconcini et al., 1999). Partial proteolytic processing produces 
an intermediate form of VEGF-C, which shows increased affinity for VEGFR-3 receptor 
(Joukov et al., 1997).  
 
During development, VEGF-C is expressed in allantois, in the wall of dorsal aorta, 
jugular area and metanephric kidneys in temporal and spatial pattern (Joukov et al., 1997; 
Karkkainen et al., 2004). VEGF-C is involved in regulation of lymphangiogenesis by 
promoting the migration and survival of lymphendotelial progenitors, and Vegf-c–
deficient mice lack lymphatic vessels, develop lymphoedema and die at E15-E16 
(Karkkainen et al., 2004). Vegf-c-heterozygous mutants are viable, however, they also 
show lymphoedema during embryogenesis. VEGF-C overexpression induces growth of 
the hyperplastic lymphatic vessel network in skin (Jeltsch et al., 1997).  
 
In later development and adulthood, VEGF-C may maintain differentiated lymphatic 
endothelium (Ferrara, 1999). VEGF-C shows also angiogenic properties, and promotes 
the growth and migration of endothelial cells by signaling through VEGFR-2 in vitro 
(Eichmann et al., 1998). In CNS, VEGF-C promotes proliferation of OLPs in optic nerve 
and olfactory bulb progenitors by signaling through VEGFR-3 (Le Bras et al., 2006). 
Furthermore, VEGF-family members and their receptors are found in several cancers 
including sympathoadrenal-lineage-derived human neuroblastomas (NBs) (Eggert et al., 
2000; Fakhari et al., 2002; Komuro et al., 2001; Meister et al., 1999). In aggressive NBs, 
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VEGF-C expression is also found to be associated with n-Myc amplification (Eggert et 
al., 2000).  
VEGF-D (Achen et al., 1998; Orlandini et al., 1996) is structurally and functionally most 
closely related to VEGF-C. Similarly to VEGF-C, also VEGF-D undergoes proteolytic 
processing (Achen et al., 1998; Chen et al., 2000; Joukov et al., 1997). During embryo 
development, VEGF-D is expressed in heart and lungs in temporal and spatial pattern 
whereas in adults its expression is mostly restricted to skeletal muscles. VEGF-D also 
induces mitogenic responses in endothelial cells in vitro.  
 
VEGF subfamily member VEGF-E is orf-virus-encoded and shows approximately 20% 
identity with VEGF-A at the amino acid level. Viral infection leads to pustular dermatitis 
that may involve endothelial cell proliferation and vascular permeability (Ferrara, 1999; 
Stacker and Achen, 1999). VEGF-F was recently isolated from snake venom (Suto et al., 
2005) and it consists of two VEGF-related proteins that show 50% structural homology 
with VEGF165 and binds selectively to VEGFR-2 (Suto et al., 2005).  
 
Placental growth factor (PlGF) has three isoforms generated after alternative splicing and 
those can form heterodimers or homodimers with VEGF-A (Hauser and Weich, 1993; 
Maglione et al., 1993). PlGF has poor capacity to induce angiogenesis or proliferation of 
endothelial cells when compared to VEGF-A. During embryogenesis PlGF is primarily 
expressed in the placenta and in trophoblastic giant cells of the pariental yolk sac together 
with VEGF-A (Stacker and Achen, 1999).  
 
VEGF receptors 
 
VEGFs signal predominantly through transmembrane receptor tyrosine kinases VEGFR-
1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4) (Figure 10). VEGF-A binds to 
both VEGFR-1 and VEGFR-2 (Ferrara and Davis-Smyth, 1997; Shibuya et al., 1990; 
Terman et al., 1991) whereas VEGF-B and PlDGF have selective affinity for VEGFR-1 
(Olofsson et al., 1998). Both VEGF-C and VEGF-D signal through VEGFR-2 and 
VEGFR-3 (Achen et al., 1998; Joukov et al., 1996; Kukk et al., 1996; Ristimaki et al., 
1998; Saaristo et al., 2002).  
 
VEGFR-1 contains an extracellular region with seven immunoglobulin (Ig)-like domains, 
a transmembrane domain and a tyrosine kinase domain (Shibuya, 2006). Organization of 
VEGFR-2 (Terman et al., 1991) and VEGFR-3 (Pajusola et al., 1992) is similar to 
VEGFR-1 and the receptors show 80% identity to VEGFR-1 tyrosine kinase domain. 
Unlike other VEGFRs, one of the Ig-like loops in VEGFR-3 is replaced by a disulfide 
bridge (Pajusola et al., 1994). All VEGFRs undergo alternative splicing that results in 
several isoforms of the receptors (Ebos et al., 2004; Hughes, 2001; Kendall and Thomas, 
1993). During embryo development, VEGFR-1 negatively regulates angiogenesis 
whereas in adults it promotes angiogenesis (reviewed in Shibuya and Claesson-Welsh, 
2006). Vegfr-1-deficient mouse embryos show overgrowth in endothelial cells, blood 
vessels disorganization, and the embryos die at E8-E9 (Fong et al., 1995). VEGFR-1 is 
expressed in endothelial cells and in the monocyte-macrophage cell lineage where it 
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regulates the cell migration (Clauss et al., 1996; Sawano et al., 2001). VEGFR-1 is also 
expressed in dendritic cells, osteoclasts and trophoblasts (Dikov et al., 2005; Kaipainen et 
al., 1993) but its function in these cell types is not clear. VEGFR-2 stimulates endothelial 
growth and angiogenesis, and Vegfr-2-deficient mice die at E8 to 9 due to lack of 
vasculogenesis and poor hematopoietic development (Shalaby et al., 1995). VEGFR-3 is 
involved in both lymphatic and blood vessel function, and Vegfr-3-deficiency causes 
abnormal remodeling of the primary vascular plexus and leads to death at E9 (Dumont et 
al., 1998). Early lymphatic development is VEGFR-3 independent but the sprouting of 
the lymphatic endothelial cells from the cardinal vein is mediated by VEGF-C and 
VEGFR-3 around E10-11 (Karkkainen et al., 2004). 
 
GPI-linked non-kinase neuropilin (Nrp) receptors Nrp1 and Nrp2 (Karkkainen et al., 
2001) are co-receptors for VEGF subfamily members. At least, VEGF-A, VEGF-B and 
VEGF-C can bind Nrps (reviewed by Matsumoto and Claesson-Welsh, 2001; Neufeld et 
al., 2002). In endothelial cells, Nrp2 can enhance VEGF-C-induced VEGFR signaling 
(Soker et al., 1998). Whereas, in nervous system Nrps bind class 3 semaphorins (Sema) 
and guide developing axons by chemo-repulsion and -attraction (Chen et al., 1998; He 
and Tessier-Lavigne, 1997; Kolodkin et al., 1997). Accordingly, Nrp1-deficient mouse 
embryos show defects in neuronal projection in CNS and PNS, dislocation of 
sympathetic neurons and their progenitors, and also cardiovascular defects (Bagri and 
Tessier-Lavigne, 2002; Kawasaki et al., 1999; Klagsbrun et al., 2002). In mouse, lack of 
Nrp2 leads to mild defects in cranial and spinal nerve organization and also to a reduction 
in the numbers of small lymphatic vessels and capillaries (Chen et al., 2000; Giger et al., 
2000; Yuan et al., 2002). Both Nrp1 and Nrp2 are expressed in mouse and human 
neuroblastoma cells (Beierle et al., 2003; Fakhari et al., 2002; Jogi et al., 2004; Marcus et 
al., 2005), and at least Nrp1 mediates Sema3A signaling during sympathetic nervous 
system patterning (Kawasaki et al., 2002). 
 
 
 
Figure 10. VEGF-family ligands and interaction with their receptors. (Modified from 
Hicklin and Ellis, 2005) 
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2 AIMS OF THE STUDY 
 
The aim of this study is to investigate how certain intrinsic and extrinsic factors affect 
self-renewal and differentiation of NSCs and NPCs. The studied cell intrinsic factors are 
the tumor suppressor p53 and pRb–family members, which are involved in cell 
proliferation and differentiation of several tissues, the proto-oncogene c-Myc and the 
cytoskeletal tumor suppressor NF2 protein merlin and the ERM protein ezrin. The 
investigated cell extrinsic factors are the classical viral oncogenes HPV E6/E7 that 
degrade both p53 and pRb–family members, and the lymphangiogenic growth factor 
VEGF-C, which has several roles during development and in tumors. The specific 
questions addressed by this study are: 
 
 
I) How do tumor suppressors p53 and pRb-family or human papilloma virus 
oncogenes E6/E7 affect neural progenitor behavior? 
 
II) Does proto-oncogene c-Myc have a role in the maintenance of neural 
progenitors? 
 
III) What is the localization and expression of NF2 protein merlin and ERM 
protein ezrin in the developing and adult brain, and in the brain derived neural 
progenitors?  
 
IV) Does lymphangiogenesis related vascular endothelial growth factor C (VEGF-
C) affect the sympathetic nervous system development? 
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3 MATERIALS AND METHODS 
 
The methods used in this study are described in the respective publications or their 
references. The experimental procedures that required the use of laboratory animals were 
performed according to ethical guidelines approved by the local authorities. 
 
 
Method Publications 
Mouse lines I, II & III 
Isolation of CNS stem cells and progenitors I, III, IV 
Mouse embryonic torso culture II 
Isolation of sympathetic progenitors II 
Culture of stem cells and progenitors I, II, III & IV 
Growth factors I, II & III 
Agarose beads II 
Retrovirus constructs I & III 
Virus package cell lines and transduction I & III 
Cell transplantation in utero I 
Cell culture and differentiation I, II, III & IV 
Immunohistochemistry  I, II, III & IV 
Western blotting I, II, III & IV 
Immunoprecipitation I 
Chemical inhibitors I & II 
RT-PCR I & III 
qRT-PCR II 
PI –staining I & III 
FACS cell sorting I & III 
Vibratome and paraffin sections II, III & IV 
Cell proliferation and self-renewal assays I, II & III 
Cell apoptosis assays I, II & III 
Cell migration assays II 
Neurite outgrowth assays II 
Blocking antibodies II 
Statistical analyses I, II & III 
 
 
Growth factors and inhibitors Source Publications 
EGF Sigma I, II, III & IV 
FGF Sigma I, II, III & IV 
NGF Sigma II 
VEGF-C Dr. V. Joukov II 
VEGF-C mutant R&D Systems II 
VEGF-D R&D Systems II 
VEGF-A R&D Systems II 
GDNF R&D Systems II 
ARTN PeproTech II 
(R)-Roscovitine Alexis Biochemicals I 
U0126 Calbiochem I & II 
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Antigen Antibodies Source Publications 
Tuj-1 monoclonal  Nordic Biosite I, II, III & IV 
GFAP antiserum Chemicon I, II, III & IV 
O4 monoclonal Chemicon I & IV 
Nestin monoclonal Chemicon I, II & III 
Tyrosine hydroxylase polyclonal Chemicon II 
p75 polyclonal Dr. M. Chao II 
GFP polyclonal Molecular Probes I 
Ki-67 polyclonal NeoMarkers I 
Bmi-1 monoclonal Abcam III 
LYVE-1 polyclonal Dr. P. Laakkonen II 
Prox-1 polyclonal Dr. T. Petrova II 
CD31 monoclonal BD Biosciences II 
VE-cadherin monoclonal BD Biosciences II 
pan cytokeratin monoclonal Sigma II 
p53 poly/monoclonal Santa Cruz I 
Rb monoclonal BD Biosciences  I 
p107 and p130 polyclonal Santa Cruz I 
c-Jun polyclonal Cell Signaling I & II 
JunD polyclonal Santa Cruz I 
p-ERK polyclonal Promega/Sigma I & II 
ERK polyclonal Santa Cruz/Promega I & II 
p-JNK and JNK polyclonal Promega I  
Akt polyclonal Cell signaling I & II 
active caspase-3 polyclonal R&D Systems II 
Ret polyclonal Santa Cruz II 
Actin polyclonal Santa Cruz I, II, III & IV 
ezrin antiserum Dr. M. Haltia IV 
merlin antiserum Santa Cruz IV 
Synapsin I monoclonal Chemicon IV 
PSD-95 monoclonal Chemicon IV 
PKA-Riβ antiserum Calbiochem IV 
c-Myc polyclonal Santa Cruz III 
Nrp1 and Nrp2 polyclonal R&D Systems II 
Ret polyclonal Santa Cruz II 
 
 
Neurosphere culture system, self-renewal capacity assay and in vitro differentiation 
 
Neural stem cells and progenitors were collected from mouse embryos at E11 (I, III & IV) 
or at E12 (II) and cultured as free-floating neurospheres in neural stem cell medium 
(NSCM): Dulbecco’s MEM (DMEM) supplemented with nutrient mixtures F12 (Sigma-
Aldrich) and B27 (Invitrogen), Glutamax (Invitrogen), growth factors FGF2 (20 ng/ml; 
Sigma-Aldrich) and EGF (40 ng/ml; Sigma-Aldrich). The neurospheres were passaged 
mechanically twice a week (I, II and III) and the experiments were performed with cells 
passaged for <15 (I and III) or <20 times (II). However, neuropheres were maintained for 
>30 passages without signs of senescence. 
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Self-renewal capacity of NSCs and NPCs was measured by clonal divisions: the 
neurospheres were dissociated mechanically (I, II and III) or enzymaticly with Trypsin-
EDTA 0.25% (IV) into single cells that were plated into 96-well plates in a density of 15 
cells/well. The number of new neurospheres was counted after 7–10 days. The data is 
shown as percentage of self-renewing cells, which was calculated by dividing the number 
of new neurospheres with the number of originally plated cells (I and II). SPCs did not 
form spheres but grew in loose cell clusters in NSCM and therefore the number of the 
clusters and the number of the cells in the clusters were counted after 7-10 days (IV). 
 
For in vitro differentiation, small neurospheres or single cells were plated on poly-D-
lysine or poly-L-lysine (Sigma-Aldrich) coated glass coverslips and cultured in FGF2 and 
EGF-free NSCM and supplemented with 2% or 5% fetal calf serum (FCS) or fetal bovine 
serum (FBS) (PromoCell) (I, II and III) or 1% FBS and 100 ng/ml NGF (Sigma-Aldrich) 
(IV).  
 
MTT cell proliferation analysis and ApopTag apoptosis assay  
 
Cell proliferation kit I (MTT; (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium 
bromide) (Roche) was also used for measuring cell proliferation in NPCs. For MTT 
analysis the non-differentiated cells were washed three times for 30 min with FGF2-EGF 
free medium before plating in a density of 20 000-30 000 cells/well into 96-well plate. 
Cells were cultured 3 to 4 days before adding MTT labeling- and solubilization reagents. 
The MTT absorbance was measured with multi-well spectrophotometer by using 
wavelengths of 585 nm and 750 nm for reference. 
ApopTag fluorecein in situ apoptosis kit (Chemicon) was used to detect apotosis in NPCs 
and the immunocytochemistry was performed according the manufacturer’s protocol.  
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4 RESULTS AND DISCUSSION 
4.1 Oncogenes and proto-oncogenes increase stem cell characteristics in CNS 
progenitors (I, II) 
 
HPV 16 E6/E7 oncogenes 
 
Several viral oncogenes such as HPV E6/E7 (Boyer et al., 1996; Davies et al., 1993; 
Scheffner et al., 1990), SV40 large-T antigen (DeCaprio, 1999), BKV TAg (Harris et al., 
1998), and adenovirus E1B/E1A oncogenes (Dyson et al., 1993; Whyte et al., 1988) are 
able to degrade the tumor suppressor p53 and pRb-family members. In this study, we 
used E6/E7 as classical viral oncogene model in order to study the effect of oncogenic 
exposure on mouse fetal CNS progenitors that were cultured as free floating 
neurospheres. In NPCs, expression of E6/E7 was found to increase the capacity for self-
renewal and proliferation (Figure 1 in I). In culture conditions that promote 
differentiation, E6/E7 oncogenes delayed the cell cycle exit and gave NPCs the ability to 
remain multipotent, but did not block the differentiation process (Figure 2,3 and 4 in I).  
 
These functions seem to be at least partly linked to degradation of p53 and pRb-family 
proteins in NPCs (I). Furthermore, E6/E7 oncogenes induced slight upregulation of 
MEK-ERK signaling, which seems to be important for NPC self-renewal (Figure 7 in I). 
In NPCs, E6 oncogene expression led to a clear reduction in the level of p53 whereas E7 
oncogene degraded all pRb-family members, pRb, p130 and p107 (Figure 1 in I). Both 
E7 and E6/E7 expressing NPCs showed increased proliferation and shorter population 
doubling time when examined by BrdU incorporation (Figure 1 in I) and MTT assay 
(Roche) (Figure 10). Moreover, E6/E7 expression caused 5 fold increase in NPC self-
renewal capacity when analyzed by secondary sphere formation assays (Figure 1 in I), 
and the secondary E6/E7 spheres were found to be bigger than the controls (Figure 11), 
which is likely due to an enhanced cell proliferation rate.  
 
The self-renewal capacity was also increased in E7 expressing NPCs and slightly but not 
significantly in E6 expressing NPCs (Figure 1 in I). These clonally formed secondary 
spheres were all able to produce neurons and astrocytes, which indicates that the spheres 
were derived from multipotent progenitors and not from more committed precursor cells.  
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Figure 11. Left panel: MTT assay reveals higher cell proliferation in E6/E7 expressing 
NPCs. Prior to analysis 15000 cells/well were cultured in 96-well-plate for 4 days. The 
chart is representative of three experiments. Error bars indicate ± SD between 5 replicas 
in the experiment. Right panel: Secondary sphere formation assay showed that the size of 
the secondary spheres in E6/E7 expressing NPCs was larger than the controls, or only E6 
or E7 expressing NPCs. Scale bar 100µm. (Piltti et al. unpublished data) 
 
In the environment that promotes differentiation, E6-, E7-, E6/E7 expressing NPCs and 
the controls attached and developed morphology of differentiated neuronal cells. When 
the culture conditions were switched back to promote growth and proliferation after two 
weeks, E6/E7 expressing cells showed frequent re-formation of the spheres (>2000 
spheres/200 000 plated cells) (Figure 2 in I). These re-formed spheres could be expanded 
in culture and after in vitro differentiation the cells showed the ability to form both 
neurons and astrocytes. Only low numbers of re-formed spheres were detected in all E6, 
E7 and the control cells (<10 spheres/200 000 plated cells) (Figure 2 in I), which 
indicates that cells showed non-reversible and complete differentiation.  
 
To study the cause of the sphere re-formation after differentiation, the cells were BrdU-
pulse labeled for 24 hrs during each day of the differentiation. The analysis revealed that 
the controls and E6 expressing progenitors silenced their cell cycle within first 48–72 hrs 
of the differentiation (Figure 3 in I). However, a high fraction (~50%) of NPCs 
expressing both E6/E7 oncogenes entered S-phase still as late as on eighth day of the 
differentiation (Figure 3 in I). In E7 expressing cells, the terminal mitosis was also 
markedly delayed but complete after four days differentiation (Figure 3 in I).  
 
Even if E6/E7 expression delayed or partly inhibited the terminal mitosis in NPCs, it did 
not block the differentiation in vitro or in vivo (Figure 4 and 5 in I). Undifferentiated 
control and E6/E7 expressing progenitors had similar expression pattern of the neural 
bHLH transcription factors Mash1, Hes1, Hes5 and Id2 (Farah et al., 2000; Ross et al., 
2003; Toma et al., 2000) when studied by RT-PCR (Figure 4 in I). Both control and 
E6/E7 NPCs were also able to form Tuj-1 positive neurons and GFAP positive astrocytes 
during 96 hrs in vitro differentiation (Figure 4 in I). Both control and E6/E7 expressing 
cell showed high proportion of nestin positive cells after 96 hrs differentiation in vitro 
indicating that cell fate determination was still on going, even though in the control group 
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the cells had exited the cell cycle. Beside of the delayed or partly inhibited terminal 
mitosis, E6/E7 expressing NPCs showed increased apoptosis during in vitro 
differentiation when analyzed with ApopTag apoptosis kit (Chemicon) (Figure 12). A 
similar type of behavior has been seen in pRb-deficient cortical progenitors that showed 
enhanced apoptosis during both in vitro and in vivo differentiation, which was most likely 
due to problems to undergo terminal mitosis (Callaghan et al., 1999; Slack et al., 1998). 
 
 
 
Figure 12. The number of apoptotic cells after 4 days in vitro differentiation of the NPCs. 
The chart represents an average of 3 experiments, *P<0.05 (Student’s T test) and error 
bars indicate SD between the experiments. 
  
In vivo transplantation of EGFP positive E6/E7 and control NPCs into brain ventricles of 
mouse embryos at E14 in utero revealed that the cells engrafted throughout the brain 
tissue. Immunohistochemistry after serial cryostat sections of the brains revealeded that 
E6/E7 expressing and control NPCs were able to form all three types of neural cells: 
neurons, astrocytes and oligodendrocytes in 96 hrs after the transplantation (Figure 5 in 
I). Both E6/E7 and control cells were negative for the neural progenitor marker nestin 
(data not shown) indicating that the cells were committed to differentiate. Contrary to the 
in vitro data, E6/E7 expressing NPCs did not show inhibited terminal mitosis after in vivo 
differentiation since no EGFP and Ki-67 double positive cells were detected (data not 
shown).  
 
It is possible that the specific microenvironment of the developing brain is able to 
overcome the oncogenic signals of E6/E7 genes. Another feasible option is that the 
transplanted NPCs that had delayed or inhibited the cell cycle exit were killed by 
apoptosis. It has been shown that rapid turnover of G1/S and G2/M-phases due to 
degradation of p53 often leads to chromosomal duplications and centrosomal 
abnormalities in E6/E7 expressing cells (Coursen et al., 1997). However, both control and 
E6/E7 expressing NPCs showed euploidy and normal cell cycle distribution when 
analyzed with propidium iodide staining (PI) as detected by fluorescence-activated cell 
sorting (FACS) flow cytometer (Figure 4 in I). The higher proliferation rate of E6/E7 
expressing NPCs was also seen in here, since the cell numbers in S and G2/M-phases 
were increased when compared to controls (Figure 4 in I). 
In epithelial cells, E6/E7 oncogenes up-regulate MAPK signaling (Antinore et al., 1996; 
Chakrabarti et al., 2004). Some of the MAPK pathway molecules were also changed in 
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E6/E7 expressing NPCs. In NPCs, E6/E7 expression caused upregulation of c-Jun and 
slight increase in extracellular signal-regulated kinase (ERK) activation, but no changes 
in JNK activation were detected (Figure 7 in I). c-Jun is involved in cell proliferation, 
differentiation, tumor transformation and apoptosis in various cell types (Herdegen et al., 
1997). During differentiation, E6/E7 expression decreased ERK phosphorylation but 
increased the expression of JunD transcription factor (Figure 7 in I).  
 
We focused on studying the MEK-ERK pathway that in neural cells functions at least in 
regulation of the proliferation, differentiation, neurite outgrowth and synaptic plasticity 
(reviewed in Grewal et al., 1999). Also in several tumors, Ras-Raf-MEK-ERK 
intracellular signaling cascade is often found to be constitutively active. In NPCs, MEK–
ERK inhibition by U0126 (Favata et al., 1998) led to approximately 50% decreased in 
cell proliferation but almost completely blocked the self-renewal (Figure 7 in I). This 
suggests that MEK/ERK pathway is essential for maintaining the stem cell characteristics 
in NPCs. Previously MEK/ERK has been shown to be important for the self-renewal of 
immature avian erythroid progenitor cells (Dazy et al., 2003). MEK-ERK inhibition 
during in vitro differentiation was able to decrease the excess apoptosis of E6/E7 
expressing NPCs perhaps by facilitating the cell cycle exit of the proliferating progenitors 
(Figure 13) (Piltti et al. unpublished data).  
 
Self-renewal is cell proliferation dependent and CDKs are essential for all types of cell 
division (Galderisi et al., 2003). NPCs express at least CDK-2, -4, -5 and -6, and all of 
these except CDK-5 are involved in cell cycle regulation (Ferguson et al., 2000). In 
NPCs, inhibition of CDKs by R-Roscovitine (Meijer et al., 1997), which targets CDK-1, -
2, -5, -7 and -9 almost equally (IC50 values >1 mM) (Bach et al., 2005) decreased both 
proliferation and self-renewal the same magnitude of 50% (Figure 7 in I) suggesting that 
self-renewal and proliferation pathways can be separated.  
 
 
 
 
Figure 13. Inhibition of ERK pathway by MEK 1/2 inhibitor during in vitro 
differentiation decreases the number of apoptotic cells in E6/E7 expressing NPCs. The 
chart represents an average of 2 experiments and error bars indicate ± SD (Piltti et al. 
unpublished data) 
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c-Myc 
 
Overexpression of Myc family members can be detected in several cancers (Grandori et 
al., 2000). In nervous system derived tumors, both c-Myc and n-Myc overexpression 
have been implicated in pathogenesis of medulloblastoma, glioma and neuroblastoma 
(Eberhart et al., 2004; Schwab, 2004; Su et al., 2006). In CNS, c-Myc is expressed in the 
walls of lateral ventricles, the area where self-renewing NSCs and NPCs are located 
(Figure 1 in II). Embryonic CNS NPCs transduced with modified viruses expressing 
tamoxifen inducible c-Myc (MycER) showed increased cell proliferation and self-
renewal when c-Myc expression was activated (Figure 2 in II). After 24 hrs of BrdU 
incorporation 29% of the control NPCs and 77% of tamoxifen induced MycER 
expressing NPCs were found to be in S-phase (Figure 2 in II). In self-renewal assays, 
tamoxifen increased the proportion of self-renewing cells five fold from 4.2% in control to 
22.5% in MycER expressing neurospheres (Figure 2 in II). Immunocytochemistry with 
antibody against annexin revealed that Myc does not enhance apoptosis in NPCs (Figure 
7 in II) unlike in some other cell types (Meyer et al., 2006). However, PI-stainings 
revealed that one of the transgenic Myc NPC populations had become tetraploid (Figure 
7 in II) reflecting the ability of Myc to induce genomic instability (Wade and Wahl, 
2006). 
  
Beside of the enhanced self-renewal capacity c-Myc overexpression significantly 
increased the ratio of the NPCs that expressed Bmi-1 and nestin, the markers related to 
undifferentiated neural progenitors. 84% of the control NPSc showed Bmi-1 expression 
and Myc overexpression increased this to 93% (Figure 2 in II). Bmi-1 has been shown to 
be important for self-renewal and proliferation of several stem cell types, including 
cerebellar NPCs and to be also one of the c-Myc transcription targets (Guccione et al., 
2006). The effets of Bmi-1 on self-renewal is at least partly mediated by its capacity to 
inhibit p16INK4a/p19Arf, the tumor suppressors upstream from p53 and pRb (Bruggeman et 
al., 2005; Molofsky et al., 2003), and Bmi-1 induced inhibition of p21Cip1 is essential for 
NSC self-renewal during development (Fasano et al., 2007). In both control and Myc 
overexpressing NPCs, Bmi-1 was downregulated during in vitro differentiation (Figure 3 
in II). Myc overexpression also increased percentage of nestin expressing NPCs from 
44% to 74% (Figure 2 in II). Similarly to Bmi-1 expression nestin expression also was 
downregulated almost totally during differentiation in both control and Myc-expressing 
cells (Figure 3 in II). Increased self-renewal capacity with increased percentage of cells 
expressing immature neural progenitor markers suggests that c-Myc is able to increase 
the pool of self-renewing NPCs and shift the differentiation balance towards a more 
primitive cellular identity. In astrocytes, Myc has been previously shown to drive the cell 
fate of GFAP-expressing cells towards a less differentiated, nestin-expressing progenitor-
like fate (Lassman et al., 2004). 
 
Even though undifferentiated Myc overexpressing neurospheres proliferated twice as 
much as the control NPCs, during in vitro differentiation the majority of the cells were 
able to respond to the surrounding environmental cues and exit the cell cycle. BrdU 
incorporation revealed that Myc overexpressing cells contained a minor cell population 
(4%) that continued proliferating on third day of differentiation when all the control cells 
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had exit the cell cycle (Figure 3 in II). Most of the attached control cells showed either 
neuronal or astrocytic morphology after 4 days in vitro differentiation, and 
immunocytochemistry revealed that the cells also expressed Tuj-1 and GFAP (Figure 3 in 
II). The Myc overexpressing cells also attached and showed Tuj-1 or GFAP expression 
but their morphology varied when compared to the control cells (Figure 3 in II). When 
NPCs were plated into 96-well plates in different densities and cultured in differentiation 
promoting conditions approximately 1-2% of the Myc overexpressing cells were able to 
form new neurospheres in two weeks (Figure 4 and 5 in II). Control NPCs did not show 
the neurosphere formation but differentiated permanently (Figure 4 in II). Sphere re-
formation in Myc expressing cells seemed to be density-dependent phenomenon since it 
took place only when the cells were plated in the density of more than 200 cells/well 
(Figure 5 in II). After reaching this seemingly critical number, the higher cell densities did 
not lead to an increase in the new neurospheres. When re-formed Myc-expressing spheres 
were replaced into culture medium supplemented with EGF and FGF the cells showed 
similar proliferation, self-renewal and differentiation capacity as the primary Myc 
overexpressing NPCs (Figure 5 in II). Western blott analysis of c-Myc and its 
downstream target nucleolin revealed that the re-formation of the spheres was not due to 
selection of clones that express more Myc (Figure 5 in II).  
 
In CNS, similarly to Myc also its binding partner Miz-1 is found to be expressed in the 
walls of lateral ventricles, the area where self-renewing NSCs and NPCs are located 
(Figure 8 in II). Myc interaction with Miz-1 has been shown to represses transcription of 
the cell cycle inhibitors such as p21CIP1 (Adhikary et al., 2003; Seoane et al., 2002; Staller 
et al., 2001). In keratinocytes, Myc regulates also adhesion and differentiation in the 
epidermal stem cell niche via binding to Miz-1 (Gebhardt et al., 2006). Similarly to wild 
type Myc NPCs, also NPCs transduced with modified retroviruses carrying a mutant 
form of Myc (MycV394D) that is unable to bind to Miz-1 (Herold et al., 2002) showed 
increased cell proliferation (Figure 6 in II). However, the self-renewal capacity of 
MycV394D overexpressing NPCs were similar to control NPCs (Figure 6 in II). Unlike 
wild type Myc NPCs MycV394D overexpressing NPCs also failed to re-form spheres 
during the differentiation (Figure 6 in II). This suggests that in NPCs c-Myc effect on 
self-renewal is at least partly mediated through Miz-1. However, the downstream targets 
of Myc-Miz interaction that are responsible of these effects remain to be revealed. Both 
E6/E7 and c-Myc data indicates that the stem cells or progenitors that are exposed to 
oncogenes or proto-oncogenes can shift their differentiation towards more primitive, 
highly proliferating cell population that is potential target for additional mutations needed 
for tumorigenesis. 
 
4.2 Tumor suppressors decrease both proliferation and self-renewal (I) 
 
p53 and pRb are the major tumor suppressor pathways that prevent cancer formation. 
Beside of controlling the cell proliferation, p53 has role in cell differentiation (Almog and 
Rotter, 1997). During embryogenesis and postnatally, p53, p27Kip1, and p16 INK4a mRNAs 
are highly expressed SVZ zone in rats (van Lookeren Campagne and Gill, 1998). 
Arguably the most important function of p53 in neurons is to prevent cell cycle re-entry 
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(Miller et al., 2003). Besides of differentiation, increase of p53 seems to accelerate the 
ageing of several tissues but the mechanisms are still unclear (Tyner et al., 2002). CNS 
NPCs collected from p53-deficient mouse embryos at E11 showed both increased 
proliferation and self-renewal (Figure 1 in I). During differentiation, terminal mitosis of 
p53-deficient NPCs was also delayed but completed after four days in culture (Figure 3 in 
I). p53-deficient NPCs showed ability to re-enter the cell cycle and re-form large 
numbers of spheres (>400 spheres/200 000 plated cells) after two weeks of differentiation 
if the growth factors, which promote cell proliferation were re-introduced (Figure 2 in I). 
This suggests that p53 not only has a role in tumor suppression but also a role in 
controlling NSC self-renewal. 
 
Also pRb has central role in various differentiation processes, including the neural 
differentiation in both CNS and PNS (reviewed in Giacinti and Giordano, 2006). In 
developing brain, pRb is expressed in dividing progenitors and post mitotic cells 
(Lipinski and Jacks, 1999). Mutations or functional inactivation of pRb gene are also 
found in several human tumors (reviewed in Giacinti and Giordano, 2006). In E6/E7 or in 
E7 expressing NPCs, restored pRb expression decreased excess cell proliferation but did 
not affect self-renewal (Figure 6 in I), which suggests that pRb controls cell proliferation 
instead of self-renewal.  
 
Previously, p16 INK4a, the tumor suppressor upstream from p53-pRb proteins was shown 
to control NPC self-renewal since inactivation of p16 INK4a partially rescued the 
incompetent self-renewal of Bmi-1-deficient NPCs (Molofsky et al., 2005). p16 INK4a 
inhibits the activity of cyclin D-CDK4/6 and keeps pRb-family members 
hypophosphorylated, which prevents E2F activation and blocks the cells from exiting G1-
phase (Ashizawa et al., 2001; Sherr and Weber, 2000). In E7 or in E6/E7 expressing 
NPCs, restored pRb did not upregulate the expression of the other degraded Rb-family 
members p107 and p130 (Figure 6 in I).  
 
In the brain of adult mice, unlike other Rb-family proteins, p107 expression is restricted 
to NPCs in the ventricular zone (Jiang et al., 1997; Vanderluit et al., 2004). Furthermore, 
p107 has been shown to be one of the factors that regulate NSC self-renewal (Vanderluit 
et al., 2004). In mouse CNS, p107-deficiency increases the number of slowly 
proliferating stem cells and enhances NPC self-renewal capacity in vitro (Vanderluit et 
al., 2004). Moreover, p107 modulates Notch-pathway that suppresses the differentiation 
of the neural cells (Hitoshi et al., 2002). p107 has been shown to bind to E2F consensus 
sites of Notch1 regulatory sequences and p107 overexpression downregulates Notch1 
activation (Vanderluit et al., 2004). In addition, p107-deficient mice show upregulated 
expression of Notch1 and its ligands Delta-like1 and Hes1 in SVZ (Vanderluit et al., 
2004). Therefore it is likely that the increase in self-renewal in E7 expressing NPCs is at 
least partly due to degradation of p107. In NSCs, pRb-family members are temporally 
regulated during the differentiation: p107 is expressed in uncommitted NSCs or NPCs 
and becomes rapidly downregulated when the cells undergo differentiation (Callaghan et 
al., 1999). Whereas, the pRb that is required for terminal mitosis is upregulated and 
activated when the differentiation is initiated (Callaghan et al., 1999; Ferguson et al., 
2000; Jiang et al., 1997). p130 shows upregulation once the differentiation is complete 
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and the expression is believed to maintain the cells differentiated (Callaghan et al., 1999; 
Ferguson et al., 2000; Jiang et al., 1997).  
 
p53 and pRb-family are not the only tumor suppressors, which affect the self-renewal and 
proliferation of NSCs. Loss of function of phosphatase and tensin homolog deleted on 
chromosome 10 (Pten) has been found in several human cancers including brain tumors 
(Vivanco and Sawyers, 2002; Xu et al., 2004). A lipid phosphatase and tumor suppressor 
Pten negatively regulates phospatidylinositol 3-kinase (PI3K)/Akt pathway and 
modulates G1 progression (reviewed in Endersby and Baker, 2008). Pten has been shown 
to regulate proliferation of NSC (Groszer et al., 2001, Li et al., 2003). Pten-deficient mice 
have enlarged and abnormal brains, and mutant brain derived neurospheres showed 
increased cell numbers suggesting an increased in the number of NSCs (Groszer et al., 
2001, Li et al., 2003).  
 
Also loss of tumor suppressor lethal giant larvae (Lgl) leads to massive tissue 
disorganization, tumor-like growth and lethal phenotypes in both Drosophila and mouse 
(Vasioukhin, 2006; Klezovitch et al., 2004). Lgl-deficient cells displayd disrupted cell 
polarity, failure of asymmetric cell division and defects in cell fate determination 
(Klezovitch et al., 2004; Ohshiro et al., 2000). Newborn Lgl-deficient mice suffer from 
severe hydrocephalus and die neonatally. A large proportion of Lgl-deficient NPCs fail to 
exit the cell cycle and differentiate which leads to continued proliferation and apoptosis 
(Klezovitch et al., 2004). Moreover, Lgl-deficient NPCs fail to localize Notch inhibitor 
Numb asymmetrically during the cell divisions (Klezovitch et al., 2004).  
 
4.3 Cytoskeletal tumor suppressor NF2 protein merlin and ERM protein ezrin are 
restricted into different cell lineages during CNS development (III) 
 
The expression pattern of merlin and ezrin in the CNS suggests that these proteins may 
also be involved in normal brain development. Western blotting revealed widespread 
expression of merlin and ezrin in various regions in adult human, rat and mouse brain 
tissues (Figure 1,2,3 and 4 in III). Analysis of mouse embryonic, postnatal, and adult 
brain protein lysates revealed that merlin expression started at E11 stage and it was 
highly expressed until P1 (Figure 1 in III). After that merlin expression was decreased but 
stilldetectable until one year of age (Figure 1 in III). Interestingly, merlin expression 
starts at the timepoint when neurogenesis is initiated in mouse. Various levels of ezrin 
was detected in mouse embryonic brain starting at E5 up to one year of age and the 
expression seemed to peak at E8, E9, E11, E12, at E18 and P1, and at P14, P21 and P28. 
Ezrin expression was highly decreased after P28 (Figure 1 in III). 
 
Human brain tissue arrays showed that merlin was predominantly detected in neurons and 
ezrin in astrocytes in most parts in the human brain (Figure 3 in III). Mouse fetal CNS 
derived NPCs that were cultured as spheres showed partial co-localization of merlin and 
ezrin (Figure 6 in III). In the beginning of in vitro differentiation when the spheres adhere 
to culture slide and the cells start to migrate out from sphere, ezrin was predominantly 
found in the outermost first migrating cell layer in short filopodia whereas merlin was 
From neural stem cells to precursors   Results and Discussion 
 
 
 52 
detected in the cell bodies (Figure 6 in III). Tuj-1 positive neurons that were 
spontaneously differentiated in spheres did not express ezrin but expressed merlin. 
Similarly as in human brain tissue arrays, merlin staining was strongest in Tuj-1 positive 
immature neurons that were ezrin negative after 5 days in vitro differentiation (Figure 7 
in III). Immunocytochemistry of in vitro differentiated progenitors also revealed that 
ezrin was expressed in all the GFAP positive cells that showed only weak merlin 
expression (Figure 7 in III). In rat primary hippocampal cell cultures, ezrin expression 
was concentrated in cell bodies and fine filopodia of the astrocytes (Figure 8 in III). The 
cells showed also weak merlin expression and it was mainly detected in cell bodies. 
Similarly to mouse NPC derived neurons, rat hippocampal neurons did not show ezrin 
expression but merlin was detected in the cell somas and extensions (Figure 8 in VI).  
 
In accordance of the previous data (Gutmann et al., 1995; Huynh et al., 1996), this study 
suggests that the cytoskeletal tumor suppressor NF2 protein merlin and ERM protein 
ezrin may be developmentally regulated. Huynh et al. 1996 detected merlin expression in 
wide range of mouse embryonic tissues starting at E10, and the expression appeared to be 
increased in fully differentiated tissues suggesting that merlin is involved in 
morphogenesis and organogenesis. We also detected changes in expression levels of 
merlin and ezrin during neural differentiation; primary cultures of rat hippocampal cells 
showed both merlin and ezrin expression in GFAP- and Tuj-1 positive cells in one to 
three days cultures (data not shown). However the neuronal expression of ezrin was not 
detected after three days cultures when the cells start to mature. Closer look at merlin’s 
subcellular localization in neurons revealed that the expression did not colocalized with 
presynaptic marker synapsin I positive structures but with some of the structures positive 
for postsynaptic density marker PSD-95 (Figure 8 in III). Moreover, merlin expression in 
postsynaptic junctions colocalized also with its binding partner RIβ (Gronholm et al., 
2003) (Figure 8 and 9 in III). Targeted disruption of gene encoding RIβ causes defections 
in hippocampal synaptic plasticity (Brandon et al., 1995; Huang et al., 1995). Therefore is 
a possibility that merlin has a role in signaling related to learning and memory.  
 
4.4 VEGF-C promotes cell proliferation and survival in developing sympathetic 
nervous system (IV) 
 
VEGF-C is essential for the early events of lymphangiogenesis since it promotes 
migration of the lymphatic endothelial precursors out from the cardinal veins to periphery 
prior to formation of the primary lymph sacs (Karkkainen et al., 2004). VEGF-C 
functions are not only restricted to endothelial cells because it can also promote 
proliferation in both OLPs in optic nerve and in NPCs in olfactory bulb (Le Bras et al., 
2006). Similarly to blood vessels and neurons the lymphatic- and peripheral nervous 
systems also share ligands that concurrently support development of the each other. In 
mouse embryo at E10-E13, VEGF-C is expressed adjacently to the areas where early 
sympathetic progenitor cells (SPCs) are located (Figure 1 in IV). 
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Immunohistochemistry of matched coronal sections of thoracic SGC revealed that Vegf-
c–deficient embryos had reduced SGC size due to a 48% decrease in number of early 
Tuj-1 positive sympathetic progenitors when compared to wild type controls at E13-E14 
(p<0.01, Student’s t-test) (Figure 1 in IV). Respectively, Vegf-c–-heterozygous embryos 
showed a 22% decrease in SGC size (p<0.05, Student’s t-test) (Figure 1 in IV). In 
cultured mouse SPCs that were isolated from premature sympathetic chain, VEGF-C 
increased proliferation and survival dose-dependently and ligand specifically (Figure 2 
and 3 in IV) suggesting that VEGF-C is acting as a paracrine factor in the developing 
SGC. In addition, VEGF-C and GFLs seem to function together in SNS development 
since in vitro VEGF-C and Ret ligands ARTN and GDNF induced similar growth levels 
in sympathetic ganglion-like structures and proliferation in SPCs (Figure 2 in IV).
VEGF-C unlikely affects the cell migration, self-renewal, neurite outgrowth, or lineage 
decision in embryonic SPCs (Figure 3 in IV). However, similarly to several other growth 
factors VEGF-C also seems to change its functions while SNS matures since at P1 
exogenously added VEGF-C did not increase cell survival but enhanced neurite 
outgrowth in sympathetic cervical ganglia (Supplemental figure 1 in IV).  
 
Our data suggests that unlike in endothelial cells or CNS progenitors (Joukov et al., 1996; 
Le Bras et al., 2006), the VEGF-C signal in embryonic SNS is not mediated through 
known VEGF-C receptors (Figure 4 in IV). In SPCs, Vegfr-2 and Vegfr-3 expression was 
found to be virtually absent (≤0.01) and Tuj-1 positive immature sympathetic chain in 
Vegfr3/lacZ+/- mouse embryos did not show Vegfr-3-promoter driven β -galactosidase 
activity (Figure 4 in IV). As earlier reported by (Chen et al., 1997 and Kolodkin et al., 
1997), embryonic SPCs expressed high levels of Nrp1 and Nrp2 (Figure 4 in IV). Nrps 
have not been shown to signal on their own (He and Tessier-Lavigne, 1997) but they are 
potential co-receptors for VEGF-C in embryonic SNS. 
 
Despite of lack of VEGFR-2 and VEGFR-3, VEGF-C stimulus enhanced ERK 
phosphorylation in SPCs (Figure 4 in IV). In neural cells, MEK/ERK intracellular 
signaling cascade can be activated by several receptors and it is implicated in multiple 
cellular responses such as proliferation, self-renewal, survival and cell death, and 
differentiation (Colucci-D'Amato et al., 2003; Thomas and Huganir, 2004). In SPCs, 
VEGF-C induced MEK/ERK pathway activation is related to cell proliferation since 
specific MEK1/2 inhibitor decreased VEGF-C induced proliferation to the same level 
with the uninduced controls (Figure 4 in IV). In SPCs, VEGF-C provided cell survival is 
unlikely mediated through PI3K/Akt that has been related to sympathetic cell survival 
(Crowder and Freeman, 1998) since VEGF-C stimulus did not change the pathway 
activation (Figure 4 in IV). VEGF-C stimulus neither resulted in changes in JNK/c-Jun 
pathway activation (Figure 4 in IV), which has been implicated in neural cell death, stress 
and degeneration (Harper and LoGrasso, 2001). 
 
GFLs and the general signaling receptor Ret are critically needed for the migration, 
proliferation and differentiation of several neural crest-derived PNS cell populations 
including the sympathetic progenitors (Enomoto et al., 2001; Pichel et al., 1996). Ret-
deficient mouse embryos (Schuchardt et al., 1994) show decreased sympathetic chain 
size when compared to wild type embryos at E11 and during later development (Enomoto 
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et al., 2001). Since Ret-deficient and Ret-heterozygous SPCs were not able to respond to 
VEGF-C we hypothesize that VEGF-C acts downstream of GFL/Ret in the signaling 
cascade of growth factors needed for SNS development. The lack of VEGF-C response in 
Ret-deficient SPCs was not due to changes in the expression levels of the conventional 
VEGF-C receptors since the amount of Nrps and VEGFRs did not differ from that in wild 
type SPCs. Previously, Ret phosphorylation has shown to take place in presence of 
exogenous VEGF-A in ureteric bud cell line (Tufro et al., 2007), but we gained no 
evidence of upregulated Ret phosphorylation in VEGF-C stimulated SPCs. Nevertheless, 
this suggests that Ret is required for the specification of sympathetic cells prior the 
VEGF-C. 
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5 CONCLUDING REMARKS AND PERSPECTIVES 
 
This study suggests that tumor suppressors regulate not only NPC proliferation but also 
their self-renewal. The mechanisms by which tumor suppressors or their downstream 
targets inhibit the self-renewal capacity remain still unclear. Moreover, signaling related 
to NPC proliferation and self-renewal are connected but can be also separated since 
active MEK-ERK pathway seems to be more necessary for the self-renewal than for the 
proliferation. Interestingly, E6/E7 expressing NPCs showed slightly higher levels of ERK 
phosphorylation levels than the controls, and the inhibition of MEK-ERK pathway 
decreased the excess proliferation and self-renewal capacity. Respectively, several 
tumors have constitutively active MEK-ERK pathway and hypothetically this could also 
contribute to the cancer stem cell maintenance. Furthermore, oncogenic exposure or loss 
of p53 function in NPCs seemed to diminish their sensitivity for microenvironmental 
cues. A small proportion cells maintained the stem cell characteristics in conditions, 
which normally promote differentiation and terminal cell cycle exit.  
 
c-Myc interaction with Miz-1 seems to be critical for its capacity to promote self-renewal 
in NPCs. However, it is still uncertain whether the effect is mediated by transcriptional 
inhibition of CDK inhibitor proteins such as p21Cip1 or by some other mechanisms. 
Developing brain and NPCs express cytoskeletal tumor suppressor NF2 protein merlin 
and ERM protein ezrin but the expression is mostly restricted into different neural cell 
lineages during the differentiation. Merlin expression in mouse brain also peaks at the 
time point when neurogenesis is initiated suggesting that merlin may have a role in neural 
differentiation and brain development. 
  
Beside tumor suppressors and oncogene studies, this thesis revealed that 
lymphangiogenic growth factor VEGF-C is novel paracrine growth factor for developing 
sympathetic nervous system. VEGF-C and GDNF family ligands seem to function 
together in sympathetic ganglia chain formation. Moreover, c-Ret, the signaling receptor 
for GDNF family ligands, is required for the specification of sympathetic lineage cells 
prior to function of VEGF-C. Unlike in CNS progenitors or endothelial cells, the VEGF-
C signal in sympathetic progenitors is mediated through VEGFR-2 and VEGFR-3 
independent alternative receptor or receptor complex that remains to be discovered. 
 
 
 
 
 
From neural stem cells to precursors   Acknowledgements 
 
 
 56 
6 ACKNOWLEDGEMENTS 
 
This research was carried out at the Developmental Biology laboratory, 
Institute of Biomedicine, University of Helsinki during 2002-2008. I want to express my 
gratitude to the Head of the Institute, professor Esa Korpi, for providing excellent 
facilities and administrative support: without quality infrastructure great scientific 
research would be impossible  
I am grateful to my supervisors for all the mentoring that I have received these 
past years. I thank Dr. Kirmo Wartiovaara for his valuable contribution to my thesis 
especially during my first four years of my studies, and professor Hannu Sariola for his 
encouragement and excellent scientific advice, based on his long-term experience in 
developmental biology and medical research. I am very grateful to Dr. Kirsi Sainio for 
her advice and guidance during my final years of my study; her constant and strong 
support helped me to push this process to its end. I warmly thank my thesis committee 
members, professor Tomi Mäkelä and Dr. Marjo Salminen for their recommendations 
and helpful advice. I would also like to kindly acknowledge Dr. Juha Partanen and Dr. 
Ari Ristimäki for their constructive comments upon reviewing my thesis. Professor Päivi 
Ojala, Tomi Mäkelä, Ms. Aija Kaitera and Dr. Elina Värtö at the Helsinki Biomedical 
Graduate School administration are warmly thanked for all the opportunities provided to 
me during the past years. We were lucky enough to share the Centre of Excellence 
position of the Academy of Finland during the first years of my studies: professor Irma 
Thesleff as the head of the Centre is acknowledged for the excellent scientific atmosphere 
the program has provided to all those involved. Professor Juha Voipio, my custos, and 
Dr. Jonna Katajisto at the Faculty of Biosciences are acknowledged for their kind 
assistance with the thesis related details and paper work. Without your constant guidance 
throughout this process I would have been lost. My most valuable collaborators have 
been professors Mart Saarma, Kari Alitalo and Olli Carpen. They provided me with the 
tools that were critical in carrying out this study successfully to the end – with luck I 
hope that this fruitful collaboration continues in the future. I warmly thank my 
postdoctoral advisors Dr. Aileen Anderson and Dr. Brian Cummings and their sweet 
daughter Camryn for the patience and the support while I have been at University of 
California, Irvine, and my current colleague Manuel Galvan for the language review of 
my thesis.  
I am grateful to all my co-authors and collaborators for their individual 
contributions and great teamwork spirit, especially to Laura Kerosuo, Mikaela 
Grönholm, Janne Hakanen, Anu Plaken, Paula Haiko, Minna Eriksson, Marika 
Kärkkäinen, Mart Saarma, Kari Alitalo, Olli Carpen and Sirpa Leppä, Marjo Salminen 
and Meilahti Experimental Animal Facility staff – your help has been valuable. I also 
want to acknowledge Drs. Anu Wartiovaara, Nina Nupponen and Juha Klefström Marika 
Linja, Tanja Lepikhova for their advice and assistance. I want to thank all my friends and 
co-students in HBGS and the other graduate schools, especially Anna Kiialainen, Kilian 
Guse, Kari Vaahtomeri, Tea Blom, Taru Muranen, Thomas Westerling, Pekka Katajisto, 
João Dias, Iulia Diaconu, Milla Mikkola, Can Hekim, Johanna Partanen, Tuomas 
Tammela, Katja Helenius, Nora Pöntynen, Marko Uutela, Topi Tervonen, Ana-Marie and 
Niklas Pakkasjärvi for all the events and parties that we shared together, and the Finnish 
Developmetal Biologists in Oulu, Turku and Helsinki for the unforgettable moments in 
Tvärminne and Hyytiälä. I also want to thank Heli Lindeberg and the other people 
From neural stem cells to precursors   Acknowledgements 
 
 
 57 
affiliated with Kuopio University for all the good old times and for giving me the spark 
that has led me here. 
I want to thank all the present and past members of the Circus Sariola for all 
the shared moments and cooperation – I will miss the crayfish parties, the fondue and 
wine tasting get-togethers, picnics, afternoon skiing and all the other great activities that 
we did together. I thank Laura for all the shared conference trips - we indeed chose the 
best ones. Valtteri and Samer are truly thanked for being my friends and labmates, even 
the busiest moments at the work were joyful with you guys. I thank Fares and Roxana for 
bringing lots of colourful attitude and laughter into the lab. Madis, Alexandre, Heli, 
Anna, Marjo, Nina, Marianna, Tiina, Satu, Anastasia, Maria, Pauli, Antti, Anita, Eric, 
Maxim, Jonna and Jouni - it was a pleasure to work and share the same labspace with 
you. My sincere thanks go to the excellent technical support, especially to Agnès but not 
forgetting Lea, Virpi, Jetta, Valtteri Harri, and Jukka Suokas for all their technical 
assistance. 
I grace all my good friends, especially Anna P, Anna K, Mikko, Kilian, 
Genevieve, Heli, Heikki, Marja and Gustavo - you were always there for me! Your 
friendship and support is very precious to me. I also want to thank Markus, Laura and 
Lotta for the gourmet dinners, delightful parties and joyful activities including the famous 
summer Olympic games. Thank you for the great times we have shared together – those 
shall continue!  
Last but surely not least, my dearest acknowledgements belong to my Mother 
and my Father, grandmother and all the rest of my kin, thank you for your love and 
support. I hope that some day this thesis will encourage my godchildren Iiris, Erno and 
Elina to reach far in their own studies. 
I have been financially supported by grants from the Helsinki Biomedical 
Graduate School, Biomedicum Helsinki Foundation, Lilly Foundation (Lilly Säätiö), 
Orion Pharma Research Foundation, Finnish Concordia Fund, Vetenskapsstiftelsen för 
Kvinnor and University of Helsinki Funds. 
 
 
 
Irvine, March 2009      
   
 
 
 
 
 
 
 
 
 
 
From neural stem cells to precursors   References 
 
 
 58 
7 REFERENCES 
 
Achen, M. G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A. F., Alitalo, K. 
and Stacker, S. A. (1998). Vascular Endothelial Growth Factor D (VEGF-D) is a Ligand 
for the Tyrosine Kinases VEGF Receptor 2 (Flk1) and VEGF Receptor 3 (Flt4). Proc. 
Natl. Acad. Sci. U. S. A. 95, 548-553. 
Adhikary, S., Peukert, K., Karsunky, H., Beuger, V., Lutz, W., Elsasser, H. P., 
Moroy, T. and Eilers, M. (2003). Miz1 is Required for Early Embryonic Development 
during Gastrulation. Mol. Cell. Biol. 23, 7648-7657. 
Airaksinen, M. S. and Saarma, M. (2002). The GDNF Family: Signalling, Biological 
Functions and Therapeutic Value. Nat. Rev. Neurosci. 3, 383-394. 
Airaksinen, M. S., Titievsky, A. and Saarma, M. (1999). GDNF Family Neurotrophic 
Factor Signaling: Four Masters, One Servant? Mol. Cell. Neurosci. 13, 313-325. 
Akin, Z. N. and Nazarali, A. J. (2005). Hox Genes and their Candidate Downstream 
Targets in the Developing Central Nervous System. Cell. Mol. Neurobiol. 25, 697-741. 
Almog, N. and Rotter, V. (1997). Involvement of p53 in Cell Differentiation and 
Development. Biochim. Biophys. Acta 1333, F1-27. 
Alvarez-Buylla, A., Garcia-Verdugo, J. M. and Tramontin, A. D. (2001). A Unified 
Hypothesis on the Lineage of Neural Stem Cells. Nat. Rev. Neurosci. 2, 287-293. 
Anders, J., Kjar, S. and Ibanez, C. F. (2001). Molecular Modeling of the Extracellular 
Domain of the RET Receptor Tyrosine Kinase Reveals Multiple Cadherin-Like Domains 
and a Calcium-Binding Site. J. Biol. Chem. 276, 35808-35817. 
Anthony, T. E., Klein, C., Fishell, G. and Heintz, N. (2004). Radial Glia Serve as 
Neuronal Progenitors in all Regions of the Central Nervous System. Neuron 41, 881-890. 
Antinore, M. J., Birrer, M. J., Patel, D., Nader, L. and McCance, D. J. (1996). The 
Human Papillomavirus Type 16 E7 Gene Product Interacts with and Trans-Activates the 
AP1 Family of Transcription Factors. EMBO J. 15, 1950-1960. 
Armstrong, J. F., Kaufman, M. H., Harrison, D. J. and Clarke, A. R. (1995). High-
Frequency Developmental Abnormalities in p53-Deficient Mice. Curr. Biol. 5, 931-936. 
Artavanis-Tsakonas, S., Rand, M. D. and Lake, R. J. (1999). Notch Signaling: Cell 
Fate Control and Signal Integration in Development. Science 284, 770-776. 
Ashizawa, S., Nishizawa, H., Yamada, M., Higashi, H., Kondo, T., Ozawa, H., 
Kakita, A. and Hatakeyama, M. (2001). Collective Inhibition of pRB Family Proteins 
by Phosphorylation in Cells with p16INK4a Loss Or Cyclin E Overexpression. J. Biol. 
Chem. 276, 11362-11370. 
Ayscough, K. R. (1998). In Vivo Functions of Actin-Binding Proteins. Curr. Opin. Cell 
Biol. 10, 102-111. 
Bach, S., Knockaert, M., Reinhardt, J., Lozach, O., Schmitt, S., Baratte, B., Koken, 
M., Coburn, S. P., Tang, L., Jiang, T. et al. (2005). Roscovitine Targets, Protein 
Kinases and Pyridoxal Kinase. J. Biol. Chem. 280, 31208-31219. 
Bagri, A. and Tessier-Lavigne, M. (2002). Neuropilins as Semaphorin Receptors: In 
Vivo Functions in Neuronal Cell Migration and Axon Guidance. Adv. Exp. Med. Biol. 
515, 13-31. 
Baloh, R. H., Tansey, M. G., Lampe, P. A., Fahrner, T. J., Enomoto, H., Simburger, 
K. S., Leitner, M. L., Araki, T., Johnson, E. M.,Jr and Milbrandt, J. (1998). Artemin, 
From neural stem cells to precursors   References 
 
 
 59 
a Novel Member of the GDNF Ligand Family, Supports Peripheral and Central Neurons 
and Signals through the GFRalpha3-RET Receptor Complex. Neuron 21, 1291-1302. 
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L. and 
Vousden, K. H. (1998). P14ARF Links the Tumour Suppressors RB and p53. Nature 
395, 124-125. 
Baudino, T. A., McKay, C., Pendeville-Samain, H., Nilsson, J. A., Maclean, K. H., 
White, E. L., Davis, A. C., Ihle, J. N. and Cleveland, J. L. (2002). C-Myc is Essential 
for Vasculogenesis and Angiogenesis during Development and Tumor Progression. 
Genes Dev. 16, 2530-2543. 
Bea, S., Tort, F., Pinyol, M., Puig, X., Hernandez, L., Hernandez, S., Fernandez, P. 
L., van Lohuizen, M., Colomer, D. and Campo, E. (2001). BMI-1 Gene Amplification 
and Overexpression in Hematological Malignancies Occur mainly in Mantle Cell 
Lymphomas. Cancer Res. 61, 2409-2412. 
Beierle, E. A., Dai, W., Langham, M. R.,Jr, Copeland, E. M.,3rd and Chen, M. K. 
(2003). VEGF Receptors are Differentially Expressed by Neuroblastoma Cells in Culture. 
J. Pediatr. Surg. 38, 514-521. 
Bellmeyer, A., Krase, J., Lindgren, J. and LaBonne, C. (2003). The Protooncogene c-
Myc is an Essential Regulator of Neural Crest Formation in Xenopus. Dev. Cell. 4, 827-
839. 
Bellomo, D., Headrick, J. P., Silins, G. U., Paterson, C. A., Thomas, P. S., Gartside, 
M., Mould, A., Cahill, M. M., Tonks, I. D., Grimmond, S. M. et al. (2000). Mice 
Lacking the Vascular Endothelial Growth Factor-B Gene (Vegfb) have Smaller Hearts, 
Dysfunctional Coronary Vasculature, and Impaired Recovery from Cardiac Ischemia. 
Circ. Res. 86, E29-35. 
Bernat, A., Avvakumov, N., Mymryk, J. S. and Banks, L. (2003). Interaction between 
the HPV E7 Oncoprotein and the Transcriptional Coactivator p300. Oncogene 22, 7871-
7881. 
Bixby, S., Kruger, G. M., Mosher, J. T., Joseph, N. M. and Morrison, S. J. (2002). 
Cell-Intrinsic Differences between Stem Cells from Different Regions of the Peripheral 
Nervous System Regulate the Generation of Neural Diversity. Neuron 35, 643-656. 
Bohling, T., Turunen, O., Jaaskelainen, J., Carpen, O., Sainio, M., Wahlstrom, T., 
Vaheri, A. and Haltia, M. (1996). Ezrin Expression in Stromal Cells of Capillary 
Hemangioblastoma. an Immunohistochemical Survey of Brain Tumors. Am. J. Pathol. 
148, 367-373. 
Bouchard, C., Thieke, K., Maier, A., Saffrich, R., Hanley-Hyde, J., Ansorge, W., 
Reed, S., Sicinski, P., Bartek, J. and Eilers, M. (1999). Direct Induction of Cyclin D2 
by Myc Contributes to Cell Cycle Progression and Sequestration of p27. EMBO J. 18, 
5321-5333. 
Bourdon, J. C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, 
D. P., Saville, M. K. and Lane, D. P. (2005). P53 Isoforms can Regulate p53 
Transcriptional Activity. Genes Dev. 19, 2122-2137. 
Boyer, S. N., Wazer, D. E. and Band, V. (1996). E7 Protein of Human Papilloma Virus-
16 Induces Degradation of Retinoblastoma Protein through the Ubiquitin-Proteasome 
Pathway. Cancer Res. 56, 4620-4624. 
Brandon, E. P., Zhuo, M., Huang, Y. Y., Qi, M., Gerhold, K. A., Burton, K. A., 
Kandel, E. R., McKnight, G. S. and Idzerda, R. L. (1995). Hippocampal Long-Term 
From neural stem cells to precursors   References 
 
 
 60 
Depression and Depotentiation are Defective in Mice Carrying a Targeted Disruption of 
the Gene Encoding the RI Beta Subunit of cAMP-Dependent Protein Kinase. Proc. Natl. 
Acad. Sci. U. S. A. 92, 8851-8855. 
Brehm, A., Nielsen, S. J., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J. 
and Kouzarides, T. (1999). The E7 Oncoprotein Associates with Mi2 and Histone 
Deacetylase Activity to Promote Cell Growth. EMBO J. 18, 2449-2458. 
Bretscher, A., Edwards, K. and Fehon, R. G. (2002). ERM Proteins and Merlin: 
Integrators at the Cell Cortex. Nat. Rev. Mol. Cell Biol. 3, 586-599. 
Briscoe, J., Sussel, L., Serup, P., Hartigan-O'Connor, D., Jessell, T. M., Rubenstein, 
J. L. and Ericson, J. (1999). Homeobox Gene Nkx2.2 and Specification of Neuronal 
Identity by Graded Sonic Hedgehog Signalling. Nature 398, 622-627. 
Bruggeman, S. W., Valk-Lingbeek, M. E., van der Stoop, P. P., Jacobs, J. J., 
Kieboom, K., Tanger, E., Hulsman, D., Leung, C., Arsenijevic, Y., Marino, S. et al. 
(2005). Ink4a and Arf Differentially Affect Cell Proliferation and Neural Stem Cell Self-
Renewal in Bmi1-Deficient Mice. Genes Dev. 19, 1438-1443. 
Brustle, O., Jones, K. N., Learish, R. D., Karram, K., Choudhary, K., Wiestler, O. 
D., Duncan, I. D. and McKay, R. D. (1999). Embryonic Stem Cell-Derived Glial 
Precursors: A Source of Myelinating Transplants. Science 285, 754-756. 
Bull, J. J., Muller-Rover, S., Patel, S. V., Chronnell, C. M., McKay, I. A. and 
Philpott, M. P. (2001). Contrasting Localization of c-Myc with Other Myc Superfamily 
Transcription Factors in the Human Hair Follicle and during the Hair Growth Cycle. J. 
Invest. Dermatol. 116, 617-622. 
Callaghan, D. A., Dong, L., Callaghan, S. M., Hou, Y. X., Dagnino, L. and Slack, R. 
S. (1999). Neural Precursor Cells Differentiating in the Absence of Rb Exhibit Delayed 
Terminal Mitosis and Deregulated E2F 1 and 3 Activity. Dev. Biol. 207, 257-270. 
Cao, Z., Umek, R. M. and McKnight, S. L. (1991). Regulated Expression of Three 
C/EBP Isoforms during Adipose Conversion of 3T3-L1 Cells. Genes Dev. 5, 1538-1552. 
Capela, A. and Temple, S. (2002). LeX/ssea-1 is Expressed by Adult Mouse CNS Stem 
Cells, Identifying them as Nonependymal. Neuron 35, 865-875. 
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., 
Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C. et al. (1996). Abnormal 
Blood Vessel Development and Lethality in Embryos Lacking a Single VEGF Allele. 
Nature 380, 435-439. 
Carmeliet, P. and Tessier-Lavigne, M. (2005). Common Mechanisms of Nerve and 
Blood Vessel Wiring. Nature 436, 193-200. 
Cartwright, P., McLean, C., Sheppard, A., Rivett, D., Jones, K. and Dalton, S. 
(2005). LIF/STAT3 Controls ES Cell Self-Renewal and Pluripotency by a Myc-
Dependent Mechanism. Development 132, 885-896. 
Casarosa, S., Fode, C. and Guillemot, F. (1999). Mash1 Regulates Neurogenesis in the 
Ventral Telencephalon. Development 126, 525-534. 
Cassidy, R. and Frisen, J. (2001). Neurobiology. Stem Cells on the Brain. Nature 412, 
690-691. 
Cau, E., Casarosa, S. and Guillemot, F. (2002). Mash1 and Ngn1 Control Distinct 
Steps of Determination and Differentiation in the Olfactory Sensory Neuron Lineage. 
Development 129, 1871-1880. 
From neural stem cells to precursors   References 
 
 
 61 
Cayouette, M. and Raff, M. (2002). Asymmetric Segregation of Numb: A Mechanism 
for Neural Specification from Drosophila to Mammals. Nat. Neurosci. 5, 1265-1269. 
Chakrabarti, O., Veeraraghavalu, K., Tergaonkar, V., Liu, Y., Androphy, E. J., 
Stanley, M. A. and Krishna, S. (2004). Human Papillomavirus Type 16 E6 Amino Acid 
83 Variants Enhance E6-Mediated MAPK Signaling and Differentially Regulate 
Tumorigenesis by Notch Signaling and Oncogenic Ras. J. Virol. 78, 5934-5945. 
Chen, H., Bagri, A., Zupicich, J. A., Zou, Y., Stoeckli, E., Pleasure, S. J., 
Lowenstein, D. H., Skarnes, W. C., Chedotal, A. and Tessier-Lavigne, M. (2000). 
Neuropilin-2 Regulates the Development of Selective Cranial and Sensory Nerves and 
Hippocampal Mossy Fiber Projections. Neuron 25, 43-56. 
Chen, H., Chedotal, A., He, Z., Goodman, C. S. and Tessier-Lavigne, M. (1997). 
Neuropilin-2, a Novel Member of the Neuropilin Family, is a High Affinity Receptor for 
the Semaphorins Sema E and Sema IV but Not Sema III. Neuron 19, 547-559. 
Chen, H., He, Z., Bagri, A. and Tessier-Lavigne, M. (1998). Semaphorin-Neuropilin 
Interactions Underlying Sympathetic Axon Responses to Class III Semaphorins. Neuron 
21, 1283-1290. 
Chenn, A. and McConnell, S. K. (1995). Cleavage Orientation and the Asymmetric 
Inheritance of Notch1 Immunoreactivity in Mammalian Neurogenesis. Cell 82, 631-641. 
Cheung, M., Chaboissier, M. C., Mynett, A., Hirst, E., Schedl, A. and Briscoe, J. 
(2005). The Transcriptional Control of Trunk Neural Crest Induction, Survival, and 
Delamination. Dev. Cell. 8, 179-192. 
Chipuk, J. E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D. D. and Green, D. R. 
(2005). PUMA Couples the Nuclear and Cytoplasmic Proapoptotic Function of p53. 
Science 309, 1732-1735. 
Chow, J., Ogunshola, O., Fan, S. Y., Li, Y., Ment, L. R. and Madri, J. A. (2001). 
Astrocyte-Derived VEGF Mediates Survival and Tube Stabilization of Hypoxic Brain 
Microvascular Endothelial Cells in Vitro. Brain Res. Dev. Brain Res. 130, 123-132. 
Claudio, J. O., Lutchman, M. and Rouleau, G. A. (1995). Widespread but Cell Type-
Specific Expression of the Mouse Neurofibromatosis Type 2 Gene. Neuroreport 6, 1942-
1946. 
Claudio, P. P., Tonini, T. and Giordano, A. (2002). The Retinoblastoma Family: Twins 
Or Distant Cousins? Genome Biol. 3, reviews3012. 
Clauss, M., Weich, H., Breier, G., Knies, U., Rockl, W., Waltenberger, J. and Risau, 
W. (1996). The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological 
Activities. Implications for a Functional Role of Placenta Growth Factor in Monocyte 
Activation and Chemotaxis. J. Biol. Chem. 271, 17629-17634. 
Cobrinik, D., Lee, M. H., Hannon, G., Mulligan, G., Bronson, R. T., Dyson, N., 
Harlow, E., Beach, D., Weinberg, R. A. and Jacks, T. (1996). Shared Role of the pRB-
Related p130 and p107 Proteins in Limb Development. Genes Dev. 10, 1633-1644. 
Coller, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N. 
and Golub, T. R. (2000). Expression Analysis with Oligonucleotide Microarrays 
Reveals that MYC Regulates Genes Involved in Growth, Cell Cycle, Signaling, and 
Adhesion. Proc. Natl. Acad. Sci. U. S. A. 97, 3260-3265. 
Colucci-D'Amato, L., Perrone-Capano, C. and di Porzio, U. (2003). Chronic 
Activation of ERK and Neurodegenerative Diseases. Bioessays 25, 1085-1095. 
From neural stem cells to precursors   References 
 
 
 62 
Conboy, I. M., Conboy, M. J., Smythe, G. M. and Rando, T. A. (2003). Notch-
Mediated Restoration of Regenerative Potential to Aged Muscle. Science 302, 1575-
1577. 
Corbin, J. G., Gaiano, N., Juliano, S. L., Poluch, S., Stancik, E. and Haydar, T. F. 
(2008). Regulation of Neural Progenitor Cell Development in the Nervous System. J. 
Neurochem. 106, 2272-2287. 
Coursen, J. D., Bennett, W. P., Gollahon, L., Shay, J. W. and Harris, C. C. (1997). 
Genomic Instability and Telomerase Activity in Human Bronchial Epithelial Cells during 
Immortalization by Human Papillomavirus-16 E6 and E7 Genes. Exp. Cell Res. 235, 245-
253. 
Crowder, R. J. and Freeman, R. S. (1998). Phosphatidylinositol 3-Kinase and Akt 
Protein Kinase are Necessary and Sufficient for the Survival of Nerve Growth Factor-
Dependent Sympathetic Neurons. J. Neurosci. 18, 2933-2943. 
Crowley, C., Spencer, S. D., Nishimura, M. C., Chen, K. S., Pitts-Meek, S., 
Armanini, M. P., Ling, L. H., McMahon, S. B., Shelton, D. L. and Levinson, A. D. 
(1994). Mice Lacking Nerve Growth Factor Display Perinatal Loss of Sensory and 
Sympathetic Neurons Yet Develop Basal Forebrain Cholinergic Neurons. Cell 76, 1001-
1011. 
Cserjesi, P., Brown, D., Lyons, G. E. and Olson, E. N. (1995). Expression of the Novel 
Basic Helix-Loop-Helix Gene eHAND in Neural Crest Derivatives and Extraembryonic 
Membranes during Mouse Development. Dev. Biol. 170, 664-678. 
Dahiya, A., Wong, S., Gonzalo, S., Gavin, M. and Dean, D. C. (2001). Linking the Rb 
and Polycomb Pathways. Mol. Cell 8, 557-569. 
Dang, C. V., O'Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C. and Li, F. 
(2006). The c-Myc Target Gene Network. Semin. Cancer Biol. 16, 253-264. 
Davies, R., Hicks, R., Crook, T., Morris, J. and Vousden, K. (1993). Human 
Papillomavirus Type 16 E7 Associates with a Histone H1 Kinase and with p107 through 
Sequences Necessary for Transformation. J. Virol. 67, 2521-2528. 
Davis, R. J. (1995). Transcriptional Regulation by MAP Kinases. Mol. Reprod. Dev. 42, 
459-467. 
Dazy, S., Damiola, F., Parisey, N., Beug, H. and Gandrillon, O. (2003). The MEK-
1/ERKs Signalling Pathway is Differentially Involved in the Self-Renewal of Early and 
Late Avian Erythroid Progenitor Cells. Oncogene 22, 9205-9216. 
de Graaff, E., Srinivas, S., Kilkenny, C., D'Agati, V., Mankoo, B. S., Costantini, F. 
and Pachnis, V. (2001). Differential Activities of the RET Tyrosine Kinase Receptor 
Isoforms during Mammalian Embryogenesis. Genes Dev. 15, 2433-2444. 
DeCaprio, J. A. (1999). The Role of the J Domain of SV40 Large T in Cellular 
Transformation. Biologicals 27, 23-28. 
Del Bene, F., Wehman, A. M., Link, B. A. and Baier, H. (2008). Regulation of 
Neurogenesis by Interkinetic Nuclear Migration through an Apical-Basal Notch Gradient. 
Cell 134, 1055-1065. 
Dellino, G. I., Schwartz, Y. B., Farkas, G., McCabe, D., Elgin, S. C. and Pirrotta, V. 
(2004). Polycomb Silencing Blocks Transcription Initiation. Mol. Cell 13, 887-893. 
den Bakker, M. A., Vissers, K. J., Molijn, A. C., Kros, J. M., Zwarthoff, E. C. and 
van der Kwast, T. H. (1999). Expression of the Neurofibromatosis Type 2 Gene in 
Human Tissues. J. Histochem. Cytochem. 47, 1471-1480. 
From neural stem cells to precursors   References 
 
 
 63 
Dikov, M. M., Ohm, J. E., Ray, N., Tchekneva, E. E., Burlison, J., Moghanaki, D., 
Nadaf, S. and Carbone, D. P. (2005). Differential Roles of Vascular Endothelial Growth 
Factor Receptors 1 and 2 in Dendritic Cell Differentiation. J. Immunol. 174, 215-222. 
Doetsch, F., Caille, I., Lim, D. A., Garcia-Verdugo, J. M. and Alvarez-Buylla, A. 
(1999). Subventricular Zone Astrocytes are Neural Stem Cells in the Adult Mammalian 
Brain. Cell 97, 703-716. 
Duff, R. S., Langtimm, C. J., Richardson, M. K. and Sieber-Blum, M. (1991). In 
Vitro Clonal Analysis of Progenitor Cell Patterns in Dorsal Root and Sympathetic 
Ganglia of the Quail Embryo. Dev. Biol. 147, 451-459. 
Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., 
Breitman, M. and Alitalo, K. (1998). Cardiovascular Failure in Mouse Embryos 
Deficient in VEGF Receptor-3. Science 282, 946-949. 
Dupin, E., Glavieux, C., Vaigot, P. and Le Douarin, N. M. (2000). Endothelin 3 
Induces the Reversion of Melanocytes to Glia through a Neural Crest-Derived Glial-
Melanocytic Progenitor. Proc. Natl. Acad. Sci. U. S. A. 97, 7882-7887. 
Dupin, E., Real, C., Glavieux-Pardanaud, C., Vaigot, P. and Le Douarin, N. M. 
(2003). Reversal of Developmental Restrictions in Neural Crest Lineages: Transition 
from Schwann Cells to Glial-Melanocytic Precursors in Vitro. Proc. Natl. Acad. Sci. U. 
S. A. 100, 5229-5233. 
Dyson, N., Dembski, M., Fattaey, A., Ngwu, C., Ewen, M. and Helin, K. (1993). 
Analysis of p107-Associated Proteins: P107 Associates with a Form of E2F that Differs 
from pRB-Associated E2F-1. J. Virol. 67, 7641-7647. 
Eberhart, C. G., Kratz, J., Wang, Y., Summers, K., Stearns, D., Cohen, K., Dang, C. 
V. and Burger, P. C. (2004). Histopathological and Molecular Prognostic Markers in 
Medulloblastoma: C-Myc, N-Myc, TrkC, and Anaplasia. J. Neuropathol. Exp. Neurol. 
63, 441-449. 
Ebos, J. M., Bocci, G., Man, S., Thorpe, P. E., Hicklin, D. J., Zhou, D., Jia, X. and 
Kerbel, R. S. (2004). A Naturally Occurring Soluble Form of Vascular Endothelial 
Growth Factor Receptor 2 Detected in Mouse and Human Plasma. Mol. Cancer. Res. 2, 
315-326. 
Eggert, A., Ikegaki, N., Kwiatkowski, J., Zhao, H., Brodeur, G. M. and Himelstein, 
B. P. (2000). High-Level Expression of Angiogenic Factors is Associated with Advanced 
Tumor Stage in Human Neuroblastomas. Clin. Cancer Res. 6, 1900-1908. 
Eichmann, A., Corbel, C., Jaffredo, T., Breant, C., Joukov, V., Kumar, V., Alitalo, 
K. and le Douarin, N. M. (1998). Avian VEGF-C: Cloning, Embryonic Expression 
Pattern and Stimulation of the Differentiation of VEGFR2-Expressing Endothelial Cell 
Precursors. Development 125, 743-752. 
Ekstrand, A. J., James, C. D., Cavenee, W. K., Seliger, B., Pettersson, R. F. and 
Collins, V. P. (1991). Genes for Epidermal Growth Factor Receptor, Transforming 
Growth Factor Alpha, and Epidermal Growth Factor and their Expression in Human 
Gliomas in Vivo. Cancer Res. 51, 2164-2172. 
el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., 
Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. (1993). WAF1, a Potential 
Mediator of p53 Tumor Suppression. Cell 75, 817-825. 
Endersby, R. and Baker, S. J. (2008). PTEN Signaling in Brain: Neuropathology and 
Tumorigenesis. Oncogene 27, 5416-5430. 
From neural stem cells to precursors   References 
 
 
 64 
Englund, C., Fink, A., Lau, C., Pham, D., Daza, R. A., Bulfone, A., Kowalczyk, T. 
and Hevner, R. F. (2005). Pax6, Tbr2, and Tbr1 are Expressed Sequentially by Radial 
Glia, Intermediate Progenitor Cells, and Postmitotic Neurons in Developing Neocortex. J. 
Neurosci. 25, 247-251. 
Enomoto, H., Crawford, P. A., Gorodinsky, A., Heuckeroth, R. O., Johnson, E. 
M.,Jr and Milbrandt, J. (2001). RET Signaling is Essential for Migration, Axonal 
Growth and Axon Guidance of Developing Sympathetic Neurons. Development 128, 
3963-3974. 
Fakhari, M., Pullirsch, D., Paya, K., Abraham, D., Hofbauer, R. and Aharinejad, S. 
(2002). Upregulation of Vascular Endothelial Growth Factor Receptors is Associated 
with Advanced Neuroblastoma. J. Pediatr. Surg. 37, 582-587. 
Farah, M. H., Olson, J. M., Sucic, H. B., Hume, R. I., Tapscott, S. J. and Turner, D. 
L. (2000). Generation of Neurons by Transient Expression of Neural bHLH Proteins in 
Mammalian Cells. Development 127, 693-702. 
Fasano, C.A., Dimos, J.T., Ivanova, N.B., Lowry, N., Lemischka, I.R. and Temple, S. 
(2007). Sh RNA Knockdown of Bmi-1 Reveals a Critical Role for p21-Rb Pathway in 
NSC Self-Renewal during Development. Cell Stem Cell 1, 87. 
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, 
W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F. et al. (1998). Identification 
of a Novel Inhibitor of Mitogen-Activated Protein Kinase Kinase. J. Biol. Chem. 273, 
18623-18632. 
Fehrmann, F. and Laimins, L. A. (2003). Human Papillomaviruses: Targeting 
Differentiating Epithelial Cells for Malignant Transformation. Oncogene 22, 5201-5207. 
Ferguson, K. L., Callaghan, S. M., O'Hare, M. J., Park, D. S. and Slack, R. S. 
(2000). The Rb-CDK4/6 Signaling Pathway is Critical in Neural Precursor Cell Cycle 
Regulation. J. Biol. Chem. 275, 33593-33600. 
Ferrara, N. (1999). Molecular and Biological Properties of Vascular Endothelial Growth 
Factor. J. Mol. Med. 77, 527-543. 
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-
Braxton, L., Hillan, K. J. and Moore, M. W. (1996). Heterozygous Embryonic 
Lethality Induced by Targeted Inactivation of the VEGF Gene. Nature 380, 439-442. 
Ferrara, N. and Davis-Smyth, T. (1997). The Biology of Vascular Endothelial Growth 
Factor. Endocr. Rev. 18, 4-25. 
Fong, G. H., Rossant, J., Gertsenstein, M. and Breitman, M. L. (1995). Role of the 
Flt-1 Receptor Tyrosine Kinase in Regulating the Assembly of Vascular Endothelium. 
Nature 376, 66-70. 
Francis, N. J. and Landis, S. C. (1999). Cellular and Molecular Determinants of 
Sympathetic Neuron Development. Annu. Rev. Neurosci. 22, 541-566. 
Fraser, S. E. and Bronner-Fraser, M. (1991). Migrating Neural Crest Cells in the 
Trunk of the Avian Embryo are Multipotent. Development 112, 913-920. 
Fre, S., Huyghe, M., Mourikis, P., Robine, S., Louvard, D. and Artavanis-Tsakonas, 
S. (2005). Notch Signals Control the Fate of Immature Progenitor Cells in the Intestine. 
Nature 435, 964-968. 
Fults, D., Pedone, C., Dai, C. and Holland, E. C. (2002). MYC Expression Promotes 
the Proliferation of Neural Progenitor Cells in Culture and in Vivo. Neoplasia 4, 32-39. 
From neural stem cells to precursors   References 
 
 
 65 
Funk, J. O., Waga, S., Harry, J. B., Espling, E., Stillman, B. and Galloway, D. A. 
(1997). Inhibition of CDK Activity and PCNA-Dependent DNA Replication by p21 is 
Blocked by Interaction with the HPV-16 E7 Oncoprotein. Genes Dev. 11, 2090-2100. 
Gage, F. H. (2000). Mammalian Neural Stem Cells. Science 287, 1433-1438. 
Gaiano, N., Nye, J. S. and Fishell, G. (2000). Radial Glial Identity is Promoted by 
Notch1 Signaling in the Murine Forebrain. Neuron 26, 395-404. 
Galderisi, U., Jori, F. P. and Giordano, A. (2003). Cell Cycle Regulation and Neural 
Differentiation. Oncogene 22, 5208-5219. 
Gammill, L. S., Gonzalez, C., Gu, C. and Bronner-Fraser, M. (2006). Guidance of 
Trunk Neural Crest Migration Requires Neuropilin 2/semaphorin 3F Signaling. 
Development 133, 99-106. 
Gartel, A. L. and Tyner, A. L. (1999). Transcriptional Regulation of the p21 
(WAF1/CIP1) Gene. Exp. Cell Res. 246, 280-289. 
Gautreau, A., Poullet, P., Louvard, D. and Arpin, M. (1999). Ezrin, a Plasma 
Membrane-Microfilament Linker, Signals Cell Survival through the Phosphatidylinositol 
3-kinase/Akt Pathway. Proc. Natl. Acad. Sci. U. S. A. 96, 7300-7305. 
Gebhardt, A., Frye, M., Herold, S., Benitah, S. A., Braun, K., Samans, B., Watt, F. 
M., Elsasser, H. P. and Eilers, M. (2006). Myc Regulates Keratinocyte Adhesion and 
Differentiation Via Complex Formation with Miz1. J. Cell Biol. 172, 139-149. 
Geiger, K. D., Stoldt, P., Schlote, W. and Derouiche, A. (2000). Ezrin 
Immunoreactivity is Associated with Increasing Malignancy of Astrocytic Tumors but is 
Absent in Oligodendrogliomas. Am. J. Pathol. 157, 1785-1793. 
Giacinti, C. and Giordano, A. (2006). RB and Cell Cycle Progression. Oncogene 25, 
5220-5227. 
Giger, R. J., Cloutier, J. F., Sahay, A., Prinjha, R. K., Levengood, D. V., Moore, S. 
E., Pickering, S., Simmons, D., Rastan, S., Walsh, F. S. et al. (2000). Neuropilin-2 is 
Required in Vivo for Selective Axon Guidance Responses to Secreted Semaphorins. 
Neuron 25, 29-41. 
Gilbert, S. F. (2008). Developmental Biology. 817. 
Giovannini, M., Robanus-Maandag, E., van der Valk, M., Niwa-Kawakita, M., 
Abramowski, V., Goutebroze, L., Woodruff, J. M., Berns, A. and Thomas, G. 
(2000). Conditional Biallelic Nf2 Mutation in the Mouse Promotes Manifestations of 
Human Neurofibromatosis Type 2. Genes Dev. 14, 1617-1630. 
Gonzalez-Agosti, C., Xu, L., Pinney, D., Beauchamp, R., Hobbs, W., Gusella, J. and 
Ramesh, V. (1996). The Merlin Tumor Suppressor Localizes Preferentially in Membrane 
Ruffles. Oncogene 13, 1239-1247. 
Goodwin, E. C. and DiMaio, D. (2000). Repression of Human Papillomavirus 
Oncogenes in HeLa Cervical Carcinoma Cells Causes the Orderly Reactivation of 
Dormant Tumor Suppressor Pathways. Proc. Natl. Acad. Sci. U. S. A. 97, 12513-12518. 
Gotz, M. and Huttner, W. B. (2005). The Cell Biology of Neurogenesis. Nat. Rev. Mol. 
Cell Biol. 6, 777-788. 
Gould, K. L., Bretscher, A., Esch, F. S. and Hunter, T. (1989). CDNA Cloning and 
Sequencing of the Protein-Tyrosine Kinase Substrate, Ezrin, Reveals Homology to Band 
4.1. EMBO J. 8, 4133-4142. 
From neural stem cells to precursors   References 
 
 
 66 
Grandori, C., Cowley, S. M., James, L. P. and Eisenman, R. N. (2000). The 
Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior. Annu. Rev. 
Cell Dev. Biol. 16, 653-699. 
Grewal, S. S., York, R. D. and Stork, P. J. (1999). Extracellular-Signal-Regulated 
Kinase Signalling in Neurons. Curr. Opin. Neurobiol. 9, 544-553. 
Gronholm, M., Muranen, T., Toby, G. G., Utermark, T., Hanemann, C. O., Golemis, 
E. A. and Carpen, O. (2006). A Functional Association between Merlin and HEI10, a 
Cell Cycle Regulator. Oncogene 25, 4389-4398. 
Gronholm, M., Sainio, M., Zhao, F., Heiska, L., Vaheri, A. and Carpen, O. (1999). 
Homotypic and Heterotypic Interaction of the Neurofibromatosis 2 Tumor Suppressor 
Protein Merlin and the ERM Protein Ezrin. J. Cell. Sci. 112 ( Pt 6), 895-904. 
Gronholm, M., Teesalu, T., Tyynela, J., Piltti, K., Bohling, T., Wartiovaara, K., 
Vaheri, A. and Carpen, O. (2005). Characterization of the NF2 Protein Merlin and the 
ERM Protein Ezrin In Human, Rat, and Mouse Central Nervous System. Mol Cell 
Neurosci 28, 683-693. 
Gronholm, M., Vossebein, L., Carlson, C. R., Kuja-Panula, J., Teesalu, T., Alfthan, 
K., Vaheri, A., Rauvala, H., Herberg, F. W., Tasken, K. et al. (2003). Merlin Links to 
the cAMP Neuronal Signaling Pathway by Anchoring the RIbeta Subunit of Protein 
Kinase A. J. Biol. Chem. 278, 41167-41172. 
Groszer, M., Erickson, R., Scripture-Adams, D. D., Lesche, R., Trumpp, A., Zack, J. 
A., Kornblum, H. I., Liu, X. and Wu, H. (2001). Negative Regulation of Neural 
stem/progenitor Cell Proliferation by the Pten Tumor Suppressor Gene in Vivo. Science 
294, 2186-2189. 
Groves, A. K., George, K. M., Tissier-Seta, J. P., Engel, J. D., Brunet, J. F. and 
Anderson, D. J. (1995). Differential Regulation of Transcription Factor Gene Expression 
and Phenotypic Markers in Developing Sympathetic Neurons. Development 121, 887-
901. 
Guccione, E., Martinato, F., Finocchiaro, G., Luzi, L., Tizzoni, L., Dall'Olio, V., 
Zardo, G., Nervi, C., Bernard, L. and Amati, B. (2006). Myc-Binding-Site 
Recognition in the Human Genome is Determined by Chromatin Context. Nat. Cell Biol. 
8, 764-770. 
Guillemot, F., Lo, L. C., Johnson, J. E., Auerbach, A., Anderson, D. J. and Joyner, 
A. L. (1993). Mammalian Achaete-Scute Homolog 1 is Required for the Early 
Development of Olfactory and Autonomic Neurons. Cell 75, 463-476. 
Gutmann, D. H., Sherman, L., Seftor, L., Haipek, C., Hoang Lu, K. and Hendrix, M. 
(1999). Increased Expression of the NF2 Tumor Suppressor Gene Product, Merlin, 
Impairs Cell Motility, Adhesionand Spreading. Hum. Mol. Genet. 8, 267-275. 
Gutmann, D. H., Wright, D. E., Geist, R. T. and Snider, W. D. (1995). Expression of 
the Neurofibromatosis 2 (NF2) Gene Isoforms during Rat Embryonic Development. 
Hum. Mol. Genet. 4, 471-478. 
Hagedorn, L., Paratore, C., Brugnoli, G., Baert, J. L., Mercader, N., Suter, U. and 
Sommer, L. (2000). The Ets Domain Transcription Factor Erm Distinguishes Rat 
Satellite Glia from Schwann Cells and is Regulated in Satellite Cells by Neuregulin 
Signaling. Dev. Biol. 219, 44-58. 
From neural stem cells to precursors   References 
 
 
 67 
Hagedorn, L., Suter, U. and Sommer, L. (1999). P0 and PMP22 Mark a Multipotent 
Neural Crest-Derived Cell Type that Displays Community Effects in Response to TGF-
Beta Family Factors. Development 126, 3781-3794. 
Haigh, J. J., Gerber, H. P., Ferrara, N. and Wagner, E. F. (2000). Conditional 
Inactivation of VEGF-A in Areas of collagen2a1 Expression Results in Embryonic 
Lethality in the Heterozygous State. Development 127, 1445-1453. 
Harper, S. J. and LoGrasso, P. (2001). Signalling for Survival and Death in Neurones: 
The Role of Stress-Activated Kinases, JNK and p38. Cell. Signal. 13, 299-310. 
Harris, K. F., Christensen, J. B., Radany, E. H. and Imperiale, M. J. (1998). Novel 
Mechanisms of E2F Induction by BK Virus Large-T Antigen: Requirement of both the 
pRb-Binding and the J Domains. Mol. Cell. Biol. 18, 1746-1756. 
Hartfuss, E., Galli, R., Heins, N. and Gotz, M. (2001). Characterization of CNS 
Precursor Subtypes and Radial Glia. Dev. Biol. 229, 15-30. 
Hashimoto, T., Zhang, X. M., Chen, B. Y. and Yang, X. J. (2006). VEGF Activates 
Divergent Intracellular Signaling Components to Regulate Retinal Progenitor Cell 
Proliferation and Neuronal Differentiation. Development 133, 2201-2210. 
Hatton, K. S., Mahon, K., Chin, L., Chiu, F. C., Lee, H. W., Peng, D., Morgenbesser, 
S. D., Horner, J. and DePinho, R. A. (1996). Expression and Activity of L-Myc in 
Normal Mouse Development. Mol. Cell. Biol. 16, 1794-1804. 
Haubensak, W., Attardo, A., Denk, W. and Huttner, W. B. (2004). Neurons Arise in 
the Basal Neuroepithelium of the Early Mammalian Telencephalon: A Major Site of 
Neurogenesis. Proc. Natl. Acad. Sci. U. S. A. 101, 3196-3201. 
Hauser, S. and Weich, H. A. (1993). A Heparin-Binding Form of Placenta Growth 
Factor (PlGF-2) is Expressed in Human Umbilical Vein Endothelial Cells and in 
Placenta. Growth Factors 9, 259-268. 
Hawley-Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R. and Schiller, J. T. 
(1989). HPV16 E6 and E7 Proteins Cooperate to Immortalize Human Foreskin 
Keratinocytes. EMBO J. 8, 3905-3910. 
Hayashi, Y., Ueki, K., Waha, A., Wiestler, O. D., Louis, D. N. and von Deimling, A. 
(1997). Association of EGFR Gene Amplification and CDKN2 (p16/MTS1) Gene 
Deletion in Glioblastoma Multiforme. Brain Pathol. 7, 871-875. 
Haydar, T. F., Ang, E.,Jr and Rakic, P. (2003). Mitotic Spindle Rotation and Mode of 
Cell Division in the Developing Telencephalon. Proc. Natl. Acad. Sci. U. S. A. 100, 
2890-2895. 
He, Z. and Tessier-Lavigne, M. (1997). Neuropilin is a Receptor for the Axonal 
Chemorepellent Semaphorin III. Cell 90, 739-751. 
Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D. 
H., Bronner-Fraser, M. and Kornblum, H. I. (2003). Cancerous Stem Cells can Arise 
from Pediatric Brain Tumors. Proc. Natl. Acad. Sci. U. S. A. 100, 15178-15183. 
Herdegen, T., Skene, P. and Bahr, M. (1997). The c-Jun Transcription Factor--
Bipotential Mediator of Neuronal Death, Survival and Regeneration. Trends Neurosci. 
20, 227-231. 
Herrera, J., Yang, H., Zhang, S. C., Proschel, C., Tresco, P., Duncan, I. D., Luskin, 
M. and Mayer-Proschel, M. (2001). Embryonic-Derived Glial-Restricted Precursor 
Cells (GRP Cells) can Differentiate into Astrocytes and Oligodendrocytes in Vivo. Exp. 
Neurol. 171, 11-21. 
From neural stem cells to precursors   References 
 
 
 68 
Heuckeroth, R. O., Enomoto, H., Grider, J. R., Golden, J. P., Hanke, J. A., 
Jackman, A., Molliver, D. C., Bardgett, M. E., Snider, W. D., Johnson, E. M.,Jr et 
al. (1999). Gene Targeting Reveals a Critical Role for Neurturin in the Development and 
Maintenance of Enteric, Sensory, and Parasympathetic Neurons. Neuron 22, 253-263. 
Hicklin, D. J. and Ellis, L. M. (2005). Role of the Vascular Endothelial Growth Factor 
Pathway in Tumor Growth and Angiogenesis. J. Clin. Oncol. 23, 1011-1027. 
Hiltunen, P. H. and Airaksinen, M. S. (2004). Sympathetic Cholinergic Target 
Innervation Requires GDNF Family Receptor GFR Alpha 2. Mol. Cell. Neurosci. 26, 
450-457. 
Hirsch, M. R., Tiveron, M. C., Guillemot, F., Brunet, J. F. and Goridis, C. (1998). 
Control of Noradrenergic Differentiation and Phox2a Expression by MASH1 in the 
Central and Peripheral Nervous System. Development 125, 599-608. 
Hirvonen, H., Makela, T. P., Sandberg, M., Kalimo, H., Vuorio, E. and Alitalo, K. 
(1990). Expression of the Myc Proto-Oncogenes in Developing Human Fetal Brain. 
Oncogene 5, 1787-1797. 
Hitoshi, S., Alexson, T., Tropepe, V., Donoviel, D., Elia, A. J., Nye, J. S., Conlon, R. 
A., Mak, T. W., Bernstein, A. and van der Kooy, D. (2002). Notch Pathway Molecules 
are Essential for the Maintenance, but Not the Generation, of Mammalian Neural Stem 
Cells. Genes Dev. 16, 846-858. 
Houle, M., Sylvestre, J. R. and Lohnes, D. (2003). Retinoic Acid Regulates a Subset of 
Cdx1 Function in Vivo. Development 130, 6555-6567. 
Howard, M. J., Stanke, M., Schneider, C., Wu, X. and Rohrer, H. (2000). The 
Transcription Factor dHAND is a Downstream Effector of BMPs in Sympathetic Neuron 
Specification. Development 127, 4073-4081. 
Huang, Y. Y., Kandel, E. R., Varshavsky, L., Brandon, E. P., Qi, M., Idzerda, R. L., 
McKnight, G. S. and Bourtchouladze, R. (1995). A Genetic Test of the Effects of 
Mutations in PKA on Mossy Fiber LTP and its Relation to Spatial and Contextual 
Learning. Cell 83, 1211-1222. 
Huber, K. (2006). The Sympathoadrenal Cell Lineage: Specification, Diversification, 
and New Perspectives. Dev. Biol. 298, 335-343. 
Huber, K., Bruhl, B., Guillemot, F., Olson, E. N., Ernsberger, U. and Unsicker, K. 
(2002). Development of Chromaffin Cells Depends on MASH1 Function. Development 
129, 4729-4738. 
Hughes, D. C. (2001). Alternative Splicing of the Human VEGFGR-3/FLT4 Gene as a 
Consequence of an Integrated Human Endogenous Retrovirus. J. Mol. Evol. 53, 77-79. 
Huttner, W. B. and Kosodo, Y. (2005). Symmetric Versus Asymmetric Cell Division 
during Neurogenesis in the Developing Vertebrate Central Nervous System. Curr. Opin. 
Cell Biol. 17, 648-657. 
Huynh, D. P. and Pulst, S. M. (1996). Neurofibromatosis 2 Antisense 
Oligodeoxynucleotides Induce Reversible Inhibition of Schwannomin Synthesis and Cell 
Adhesion in STS26T and T98G Cells. Oncogene 13, 73-84. 
Huynh, D. P., Tran, T. M., Nechiporuk, T. and Pulst, S. M. (1996). Expression of 
Neurofibromatosis 2 Transcript and Gene Product during Mouse Fetal Development. Cell 
Growth Differ. 7, 1551-1561. 
Irvin, D. K., Zurcher, S. D., Nguyen, T., Weinmaster, G. and Kornblum, H. I. 
(2001). Expression Patterns of Notch1, Notch2, and Notch3 Suggest Multiple Functional 
From neural stem cells to precursors   References 
 
 
 69 
Roles for the Notch-DSL Signaling System during Brain Development. J. Comp. Neurol. 
436, 167-181. 
Iso, T., Kedes, L. and Hamamori, Y. (2003). HES and HERP Families: Multiple 
Effectors of the Notch Signaling Pathway. J. Cell. Physiol. 194, 237-255. 
Jankovski, A. and Sotelo, C. (1996). Subventricular Zone-Olfactory Bulb Migratory 
Pathway in the Adult Mouse: Cellular Composition and Specificity as Determined by 
Heterochronic and Heterotopic Transplantation. J. Comp. Neurol. 371, 376-396. 
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, 
M., Fukumura, D., Jain, R. K. and Alitalo, K. (1997). Hyperplasia of Lymphatic 
Vessels in VEGF-C Transgenic Mice. Science 276, 1423-1425. 
Jensen, J. B. and Parmar, M. (2006). Strengths and Limitations of the Neurosphere 
Culture System. Mol. Neurobiol. 34, 153-161. 
Jeon, S., Allen-Hoffmann, B. L. and Lambert, P. F. (1995). Integration of Human 
Papillomavirus Type 16 into the Human Genome Correlates with a Selective Growth 
Advantage of Cells. J. Virol. 69, 2989-2997. 
Jiang, Z., Zacksenhaus, E., Gallie, B. L. and Phillips, R. A. (1997). The 
Retinoblastoma Gene Family is Differentially Expressed during Embryogenesis. 
Oncogene 14, 1789-1797. 
Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L. and Greenberg, D. A. (2002). Vascular 
Endothelial Growth Factor (VEGF) Stimulates Neurogenesis in Vitro and in Vivo. Proc. 
Natl. Acad. Sci. U. S. A. 99, 11946-11950. 
Jin, K. L., Mao, X. O. and Greenberg, D. A. (2000). Vascular Endothelial Growth 
Factor Rescues HN33 Neural Cells from Death Induced by Serum Withdrawal. J. Mol. 
Neurosci. 14, 197-203. 
Jogi, A., Vallon-Christersson, J., Holmquist, L., Axelson, H., Borg, A. and Pahlman, 
S. (2004). Human Neuroblastoma Cells Exposed to Hypoxia: Induction of Genes 
Associated with Growth, Survival, and Aggressive Behavior. Exp. Cell Res. 295, 469-
487. 
Jones, D. L., Alani, R. M. and Munger, K. (1997). The Human Papillomavirus E7 
Oncoprotein can Uncouple Cellular Differentiation and Proliferation in Human 
Keratinocytes by Abrogating p21Cip1-Mediated Inhibition of cdk2. Genes Dev. 11, 
2101-2111. 
Jordan, M. A. and Wilson, L. (1998). Microtubules and Actin Filaments: Dynamic 
Targets for Cancer Chemotherapy. Curr. Opin. Cell Biol. 10, 123-130. 
Joukov, V., Kaipainen, A., Jeltsch, M., Pajusola, K., Olofsson, B., Kumar, V., 
Eriksson, U. and Alitalo, K. (1997). Vascular Endothelial Growth Factors VEGF-B and 
VEGF-C. J. Cell. Physiol. 173, 211-215. 
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, 
O., Kalkkinen, N. and Alitalo, K. (1996). A Novel Vascular Endothelial Growth Factor, 
VEGF-C, is a Ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) Receptor Tyrosine 
Kinases. EMBO J. 15, 1751. 
Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksela, 
O., Kalkkinen, N. and Alitalo, K. (1997). Proteolytic Processing Regulates Receptor 
Specificity and Activity of VEGF-C. EMBO J. 16, 3898-3911. 
Kaipainen, A., Korhonen, J., Pajusola, K., Aprelikova, O., Persico, M. G., Terman, 
B. I. and Alitalo, K. (1993). The Related FLT4, FLT1, and KDR Receptor Tyrosine 
From neural stem cells to precursors   References 
 
 
 70 
Kinases show Distinct Expression Patterns in Human Fetal Endothelial Cells. J. Exp. 
Med. 178, 2077-2088. 
Kalamarides, M., Niwa-Kawakita, M., Leblois, H., Abramowski, V., Perricaudet, 
M., Janin, A., Thomas, G., Gutmann, D. H. and Giovannini, M. (2002). Nf2 Gene 
Inactivation in Arachnoidal Cells is Rate-Limiting for Meningioma Development in the 
Mouse. Genes Dev. 16, 1060-1065. 
Kalyani, A. J., Piper, D., Mujtaba, T., Lucero, M. T. and Rao, M. S. (1998). Spinal 
Cord Neuronal Precursors Generate Multiple Neuronal Phenotypes in Culture. J. 
Neurosci. 18, 7856-7868. 
Kandel, E. R., Schwartz, J. H. and Jessel, T. M. (2000). Principles of Neural Science. 
1414. 
Karkkainen, M. J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T. V., 
Jeltsch, M., Jackson, D. G., Talikka, M., Rauvala, H. et al. (2004). Vascular 
Endothelial Growth Factor C is Required for Sprouting of the First Lymphatic Vessels 
from Embryonic Veins. Nat. Immunol. 5, 74-80. 
Karkkainen, M. J., Saaristo, A., Jussila, L., Karila, K. A., Lawrence, E. C., Pajusola, 
K., Bueler, H., Eichmann, A., Kauppinen, R., Kettunen, M. I. et al. (2001). A Model 
for Gene Therapy of Human Hereditary Lymphedema. Proc. Natl. Acad. Sci. U. S. A. 98, 
12677-12682. 
Karn, J., Watson, J. V., Lowe, A. D., Green, S. M. and Vedeckis, W. (1989). 
Regulation of Cell Cycle Duration by c-Myc Levels. Oncogene 4, 773-787. 
Kasemeier-Kulesa, J. C., Bradley, R., Pasquale, E. B., Lefcort, F. and Kulesa, P. M. 
(2006). Eph/ephrins and N-Cadherin Coordinate to Control the Pattern of Sympathetic 
Ganglia. Development 133, 4839-4847. 
Kaul, S. C., Mitsui, Y., Komatsu, Y., Reddel, R. R. and Wadhwa, R. (1996). A 
Highly Expressed 81 kDa Protein in Immortalized Mouse Fibroblast: Its Proliferative 
Function and Identity with Ezrin. Oncogene 13, 1231-1237. 
Kawasaki, T., Bekku, Y., Suto, F., Kitsukawa, T., Taniguchi, M., Nagatsu, I., 
Nagatsu, T., Itoh, K., Yagi, T. and Fujisawa, H. (2002). Requirement of Neuropilin 1-
Mediated Sema3A Signals in Patterning of the Sympathetic Nervous System. 
Development 129, 671-680. 
Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T. and 
Fujisawa, H. (1999). A Requirement for Neuropilin-1 in Embryonic Vessel Formation. 
Development 126, 4895-4902. 
Kendall, R. L. and Thomas, K. A. (1993). Inhibition of Vascular Endothelial Cell 
Growth Factor Activity by an Endogenously Encoded Soluble Receptor. Proc. Natl. 
Acad. Sci. U. S. A. 90, 10705-10709. 
Kerosuo, L., Piltti, K., Fox, H., Angers-Loustau, A., Hayry, V., Eilers, M., Sariola, 
H., and Wartiovaara, K. (2008). C-myc Increases Self-renewal in Neural Progenitor 
Cells Through Miz-1. J Cell Sci 121, 3941-3950. 
Kim, H., Li, Q., Hempstead, B. L. and Madri, J. A. (2004a). Paracrine and Autocrine 
Functions of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor 
(NGF) in Brain-Derived Endothelial Cells. J. Biol. Chem. 279, 33538-33546. 
Kim, S. and C. Walsh (2007). Numb, neurogenesis and epithelial polarity. Nature 
Neurosci. 10, 812-813. 
From neural stem cells to precursors   References 
 
 
 71 
Kim, J. H., Yoon, S. Y., Kim, C. N., Joo, J. H., Moon, S. K., Choe, I. S., Choe, Y. K. 
and Kim, J. W. (2004b). The Bmi-1 Oncoprotein is Overexpressed in Human Colorectal 
Cancer and Correlates with the Reduced p16INK4a/p14ARF Proteins. Cancer Lett. 203, 
217-224. 
Klagsbrun, M., Takashima, S. and Mamluk, R. (2002). The Role of Neuropilin in 
Vascular and Tumor Biology. Adv. Exp. Med. Biol. 515, 33-48. 
Klezovitch, O., Fernandez, T. E., Tapscott, S. J. and Vasioukhin, V. (2004). Loss of 
Cell Polarity Causes Severe Brain Dysplasia in Lgl1 Knockout Mice. Genes Dev. 18, 
559-571. 
Knies-Bamforth, U. E., Fox, S. B., Poulsom, R., Evan, G. I. and Harris, A. L. (2004). 
C-Myc Interacts with Hypoxia to Induce Angiogenesis in Vivo by a Vascular Endothelial 
Growth Factor-Dependent Mechanism. Cancer Res. 64, 6563-6570. 
Knoepfler, P. S., Cheng, P. F. and Eisenman, R. N. (2002). N-Myc is Essential during 
Neurogenesis for the Rapid Expansion of Progenitor Cell Populations and the Inhibition 
of Neuronal Differentiation. Genes Dev. 16, 2699-2712. 
Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y. T., Giger, R. J. and Ginty, 
D. D. (1997). Neuropilin is a Semaphorin III Receptor. Cell 90, 753-762. 
Komuro, H., Kaneko, S., Kaneko, M. and Nakanishi, Y. (2001). Expression of 
Angiogenic Factors and Tumor Progression in Human Neuroblastoma. J. Cancer Res. 
Clin. Oncol. 127, 739-743. 
Kornblum, H. I. (2007). Introduction to Neural Stem Cells. Stroke 38, 810-816. 
Kotzbauer, P. T., Lampe, P. A., Heuckeroth, R. O., Golden, J. P., Creedon, D. J., 
Johnson, E. M.,Jr and Milbrandt, J. (1996). Neurturin, a Relative of Glial-Cell-Line-
Derived Neurotrophic Factor. Nature 384, 467-470. 
Kriegstein, A. R. and Gotz, M. (2003). Radial Glia Diversity: A Matter of Cell Fate. 
Glia 43, 37-43. 
Kruger, G. M., Mosher, J. T., Bixby, S., Joseph, N., Iwashita, T. and Morrison, S. J. 
(2002). Neural Crest Stem Cells Persist in the Adult Gut but Undergo Changes in Self-
Renewal, Neuronal Subtype Potential, and Factor Responsiveness. Neuron 35, 657-669. 
Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V. and 
Alitalo, K. (1996). VEGF-C Receptor Binding and Pattern of Expression with VEGFR-3 
Suggests a Role in Lymphatic Vascular Development. Development 122, 3829-3837. 
Kuruvilla, R., Zweifel, L. S., Glebova, N. O., Lonze, B. E., Valdez, G., Ye, H. and 
Ginty, D. D. (2004). A Neurotrophin Signaling Cascade Coordinates Sympathetic 
Neuron Development through Differential Control of TrkA Trafficking and Retrograde 
Signaling. Cell 118, 243-255. 
LaBonne, C. and Bronner-Fraser, M. (1999). Molecular Mechanisms of Neural Crest 
Formation. Annu. Rev. Cell Dev. Biol. 15, 81-112. 
Lassman, A. B., Dai, C., Fuller, G. N., Vickers, A. J. and Holland, E. C. (2004). 
Overexpression of c-MYC Promotes an Undifferentiated Phenotype in Cultured 
Astrocytes and Allows Elevated Ras and Akt Signaling to Induce Gliomas from GFAP-
Expressing Cells in Mice. Neuron. Glia Biol. 1, 157-163. 
Le Bras, B., Barallobre, M. J., Homman-Ludiye, J., Ny, A., Wyns, S., Tammela, T., 
Haiko, P., Karkkainen, M. J., Yuan, L., Muriel, M. P. et al. (2006). VEGF-C is a 
Trophic Factor for Neural Progenitors in the Vertebrate Embryonic Brain. Nat. Neurosci. 
9, 340-348. 
From neural stem cells to precursors   References 
 
 
 72 
Le Douarin, N. M., Creuzet, S., Couly, G. and Dupin, E. (2004). Neural Crest Cell 
Plasticity and its Limits. Development 131, 4637-4650. 
LeCouter, J. E., Kablar, B., Whyte, P. F., Ying, C. and Rudnicki, M. A. (1998). 
Strain-Dependent Embryonic Lethality in Mice Lacking the Retinoblastoma-Related 
p130 Gene. Development 125, 4669-4679. 
Lee, E. Y., Chang, C. Y., Hu, N., Wang, Y. C., Lai, C. C., Herrup, K., Lee, W. H. 
and Bradley, A. (1992). Mice Deficient for Rb are Nonviable and show Defects in 
Neurogenesis and Haematopoiesis. Nature 359, 288-294. 
Leone, G., Sears, R., Huang, E., Rempel, R., Nuckolls, F., Park, C. H., Giangrande, 
P., Wu, L., Saavedra, H. I., Field, S. J. et al. (2001). Myc Requires Distinct E2F 
Activities to Induce S Phase and Apoptosis. Mol. Cell 8, 105-113. 
Leung, C., Lingbeek, M., Shakhova, O., Liu, J., Tanger, E., Saremaslani, P., Van 
Lohuizen, M. and Marino, S. (2004). Bmi1 is Essential for Cerebellar Development and 
is Overexpressed in Human Medulloblastomas. Nature 428, 337-341. 
Levine, A. J. and Brivanlou, A. H. (2007). Proposal of a Model of Mammalian Neural 
Induction. Dev. Biol. 308, 247-256. 
Li, L., Liu, F. and Ross, A. H. (2003). PTEN Regulation of Neural Development and 
CNS Stem Cells. J. Cell. Biochem. 88, 24-28. 
Liem, K. F.,Jr, Tremml, G. and Jessell, T. M. (1997). A Role for the Roof Plate and its 
Resident TGFbeta-Related Proteins in Neuronal Patterning in the Dorsal Spinal Cord. 
Cell 91, 127-138. 
Lindfors, P. H., Lindahl, M., Rossi, J., Saarma, M. and Airaksinen, M. S. (2006). 
Ablation of Persephin Receptor Glial Cell Line-Derived Neurotrophic Factor Family 
Receptor alpha4 Impairs Thyroid Calcitonin Production in Young Mice. Endocrinology 
147, 2237-2244. 
Lipinski, M. M. and Jacks, T. (1999). The Retinoblastoma Gene Family in 
Differentiation and Development. Oncogene 18, 7873-7882. 
Liu, H., Dibling, B., Spike, B., Dirlam, A. and Macleod, K. (2004). New Roles for the 
RB Tumor Suppressor Protein. Curr. Opin. Genet. Dev. 14, 55-64. 
Lo, L. C., Johnson, J. E., Wuenschell, C. W., Saito, T. and Anderson, D. J. (1991). 
Mammalian Achaete-Scute Homolog 1 is Transiently Expressed by Spatially Restricted 
Subsets of Early Neuroepithelial and Neural Crest Cells. Genes Dev. 5, 1524-1537. 
Longworth, M. S. and Laimins, L. A. (2004). Pathogenesis of Human Papillomaviruses 
in Differentiating Epithelia. Microbiol. Mol. Biol. Rev. 68, 362-372. 
Louis, D. N., Ramesh, V. and Gusella, J. F. (1995). Neuropathology and Molecular 
Genetics of Neurofibromatosis 2 and Related Tumors. Brain Pathol. 5, 163-172. 
Lowe, D. B., Shearer, M. H., Jumper, C. A. and Kennedy, R. C. (2007). SV40 
Association with Human Malignancies and Mechanisms of Tumor Immunity by Large 
Tumor Antigen. Cell Mol. Life Sci. 64, 803-814. 
Lu, Q. R., Yuk, D., Alberta, J. A., Zhu, Z., Pawlitzky, I., Chan, J., McMahon, A. P., 
Stiles, C. D. and Rowitch, D. H. (2000). Sonic Hedgehog--Regulated Oligodendrocyte 
Lineage Genes Encoding bHLH Proteins in the Mammalian Central Nervous System. 
Neuron 25, 317-329. 
Lumsden, A. and Krumlauf, R. (1996). Patterning the Vertebrate Neuraxis. Science 
274, 1109-1115. 
From neural stem cells to precursors   References 
 
 
 73 
Luo, R. X., Postigo, A. A. and Dean, D. C. (1998). Rb Interacts with Histone 
Deacetylase to Repress Transcription. Cell 92, 463-473. 
Ma, Q., Chen, Z., del Barco Barrantes, I., de la Pompa, J. L. and Anderson, D. J. 
(1998). Neurogenin1 is Essential for the Determination of Neuronal Precursors for 
Proximal Cranial Sensory Ganglia. Neuron 20, 469-482. 
Macleod, K. F., Hu, Y. and Jacks, T. (1996). Loss of Rb Activates both p53-Dependent 
and Independent Cell Death Pathways in the Developing Mouse Nervous System. EMBO 
J. 15, 6178-6188. 
Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O., Alitalo, 
K., Del Vecchio, S., Lei, K. J., Chou, J. Y. and Persico, M. G. (1993). Two Alternative 
mRNAs Coding for the Angiogenic Factor, Placenta Growth Factor (PlGF), are 
Transcribed from a Single Gene of Chromosome 14. Oncogene 8, 925-931. 
Makinen, T., Veikkola, T., Mustjoki, S., Karpanen, T., Catimel, B., Nice, E. C., 
Wise, L., Mercer, A., Kowalski, H., Kerjaschki, D. et al. (2001). Isolated Lymphatic 
Endothelial Cells Transduce Growth, Survival and Migratory Signals Via the VEGF-C/D 
Receptor VEGFR-3. EMBO J. 20, 4762-4773. 
Malatesta, P., Hack, M. A., Hartfuss, E., Kettenmann, H., Klinkert, W., Kirchhoff, 
F. and Gotz, M. (2003). Neuronal Or Glial Progeny: Regional Differences in Radial Glia 
Fate. Neuron 37, 751-764. 
Malatesta, P., Hartfuss, E. and Gotz, M. (2000). Isolation of Radial Glial Cells by 
Fluorescent-Activated Cell Sorting Reveals a Neuronal Lineage. Development 127, 5253-
5263. 
Mandriota, S. J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D., Prevo, R., 
Banerji, S., Huarte, J., Montesano, R., Jackson, D. G. et al. (2001). Vascular 
Endothelial Growth Factor-C-Mediated Lymphangiogenesis Promotes Tumour 
Metastasis. EMBO J. 20, 672-682. 
Marconcini, L., Marchio, S., Morbidelli, L., Cartocci, E., Albini, A., Ziche, M., 
Bussolino, F. and Oliviero, S. (1999). C-Fos-Induced Growth factor/vascular 
Endothelial Growth Factor D Induces Angiogenesis in Vivo and in Vitro. Proc. Natl. 
Acad. Sci. U. S. A. 96, 9671-9676. 
Marcus, K., Johnson, M., Adam, R. M., O'Reilly, M. S., Donovan, M., Atala, A., 
Freeman, M. R. and Soker, S. (2005). Tumor Cell-Associated Neuropilin-1 and 
Vascular Endothelial Growth Factor Expression as Determinants of Tumor Growth in 
Neuroblastoma. Neuropathology 25, 178-187. 
Martinez-Barbera, J. P., Signore, M., Boyl, P. P., Puelles, E., Acampora, D., Gogoi, 
R., Schubert, F., Lumsden, A. and Simeone, A. (2001). Regionalisation of Anterior 
Neuroectoderm and its Competence in Responding to Forebrain and Midbrain Inducing 
Activities Depend on Mutual Antagonism between OTX2 and GBX2. Development 128, 
4789-4800. 
Matsumoto, T. and Claesson-Welsh, L. (2001). VEGF Receptor Signal Transduction. 
Sci. STKE 2001, RE21. 
Maurer, M. H., Tripps, W. K., Feldmann, R. E.,Jr and Kuschinsky, W. (2003). 
Expression of Vascular Endothelial Growth Factor and its Receptors in Rat Neural Stem 
Cells. Neurosci. Lett. 344, 165-168. 
From neural stem cells to precursors   References 
 
 
 74 
Mayer-Proschel, M., Kalyani, A. J., Mujtaba, T. and Rao, M. S. (1997). Isolation of 
Lineage-Restricted Neuronal Precursors from Multipotent Neuroepithelial Stem Cells. 
Neuron 19, 773-785. 
McClatchey, A. I., Saotome, I., Ramesh, V., Gusella, J. F. and Jacks, T. (1997). The 
Nf2 Tumor Suppressor Gene Product is Essential for Extraembryonic Development 
Immediately Prior to Gastrulation. Genes Dev. 11, 1253-1265. 
McKay, R. (1997). Stem Cells in the Central Nervous System. Science 276, 66-71. 
Meakin, S. O. and Shooter, E. M. (1992). The Nerve Growth Factor Family of 
Receptors. Trends Neurosci. 15, 323-331. 
Meijer, L., Borgne, A., Mulner, O., Chong, J. P., Blow, J. J., Inagaki, N., Inagaki, 
M., Delcros, J. G. and Moulinoux, J. P. (1997). Biochemical and Cellular Effects of 
Roscovitine, a Potent and Selective Inhibitor of the Cyclin-Dependent Kinases cdc2, 
cdk2 and cdk5. Eur. J. Biochem. 243, 527-536. 
Meister, B., Grunebach, F., Bautz, F., Brugger, W., Fink, F. M., Kanz, L. and 
Mohle, R. (1999). Expression of Vascular Endothelial Growth Factor (VEGF) and its 
Receptors in Human Neuroblastoma. Eur. J. Cancer 35, 445-449. 
Menard, C., Hein, P., Paquin, A., Savelson, A., Yang, X. M., Lederfein, D., Barnabe-
Heider, F., Mir, A. A., Sterneck, E., Peterson, A. C. et al. (2002). An Essential Role 
for a MEK-C/EBP Pathway during Growth Factor-Regulated Cortical Neurogenesis. 
Neuron 36, 597-610. 
Meng, X., Lindahl, M., Hyvonen, M. E., Parvinen, M., de Rooij, D. G., Hess, M. W., 
Raatikainen-Ahokas, A., Sainio, K., Rauvala, H., Lakso, M. et al. (2000). Regulation 
of Cell Fate Decision of Undifferentiated Spermatogonia by GDNF. Science 287, 1489-
1493. 
Meyer, N., Kim, S. S. and Penn, L. Z. (2006). The Oscar-Worthy Role of Myc in 
Apoptosis. Semin. Cancer Biol. 16, 275-287. 
Milbrandt, J., de Sauvage, F. J., Fahrner, T. J., Baloh, R. H., Leitner, M. L., Tansey, 
M. G., Lampe, P. A., Heuckeroth, R. O., Kotzbauer, P. T., Simburger, K. S. et al. 
(1998). Persephin, a Novel Neurotrophic Factor Related to GDNF and Neurturin. Neuron 
20, 245-253. 
Miller, M. W., Peter, A., Wharton, S. B. and Wyllie, A. H. (2003). Proliferation and 
Death of Conditionally Immortalized Neural Cells from Murine Neocortex: P53 Alters 
the Ability of Neuron-Like Cells to Re-Enter the Cell Cycle. Brain Res. 965, 57-66. 
Molofsky, A. V., He, S., Bydon, M., Morrison, S. J. and Pardal, R. (2005). Bmi-1 
Promotes Neural Stem Cell Self-Renewal and Neural Development but Not Mouse 
Growth and Survival by Repressing the p16Ink4a and p19Arf Senescence Pathways. 
Genes Dev. 19, 1432-1437. 
Molofsky, A. V., Pardal, R., Iwashita, T., Park, I. K., Clarke, M. F. and Morrison, S. 
J. (2003). Bmi-1 Dependence Distinguishes Neural Stem Cell Self-Renewal from 
Progenitor Proliferation. Nature 425, 962-967. 
Mompeo, B., Engele, J. and Spanel-Borowski, K. (2003). Endothelial Cell Influence on 
Dorsal Root Ganglion Cell Formation. J. Neurocytol. 32, 123-129. 
Morrison, S. J., Perez, S. E., Qiao, Z., Verdi, J. M., Hicks, C., Weinmaster, G. and 
Anderson, D. J. (2000). Transient Notch Activation Initiates an Irreversible Switch from 
Neurogenesis to Gliogenesis by Neural Crest Stem Cells. Cell 101, 499-510. 
From neural stem cells to precursors   References 
 
 
 75 
Morrison, S. J., White, P. M., Zock, C. and Anderson, D. J. (1999). Prospective 
Identification, Isolation by Flow Cytometry, and in Vivo Self-Renewal of Multipotent 
Mammalian Neural Crest Stem Cells. Cell 96, 737-749. 
Morrow, T., Song, M. R. and Ghosh, A. (2001). Sequential Specification of Neurons 
and Glia by Developmentally Regulated Extracellular Factors. Development 128, 3585-
3594. 
Muller, Y. A., Christinger, H. W., Keyt, B. A. and de Vos, A. M. (1997). The Crystal 
Structure of Vascular Endothelial Growth Factor (VEGF) Refined to 1.93 A Resolution: 
Multiple Copy Flexibility and Receptor Binding. Structure 5, 1325-1338. 
Munger, K., Baldwin, A., Edwards, K. M., Hayakawa, H., Nguyen, C. L., Owens, 
M., Grace, M. and Huh, K. (2004). Mechanisms of Human Papillomavirus-Induced 
Oncogenesis. J. Virol. 78, 11451-11460. 
Muranen, T., Gronholm, M., Renkema, G. H. and Carpen, O. (2005). Cell Cycle-
Dependent Nucleocytoplasmic Shuttling of the Neurofibromatosis 2 Tumour Suppressor 
Merlin. Oncogene 24, 1150-1158. 
Murciano, A., Zamora, J., Lopez-Sanchez, J. and Frade, J. M. (2002). Interkinetic 
Nuclear Movement may Provide Spatial Clues to the Regulation of Neurogenesis. Mol. 
Cell. Neurosci. 21, 285-300. 
Murphy, M. J., Wilson, A. and Trumpp, A. (2005). More than just Proliferation: Myc 
Function in Stem Cells. Trends Cell Biol. 15, 128-137. 
Murray-Zmijewski, F., Lane, D. P. and Bourdon, J. C. (2006). P53/p63/p73 Isoforms: 
An Orchestra of Isoforms to Harmonise Cell Differentiation and Response to Stress. Cell 
Death Differ. 13, 962-972. 
Myers, S. M., Eng, C., Ponder, B. A. and Mulligan, L. M. (1995). Characterization of 
RET Proto-Oncogene 3' Splicing Variants and Polyadenylation Sites: A Novel C-
Terminus for RET. Oncogene 11, 2039-2045. 
Nag, S., Eskandarian, M. R., Davis, J. and Eubanks, J. H. (2002). Differential 
Expression of Vascular Endothelial Growth Factor-A (VEGF-A) and VEGF-B After 
Brain Injury. J. Neuropathol. Exp. Neurol. 61, 778-788. 
Nakashima, K., Takizawa, T., Ochiai, W., Yanagisawa, M., Hisatsune, T., 
Nakafuku, M., Miyazono, K., Kishimoto, T., Kageyama, R. and Taga, T. (2001). 
BMP2-Mediated Alteration in the Developmental Pathway of Fetal Mouse Brain Cells 
from Neurogenesis to Astrocytogenesis. Proc. Natl. Acad. Sci. U. S. A. 98, 5868-5873. 
Nakashima, K., Yanagisawa, M., Arakawa, H., Kimura, N., Hisatsune, T., 
Kawabata, M., Miyazono, K. and Taga, T. (1999). Synergistic Signaling in Fetal Brain 
by STAT3-Smad1 Complex Bridged by p300. Science 284, 479-482. 
Nataf, V. and Le Douarin, N. M. (2000). Induction of Melanogenesis by 
Tetradecanoylphorbol-13 Acetate and Endothelin 3 in Embryonic Avian Peripheral 
Nerve Cultures. Pigment Cell Res. 13, 172-178. 
Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltorak, Z. (1999). Vascular 
Endothelial Growth Factor (VEGF) and its Receptors. FASEB J. 13, 9-22. 
Neufeld, G., Cohen, T., Shraga, N., Lange, T., Kessler, O. and Herzog, Y. (2002). 
The Neuropilins: Multifunctional Semaphorin and VEGF Receptors that Modulate Axon 
Guidance and Angiogenesis. Trends Cardiovasc. Med. 12, 13-19. 
Nevels, M., Tauber, B., Spruss, T., Wolf, H. and Dobner, T. (2001). "Hit-and-Run" 
Transformation by Adenovirus Oncogenes. J. Virol. 75, 3089-3094. 
From neural stem cells to precursors   References 
 
 
 76 
Nieto, M., Monuki, E. S., Tang, H., Imitola, J., Haubst, N., Khoury, S. J., 
Cunningham, J., Gotz, M. and Walsh, C. A. (2004). Expression of Cux-1 and Cux-2 in 
the Subventricular Zone and Upper Layers II-IV of the Cerebral Cortex. J. Comp. Neurol. 
479, 168-180. 
Nieto, M., Schuurmans, C., Britz, O. and Guillemot, F. (2001). Neural bHLH Genes 
Control the Neuronal Versus Glial Fate Decision in Cortical Progenitors. Neuron 29, 401-
413. 
Nishino, J., Mochida, K., Ohfuji, Y., Shimazaki, T., Meno, C., Ohishi, S., Matsuda, 
Y., Fujii, H., Saijoh, Y. and Hamada, H. (1999). GFR alpha3, a Component of the 
Artemin Receptor, is Required for Migration and Survival of the Superior Cervical 
Ganglion. Neuron 23, 725-736. 
Nishiyama, A., Komitova, M., Suzuki, R. and Zhu, X. (2009). Polydendrocytes (NG2 
Cells): Multifunctional Cells with Lineage Plasticity. Nat. Rev. Neurosci. 10, 9-22. 
Noctor, S. C., Flint, A. C., Weissman, T. A., Wong, W. S., Clinton, B. K. and 
Kriegstein, A. R. (2002). Dividing Precursor Cells of the Embryonic Cortical 
Ventricular Zone have Morphological and Molecular Characteristics of Radial Glia. J. 
Neurosci. 22, 3161-3173. 
Noctor, S. C., Martinez-Cerdeno, V., Ivic, L. and Kriegstein, A. R. (2004). Cortical 
Neurons Arise in Symmetric and Asymmetric Division Zones and Migrate through 
Specific Phases. Nat. Neurosci. 7, 136-144. 
Ohshiro, T., Yagami, T., Zhang, C. and Matsuzaki, F. (2000). Role of Cortical 
Tumour-Suppressor Proteins in Asymmetric Division of Drosophila Neuroblast. Nature 
408, 593-596. 
Ohtsuka, T., Sakamoto, M., Guillemot, F. and Kageyama, R. (2001). Roles of the 
Basic Helix-Loop-Helix Genes Hes1 and Hes5 in Expansion of Neural Stem Cells of the 
Developing Brain. J. Biol. Chem. 276, 30467-30474. 
Olofsson, B., Korpelainen, E., Pepper, M. S., Mandriota, S. J., Aase, K., Kumar, V., 
Gunji, Y., Jeltsch, M. M., Shibuya, M., Alitalo, K. et al. (1998). Vascular Endothelial 
Growth Factor B (VEGF-B) Binds to VEGF Receptor-1 and Regulates Plasminogen 
Activator Activity in Endothelial Cells. Proc. Natl. Acad. Sci. U. S. A. 95, 11709-11714. 
Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V., Saksela, O., 
Orpana, A., Pettersson, R. F., Alitalo, K. and Eriksson, U. (1996a). Vascular 
Endothelial Growth Factor B, a Novel Growth Factor for Endothelial Cells. Proc. Natl. 
Acad. Sci. U. S. A. 93, 2576-2581. 
Olofsson, B., Pajusola, K., von Euler, G., Chilov, D., Alitalo, K. and Eriksson, U. 
(1996b). Genomic Organization of the Mouse and Human Genes for Vascular 
Endothelial Growth Factor B (VEGF-B) and Characterization of a Second Splice 
Isoform. J. Biol. Chem. 271, 19310-19317. 
Orlandini, M., Marconcini, L., Ferruzzi, R. and Oliviero, S. (1996). Identification of a 
c-Fos-Induced Gene that is Related to the Platelet-Derived Growth factor/vascular 
Endothelial Growth Factor Family. Proc. Natl. Acad. Sci. U. S. A. 93, 11675-11680. 
Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, 
R. and Alitalo, K. (1992). FLT4 Receptor Tyrosine Kinase Contains Seven 
Immunoglobulin-Like Loops and is Expressed in Multiple Human Tissues and Cell 
Lines. Cancer Res. 52, 5738-5743. 
From neural stem cells to precursors   References 
 
 
 77 
Pajusola, K., Aprelikova, O., Pelicci, G., Weich, H., Claesson-Welsh, L. and Alitalo, 
K. (1994). Signalling Properties of FLT4, a Proteolytically Processed Receptor Tyrosine 
Kinase Related to Two VEGF Receptors. Oncogene 9, 3545-3555. 
Palmer, T. D., Willhoite, A. R. and Gage, F. H. (2000). Vascular Niche for Adult 
Hippocampal Neurogenesis. J. Comp. Neurol. 425, 479-494. 
Paratcha, G., Ledda, F. and Ibanez, C. F. (2003). The Neural Cell Adhesion Molecule 
NCAM is an Alternative Signaling Receptor for GDNF Family Ligands. Cell 113, 867-
879. 
Partanen, J. (2007). FGF Signalling Pathways in Development of the Midbrain and 
Anterior Hindbrain. J. Neurochem. 101, 1185-1193. 
Pattyn, A., Morin, X., Cremer, H., Goridis, C. and Brunet, J. F. (1997). Expression 
and Interactions of the Two Closely Related Homeobox Genes Phox2a and Phox2b 
during Neurogenesis. Development 124, 4065-4075. 
Peretto, P., Merighi, A., Fasolo, A. and Bonfanti, L. (1999). The Subependymal Layer 
in Rodents: A Site of Structural Plasticity and Cell Migration in the Adult Mammalian 
Brain. Brain Res. Bull. 49, 221-243. 
Petersen, P. H., Zou, K., Hwang, J. K., Jan, Y. N. and Zhong, W. (2002). Progenitor 
Cell Maintenance Requires Numb and Numblike during Mouse Neurogenesis. Nature 
419, 929-934. 
Pichel, J. G., Shen, L., Sheng, H. Z., Granholm, A. C., Drago, J., Grinberg, A., Lee, 
E. J., Huang, S. P., Saarma, M., Hoffer, B. J. et al. (1996). Defects in Enteric 
Innervation and Kidney Development in Mice Lacking GDNF. Nature 382, 73-76. 
Pick, M., Azzola, L., Mossman, A., Stanley, E. G. and Elefanty, A. G. (2007). 
Differentiation of Human Embryonic Stem Cells in Serum Free Medium Reveals Distinct 
Roles for BMP4, VEGF, SCF and FGF2 in Hematopoiesis. Stem Cells. 
Pierani, A., Brenner-Morton, S., Chiang, C. and Jessell, T. M. (1999). A Sonic 
Hedgehog-Independent, Retinoid-Activated Pathway of Neurogenesis in the Ventral 
Spinal Cord. Cell 97, 903-915. 
Piltti, K., Kerosuo, L., Hakanen, J., Eriksson, M., Angers-Loustau, A., Leppa, S., 
Salminen, M., Sariola, H. and Wartiovaara, K. (2006). E6/E7 Oncogenes Increase and 
Tumor Suppressors Decrease the Proportion of Self-renewing Neural Progenitor Cells. 
Oncogene 10, 4880-4889. 
Pla, P., Moore, R., Morali, O. G., Grille, S., Martinozzi, S., Delmas, V. and Larue, L. 
(2001). Cadherins in Neural Crest Cell Development and Transformation. J. Cell. 
Physiol. 189, 121-132. 
Popsueva, A., Poteryaev, D., Arighi, E., Meng, X., Angers-Loustau, A., Kaplan, D., 
Saarma, M. and Sariola, H. (2003). GDNF Promotes Tubulogenesis of GFRalpha1-
Expressing MDCK Cells by Src-Mediated Phosphorylation of Met Receptor Tyrosine 
Kinase. J. Cell Biol. 161, 119-129. 
Porteus, M. H., Bulfone, A., Liu, J. K., Puelles, L., Lo, L. C. and Rubenstein, J. L. 
(1994). DLX-2, MASH-1, and MAP-2 Expression and Bromodeoxyuridine Incorporation 
Define Molecularly Distinct Cell Populations in the Embryonic Mouse Forebrain. J. 
Neurosci. 14, 6370-6383. 
Qian, X., Shen, Q., Goderie, S. K., He, W., Capela, A., Davis, A. A. and Temple, S. 
(2000). Timing of CNS Cell Generation: A Programmed Sequence of Neuron and Glial 
Cell Production from Isolated Murine Cortical Stem Cells. Neuron 28, 69-80. 
From neural stem cells to precursors   References 
 
 
 78 
Raab, S., Beck, H., Gaumann, A., Yuce, A., Gerber, H. P., Plate, K., Hammes, H. P., 
Ferrara, N. and Breier, G. (2004). Impaired Brain Angiogenesis and Neuronal 
Apoptosis Induced by Conditional Homozygous Inactivation of Vascular Endothelial 
Growth Factor. Thromb. Haemost. 91, 595-605. 
Ramaekers, F. C. and Bosman, F. T. (2004). The Cytoskeleton and Disease. J. Pathol. 
204, 351-354. 
Rehman, A. O. and Wang, C. Y. (2006). Notch Signaling in the Regulation of Tumor 
Angiogenesis. Trends Cell Biol. 16, 293-300. 
Reissmann, E., Ernsberger, U., Francis-West, P. H., Rueger, D., Brickell, P. M. and 
Rohrer, H. (1996). Involvement of Bone Morphogenetic Protein-4 and Bone 
Morphogenetic Protein-7 in the Differentiation of the Adrenergic Phenotype in 
Developing Sympathetic Neurons. Development 122, 2079-2088. 
Reynolds, B. A., Tetzlaff, W. and Weiss, S. (1992). A Multipotent EGF-Responsive 
Striatal Embryonic Progenitor Cell Produces Neurons and Astrocytes. J. Neurosci. 12, 
4565-4574. 
Reynolds, B. A. and Weiss, S. (1992). Generation of Neurons and Astrocytes from 
Isolated Cells of the Adult Mammalian Central Nervous System. Science 255, 1707-
1710. 
Rietze, R. L., Valcanis, H., Brooker, G. F., Thomas, T., Voss, A. K. and Bartlett, P. 
F. (2001). Purification of a Pluripotent Neural Stem Cell from the Adult Mouse Brain. 
Nature 412, 736-739. 
Ristimaki, A., Narko, K., Enholm, B., Joukov, V. and Alitalo, K. (1998). 
Proinflammatory Cytokines Regulate Expression of the Lymphatic Endothelial Mitogen 
Vascular Endothelial Growth Factor-C. J. Biol. Chem. 273, 8413-8418. 
Rizvi, T. A., Huang, Y., Sidani, A., Atit, R., Largaespada, D. A., Boissy, R. E. and 
Ratner, N. (2002). A Novel Cytokine Pathway Suppresses Glial Cell Melanogenesis 
After Injury to Adult Nerve. J. Neurosci. 22, 9831-9840. 
Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L. and Wolffe, 
A. P. (2000). DNMT1 Forms a Complex with Rb, E2F1 and HDAC1 and Represses 
Transcription from E2F-Responsive Promoters. Nat. Genet. 25, 338-342. 
Roelink, H., Porter, J. A., Chiang, C., Tanabe, Y., Chang, D. T., Beachy, P. A. and 
Jessell, T. M. (1995). Floor Plate and Motor Neuron Induction by Different 
Concentrations of the Amino-Terminal Cleavage Product of Sonic Hedgehog 
Autoproteolysis. Cell 81, 445-455. 
Ross, S. E., Greenberg, M. E. and Stiles, C. D. (2003). Basic Helix-Loop-Helix Factors 
in Cortical Development. Neuron 39, 13-25. 
Rossi, J., Luukko, K., Poteryaev, D., Laurikainen, A., Sun, Y. F., Laakso, T., 
Eerikainen, S., Tuominen, R., Lakso, M., Rauvala, H. et al. (1999). Retarded Growth 
and Deficits in the Enteric and Parasympathetic Nervous System in Mice Lacking GFR 
alpha2, a Functional Neurturin Receptor. Neuron 22, 243-252. 
Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., 
Hoang-Xuan, K., Demczuk, S., Desmaze, C. and Plougastel, B. (1993). Alteration in a 
New Gene Encoding a Putative Membrane-Organizing Protein Causes Neuro-
Fibromatosis Type 2. Nature 363, 515-521. 
From neural stem cells to precursors   References 
 
 
 79 
Saaristo, A., Veikkola, T., Tammela, T., Enholm, B., Karkkainen, M. J., Pajusola, 
K., Bueler, H., Yla-Herttuala, S. and Alitalo, K. (2002). Lymphangiogenic Gene 
Therapy with Minimal Blood Vascular Side Effects. J. Exp. Med. 196, 719-730. 
Sainio, M., Zhao, F., Heiska, L., Turunen, O., den Bakker, M., Zwarthoff, E., 
Lutchman, M., Rouleau, G. A., Jaaskelainen, J., Vaheri, A. et al. (1997). 
Neurofibromatosis 2 Tumor Suppressor Protein Colocalizes with Ezrin and CD44 and 
Associates with Actin-Containing Cytoskeleton. J. Cell. Sci. 110 ( Pt 18), 2249-2260. 
Sariola, H. and Saarma, M. (2003). Novel Functions and Signalling Pathways for 
GDNF. J. Cell. Sci. 116, 3855-3862. 
Sauka-Spengler, T. and Bronner-Fraser, M. (2006). Development and Evolution of 
the Migratory Neural Crest: A Gene Regulatory Perspective. Curr. Opin. Genet. Dev. 16, 
360-366. 
Sawai, S., Shimono, A., Hanaoka, K. and Kondoh, H. (1991). Embryonic Lethality 
Resulting from Disruption of both N-Myc Alleles in Mouse Zygotes. New Biol. 3, 861-
869. 
Sawai, S., Shimono, A., Wakamatsu, Y., Palmes, C., Hanaoka, K. and Kondoh, H. 
(1993). Defects of Embryonic Organogenesis Resulting from Targeted Disruption of the 
N-Myc Gene in the Mouse. Development 117, 1445-1455. 
Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T. and Shibuya, M. 
(2001). Flt-1, Vascular Endothelial Growth Factor Receptor 1, is a Novel Cell Surface 
Marker for the Lineage of Monocyte-Macrophages in Humans. Blood 97, 785-791. 
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. and Howley, P. M. 
(1990). The E6 Oncoprotein Encoded by Human Papillomavirus Types 16 and 18 
Promotes the Degradation of p53. Cell 63, 1129-1136. 
Schoenwolf, G. C. (1991). Cell Movements Driving Neurulation in Avian Embryos. 
Development Suppl 2, 157-168. 
Schratzberger, P., Schratzberger, G., Silver, M., Curry, C., Kearney, M., Magner, 
M., Alroy, J., Adelman, L. S., Weinberg, D. H., Ropper, A. H. et al. (2000). Favorable 
Effect of VEGF Gene Transfer on Ischemic Peripheral Neuropathy. Nat. Med. 6, 405-
413. 
Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F. and Pachnis, V. 
(1994). Defects in the Kidney and Enteric Nervous System of Mice Lacking the Tyrosine 
Kinase Receptor Ret. Nature 367, 380-383. 
Schulze, K. M., Hanemann, C. O., Muller, H. W. and Hanenberg, H. (2002). 
Transduction of Wild-Type Merlin into Human Schwannoma Cells Decreases 
Schwannoma Cell Growth and Induces Apoptosis. Hum. Mol. Genet. 11, 69-76. 
Schwab, M. (2004). MYCN in Neuronal Tumours. Cancer Lett. 204, 179-187. 
Seoane, J., Le, H. V. and Massague, J. (2002). Myc Suppression of the p21(Cip1) Cdk 
Inhibitor Influences the Outcome of the p53 Response to DNA Damage. Nature 419, 
729-734. 
Shah, N. M., Groves, A. K. and Anderson, D. J. (1996). Alternative Neural Crest Cell 
Fates are Instructively Promoted by TGFbeta Superfamily Members. Cell 85, 331-343. 
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, 
M. L. and Schuh, A. C. (1995). Failure of Blood-Island Formation and Vasculogenesis 
in Flk-1-Deficient Mice. Nature 376, 62-66. 
From neural stem cells to precursors   References 
 
 
 80 
Shen, Q., Goderie, S. K., Jin, L., Karanth, N., Sun, Y., Abramova, N., Vincent, P., 
Pumiglia, K. and Temple, S. (2004). Endothelial Cells Stimulate Self-Renewal and 
Expand Neurogenesis of Neural Stem Cells. Science 304, 1338-1340. 
Sherr, C. J. (1996). Cancer Cell Cycles. Science 274, 1672-1677. 
Sherr, C. J. and Weber, J. D. (2000). The ARF/p53 Pathway. Curr. Opin. Genet. Dev. 
10, 94-99. 
Sherr, C. J. and Roberts, J. M. (1999). CDK Inhibitors: Positive and Negative 
Regulators of G1-Phase Progression. Genes Dev. 13, 1501-1512. 
Shibuya, M. (2006). Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1/Flt-1): 
A Dual Regulator for Angiogenesis. Angiogenesis 9, 225-30; discussion 231. 
Shibuya, M. and Claesson-Welsh, L. (2006). Signal Transduction by VEGF Receptors 
in Regulation of Angiogenesis and Lymphangiogenesis. Exp. Cell Res. 312, 549-560. 
Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H. and  
Silvestre, J. S., Tamarat, R., Ebrahimian, T. G., Le-Roux, A., Clergue, M., 
Emmanuel, F., Duriez, M., Schwartz, B., Branellec, D. and Levy, B. I. (2003). 
Vascular Endothelial Growth Factor-B Promotes in Vivo Angiogenesis. Circ. Res. 93, 
114-123. 
Shimamura, K. and Rubenstein, J. L. (1997). Inductive Interactions Direct Early 
Regionalization of the Mouse Forebrain. Development 124, 2709-2718. 
Skoff, R. P. and Knapp, P. E. (1991). Division of Astroblasts and Oligodendroblasts in 
Postnatal Rodent Brain: Evidence for Separate Astrocyte and Oligodendrocyte Lineages. 
Glia 4, 165-174. 
Slack, R. S., El-Bizri, H., Wong, J., Belliveau, D. J. and Miller, F. D. (1998). A 
Critical Temporal Requirement for the Retinoblastoma Protein Family during Neuronal 
Determination. J. Cell Biol. 140, 1497-1509. 
Smeyne, R. J., Klein, R., Schnapp, A., Long, L. K., Bryant, S., Lewin, A., Lira, S. A. 
and Barbacid, M. (1994). Severe Sensory and Sympathetic Neuropathies in Mice 
Carrying a Disrupted Trk/NGF Receptor Gene. Nature 368, 246-249. 
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G. and Klagsbrun, M. (1998). 
Neuropilin-1 is Expressed by Endothelial and Tumor Cells as an Isoform-Specific 
Receptor for Vascular Endothelial Growth Factor. Cell 92, 735-745. 
Sommer, L., Ma, Q. and Anderson, D. J. (1996). Neurogenins, a Novel Family of 
Atonal-Related bHLH Transcription Factors, are Putative Mammalian Neuronal 
Determination Genes that Reveal Progenitor Cell Heterogeneity in the Developing CNS 
and PNS. Mol. Cell. Neurosci. 8, 221-241. 
Sommer, L., Shah, N., Rao, M. and Anderson, D. J. (1995). The Cellular Function of 
MASH1 in Autonomic Neurogenesis. Neuron 15, 1245-1258. 
Sondell, M., Lundborg, G. and Kanje, M. (1999). Vascular Endothelial Growth Factor 
has Neurotrophic Activity and Stimulates Axonal Outgrowth, Enhancing Cell Survival 
and Schwann Cell Proliferation in the Peripheral Nervous System. J. Neurosci. 19, 5731-
5740. 
Spana, E. P. and Doe, C. Q. (1996). Numb Antagonizes Notch Signaling to Specify 
Sibling Neuron Cell Fates. Neuron 17, 21-26. 
Stacker, S. A. and Achen, M. G. (1999). The Vascular Endothelial Growth Factor 
Family: Signalling for Vascular Development. Growth Factors 17, 1-11. 
From neural stem cells to precursors   References 
 
 
 81 
Staller, P., Peukert, K., Kiermaier, A., Seoane, J., Lukas, J., Karsunky, H., Moroy, 
T., Bartek, J., Massague, J., Hanel, F. et al. (2001). Repression of p15INK4b 
Expression by Myc through Association with Miz-1. Nat. Cell Biol. 3, 392-399. 
Sterneck, E. and Johnson, P. F. (1998). CCAAT/enhancer Binding Protein Beta is a 
Neuronal Transcriptional Regulator Activated by Nerve Growth Factor Receptor 
Signaling. J. Neurochem. 70, 2424-2433. 
Stiegler, P., Kasten, M. and Giordano, A. (1998). The RB Family of Cell Cycle 
Regulatory Factors. J. Cell. Biochem. Suppl. 30-31, 30-36. 
Stolt, C. C., Rehberg, S., Ader, M., Lommes, P., Riethmacher, D., Schachner, M., 
Bartsch, U. and Wegner, M. (2002). Terminal Differentiation of Myelin-Forming 
Oligodendrocytes Depends on the Transcription Factor Sox10. Genes Dev. 16, 165-170. 
Su, X., Gopalakrishnan, V., Stearns, D., Aldape, K., Lang, F. F., Fuller, G., Snyder, 
E., Eberhart, C. G. and Majumder, S. (2006). Abnormal Expression of REST/NRSF 
and Myc in Neural stem/progenitor Cells Causes Cerebellar Tumors by Blocking 
Neuronal Differentiation. Mol. Cell. Biol. 26, 1666-1678. 
Sun, C. X., Robb, V. A. and Gutmann, D. H. (2002). Protein 4.1 Tumor Suppressors: 
Getting a FERM Grip on Growth Regulation. J. Cell. Sci. 115, 3991-4000. 
Sun, Y., Jin, K., Childs, J. T., Xie, L., Mao, X. O. and Greenberg, D. A. (2004). 
Increased Severity of Cerebral Ischemic Injury in Vascular Endothelial Growth Factor-B-
Deficient Mice. J. Cereb. Blood Flow Metab. 24, 1146-1152. 
Sun, Y., Jin, K., Childs, J. T., Xie, L., Mao, X. O. and Greenberg, D. A. (2006). 
Vascular Endothelial Growth Factor-B (VEGFB) Stimulates Neurogenesis: Evidence 
from Knockout Mice and Growth Factor Administration. Dev. Biol. 289, 329-335. 
Sun, Y., Nadal-Vicens, M., Misono, S., Lin, M. Z., Zubiaga, A., Hua, X., Fan, G. and 
Greenberg, M. E. (2001). Neurogenin Promotes Neurogenesis and Inhibits Glial 
Differentiation by Independent Mechanisms. Cell 104, 365-376. 
Suto, K., Yamazaki, Y., Morita, T. and Mizuno, H. (2005). Crystal Structures of Novel 
Vascular Endothelial Growth Factors (VEGF) from Snake Venoms: Insight into Selective 
VEGF Binding to Kinase Insert Domain-Containing Receptor but Not to Fms-Like 
Tyrosine Kinase-1. J. Biol. Chem. 280, 2126-2131. 
Tahira, T., Ishizaka, Y., Itoh, F., Sugimura, T. and Nagao, M. (1990). 
Characterization of Ret Proto-Oncogene mRNAs Encoding Two Isoforms of the Protein 
Product in a Human Neuroblastoma Cell Line. Oncogene 5, 97-102. 
Takahashi, S., Shimizu, R., Suwabe, N., Kuroha, T., Yoh, K., Ohta, J., Nishimura, 
S., Lim, K. C., Engel, J. D. and Yamamoto, M. (2000). GATA Factor Transgenes 
Under GATA-1 Locus Control Rescue Germline GATA-1 Mutant Deficiencies. Blood 
96, 910-916. 
Tammela, T., Enholm, B., Alitalo, K. and Paavonen, K. (2005). The Biology of 
Vascular Endothelial Growth Factors. Cardiovasc. Res. 65, 550-563. 
Tekki-Kessaris, N., Woodruff, R., Hall, A. C., Gaffield, W., Kimura, S., Stiles, C. D., 
Rowitch, D. H. and Richardson, W. D. (2001). Hedgehog-Dependent Oligodendrocyte 
Lineage Specification in the Telencephalon. Development 128, 2545-2554. 
Temple, S. (2001). The Development of Neural Stem Cells. Nature 414, 112-117. 
Terman, B. I., Carrion, M. E., Kovacs, E., Rasmussen, B. A., Eddy, R. L. and 
Shows, T. B. (1991). Identification of a New Endothelial Cell Growth Factor Receptor 
Tyrosine Kinase. Oncogene 6, 1677-1683. 
From neural stem cells to precursors   References 
 
 
 82 
Testaz, S. and Duband, J. L. (2001). Central Role of the alpha4beta1 Integrin in the 
Coordination of Avian Truncal Neural Crest Cell Adhesion, Migration, and Survival. 
Dev. Dyn. 222, 127-140. 
Thomas, G. M. and Huganir, R. L. (2004). MAPK Cascade Signalling and Synaptic 
Plasticity. Nat. Rev. Neurosci. 5, 173-183. 
Thomas, J. L., Spassky, N., Perez Villegas, E. M., Olivier, C., Cobos, I., Goujet-Zalc, 
C., Martinez, S. and Zalc, B. (2000). Spatiotemporal Development of Oligodendrocytes 
in the Embryonic Brain. J. Neurosci. Res. 59, 471-476. 
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., 
Marshall, V. S. and Jones, J. M. (1998). Embryonic Stem Cell Lines Derived from 
Human Blastocysts. Science 282, 1145-1147. 
Tognon, M., Corallini, A., Martini, F., Negrini, M. and Barbanti-Brodano, G. 
(2003). Oncogenic Transformation by BK Virus and Association with Human Tumors. 
Oncogene 22, 5192-5200. 
Toma, J. G., El-Bizri, H., Barnabe-Heider, F., Aloyz, R. and Miller, F. D. (2000). 
Evidence that Helix-Loop-Helix Proteins Collaborate with Retinoblastoma Tumor 
Suppressor Protein to Regulate Cortical Neurogenesis. J. Neurosci. 20, 7648-7656. 
Trentin, A., Glavieux-Pardanaud, C., Le Douarin, N. M. and Dupin, E. (2004). Self-
Renewal Capacity is a Widespread Property of various Types of Neural Crest Precursor 
Cells. Proc. Natl. Acad. Sci. U. S. A. 101, 4495-4500. 
Trofatter, J. A., MacCollin, M. M., Rutter, J. L., Murrell, J. R., Duyao, M. P., 
Parry, D. M., Eldridge, R., Kley, N., Menon, A. G. and Pulaski, K. (1993). A Novel 
Moesin-, Ezrin-, Radixin-Like Gene is a Candidate for the Neurofibromatosis 2 Tumor 
Suppressor. Cell 75, 826. 
Trumpp, A., Refaeli, Y., Oskarsson, T., Gasser, S., Murphy, M., Martin, G. R. and 
Bishop, J. M. (2001). C-Myc Regulates Mammalian Body Size by Controlling Cell 
Number but Not Cell Size. Nature 414, 768-773. 
Tsarovina, K., Pattyn, A., Stubbusch, J., Muller, F., van der Wees, J., Schneider, C., 
Brunet, J. F. and Rohrer, H. (2004). Essential Role of Gata Transcription Factors in 
Sympathetic Neuron Development. Development 131, 4775-4786. 
Tsui-Pierchala, B. A., Ahrens, R. C., Crowder, R. J., Milbrandt, J. and Johnson, E. 
M.,Jr. (2002). The Long and Short Isoforms of Ret Function as Independent Signaling 
Complexes. J. Biol. Chem. 277, 34618-34625. 
Tucker, R. P., Hagios, C., Chiquet-Ehrismann, R., Lawler, J., Hall, R. J. and 
Erickson, C. A. (1999). Thrombospondin-1 and Neural Crest Cell Migration. Dev. Dyn. 
214, 312-322. 
Tufro, A., Teichman, J., Banu, N. and Villegas, G. (2007). Crosstalk between VEGF-
A/VEGFR2 and GDNF/RET Signaling Pathways. Biochem. Biophys. Res. Commun. 358, 
410-416. 
Turunen, O., Winqvist, R., Pakkanen, R., Grzeschik, K. H., Wahlstrom, T. and 
Vaheri, A. (1989). Cytovillin, a Microvillar Mr 75,000 Protein. cDNA Sequence, 
Prokaryotic Expression, and Chromosomal Localization. J. Biol. Chem. 264, 16727-
16732. 
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., 
Lu, X., Soron, G., Cooper, B., Brayton, C. et al. (2002). P53 Mutant Mice that Display 
Early Ageing-Associated Phenotypes. Nature 415, 45-53. 
From neural stem cells to precursors   References 
 
 
 83 
Uchida, N., Buck, D. W., He, D., Reitsma, M. J., Masek, M., Phan, T. V., 
Tsukamoto, A. S., Gage, F. H. and Weissman, I. L. (2000). Direct Isolation of Human 
Central Nervous System Stem Cells. Proc. Natl. Acad. Sci. U. S. A. 97, 14720-14725. 
Valk-Lingbeek, M. E., Bruggeman, S. W. and van Lohuizen, M. (2004). Stem Cells 
and Cancer; the Polycomb Connection. Cell 118, 409-418. 
van Lookeren Campagne, M. and Gill, R. (1998). Tumor-Suppressor p53 is Expressed 
in Proliferating and Newly Formed Neurons of the Embryonic and Postnatal Rat Brain: 
Comparison with Expression of the Cell Cycle Regulators p21Waf1/Cip1, p27Kip1, 
p57Kip2, p16Ink4a, Cyclin G1, and the Proto-Oncogene Bax. J. Comp. Neurol. 397, 181-
198. 
Vanderluit, J. L., Ferguson, K. L., Nikoletopoulou, V., Parker, M., Ruzhynsky, V., 
Alexson, T., McNamara, S. M., Park, D. S., Rudnicki, M. and Slack, R. S. (2004). 
P107 Regulates Neural Precursor Cells in the Mammalian Brain. J. Cell Biol. 166, 853-
863. 
Vasioukhin, V. (2006). Lethal Giant Puzzle of Lgl. Dev. Neurosci. 28, 13-24. 
Veeraraghavalu, K., Pett, M., Kumar, R. V., Nair, P., Rangarajan, A., Stanley, M. 
A. and Krishna, S. (2004). Papillomavirus-Mediated Neoplastic Progression is 
Associated with Reciprocal Changes in JAGGED1 and Manic Fringe Expression Linked 
to Notch Activation. J. Virol. 78, 8687-8700. 
Veiga-Fernandes, H., Coles, M. C., Foster, K. E., Patel, A., Williams, A., Natarajan, 
D., Barlow, A., Pachnis, V. and Kioussis, D. (2007). Tyrosine Kinase Receptor RET is 
a Key Regulator of Peyer's Patch Organogenesis. Nature 446, 547-551. 
Veldman, T., Horikawa, I., Barrett, J. C. and Schlegel, R. (2001). Transcriptional 
Activation of the Telomerase hTERT Gene by Human Papillomavirus Type 16 E6 
Oncoprotein. J. Virol. 75, 4467-4472. 
Vivanco, I. and Sawyers, C. L. (2002). The Phosphatidylinositol 3-Kinase AKT 
Pathway in Human Cancer. Nat. Rev. Cancer. 2, 489-501. 
von Rahden, B. H., Stein, H. J., Puhringer-Oppermann, F. and Sarbia, M. (2006). C-
Myc Amplification is Frequent in Esophageal Adenocarcinoma and Correlated with the 
Upregulation of VEGF-A Expression. Neoplasia 8, 702-707. 
Wada, T., Haigh, J. J., Ema, M., Hitoshi, S., Chaddah, R., Rossant, J., Nagy, A. and 
van der Kooy, D. (2006). Vascular Endothelial Growth Factor Directly Inhibits Primitive 
Neural Stem Cell Survival but Promotes Definitive Neural Stem Cell Survival. J. 
Neurosci. 26, 6803-6812. 
Wade, M. and Wahl, G. M. (2006). C-Myc, Genome Instability, and Tumorigenesis: 
The Devil is in the Details. Curr. Top. Microbiol. Immunol. 302, 169-203. 
Wang, H. U. and Anderson, D. J. (1997). Eph Family Transmembrane Ligands can 
Mediate Repulsive Guidance of Trunk Neural Crest Migration and Motor Axon 
Outgrowth. Neuron 18, 383-396. 
Wang, J. Y., Naderi, S. and Chen, T. T. (2001). Role of Retinoblastoma Tumor 
Suppressor Protein in DNA Damage Response. Acta Oncol. 40, 689-695. 
Ward, N. L. and Lamanna, J. C. (2004). The Neurovascular Unit and its Growth 
Factors: Coordinated Response in the Vascular and Nervous Systems. Neurol. Res. 26, 
870-883. 
Weigmann, A., Corbeil, D., Hellwig, A. and Huttner, W. B. (1997). Prominin, a Novel 
Microvilli-Specific Polytopic Membrane Protein of the Apical Surface of Epithelial 
From neural stem cells to precursors   References 
 
 
 84 
Cells, is Targeted to Plasmalemmal Protrusions of Non-Epithelial Cells. Proc. Natl. 
Acad. Sci. U. S. A. 94, 12425-12430. 
Weijzen, S., Zlobin, A., Braid, M., Miele, L. and Kast, W. M. (2003). HPV16 E6 and 
E7 Oncoproteins Regulate Notch-1 Expression and Cooperate to Induce Transformation. 
J. Cell. Physiol. 194, 356-362. 
Wernig, M., Zhao, J. P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., 
Constantine-Paton, M., Isacson, O. and Jaenisch, R. (2008). Neurons Derived from 
Reprogrammed Fibroblasts Functionally Integrate into the Fetal Brain and Improve 
Symptoms of Rats with Parkinson's Disease. Proc. Natl. Acad. Sci. U. S. A. 105, 5856-
5861. 
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., 
Weinberg, R. A. and Harlow, E. (1988). Association between an Oncogene and an 
Anti-Oncogene: The Adenovirus E1A Proteins Bind to the Retinoblastoma Gene Product. 
Nature 334, 124-129. 
Wilcock, A. C., Swedlow, J. R. and Storey, K. G. (2007). Mitotic Spindle Orientation 
Distinguishes Stem Cell and Terminal Modes of Neuron Production in the Early Spinal 
Cord. Development 134, 1943-1954. 
Wilson, A., Murphy, M. J., Oskarsson, T., Kaloulis, K., Bettess, M. D., Oser, G. M., 
Pasche, A. C., Knabenhans, C., Macdonald, H. R. and Trumpp, A. (2004). C-Myc 
Controls the Balance between Hematopoietic Stem Cell Self-Renewal and 
Differentiation. Genes Dev. 18, 2747-2763. 
Worley, D. S., Pisano, J. M., Choi, E. D., Walus, L., Hession, C. A., Cate, R. L., 
Sanicola, M. and Birren, S. J. (2000). Developmental Regulation of GDNF Response 
and Receptor Expression in the Enteric Nervous System. Development 127, 4383-4393. 
Xiao, Z. X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J., Sellers, W. R. and 
Livingston, D. M. (1995). Interaction between the Retinoblastoma Protein and the 
Oncoprotein MDM2. Nature 375, 694-698. 
Xu, X. N., Wang, J. H., Li, J. Y., Liu, H. S., Lu, Y. and Qi, J. B. (2004). Gene 
Expression of PTEN in Human Glioma. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16, 563. 
Yadirgi, G. and Marino, S. (2009). Adult Neural Stem Cells and their Role in Brain 
Pathology. J. Pathol. 217, 242-253. 
Yeh, W. C., Cao, Z., Classon, M. and McKnight, S. L. (1995). Cascade Regulation of 
Terminal Adipocyte Differentiation by Three Members of the C/EBP Family of Leucine 
Zipper Proteins. Genes Dev. 9, 168-181. 
Yoshikawa, K. (2000). Cell Cycle Regulators in Neural Stem Cells and Postmitotic 
Neurons. Neurosci. Res. 37, 1-14. 
Yu, Y., Khan, J., Khanna, C., Helman, L., Meltzer, P. S. and Merlino, G. (2004). 
Expression Profiling Identifies the Cytoskeletal Organizer Ezrin and the Developmental 
Homeoprotein Six-1 as Key Metastatic Regulators. Nat. Med. 10, 175-181. 
Yuan, L., Moyon, D., Pardanaud, L., Breant, C., Karkkainen, M. J., Alitalo, K. and 
Eichmann, A. (2002). Abnormal Lymphatic Vessel Development in Neuropilin 2 Mutant 
Mice. Development 129, 4797-4806. 
Zachary, I. (1998). Vascular Endothelial Growth Factor. Int. J. Biochem. Cell Biol. 30, 
1169-1174. 
From neural stem cells to precursors   References 
 
 
 85 
Zanet, J., Pibre, S., Jacquet, C., Ramirez, A., de Alboran, I. M. and Gandarillas, A. 
(2005). Endogenous Myc Controls Mammalian Epidermal Cell Size, Hyperproliferation, 
Endoreplication and Stem Cell Amplification. J. Cell. Sci. 118, 1693-1704. 
Zhong, W., Jiang, M. M., Schonemann, M. D., Meneses, J. J., Pedersen, R. A., Jan, 
L. Y. and Jan, Y. N. (2000). Mouse Numb is an Essential Gene Involved in Cortical 
Neurogenesis. Proc. Natl. Acad. Sci. U. S. A. 97, 6844-6849. 
Zilian, O., Saner, C., Hagedorn, L., Lee, H. Y., Sauberli, E., Suter, U., Sommer, L. 
and Aguet, M. (2001). Multiple Roles of Mouse Numb in Tuning Developmental Cell 
Fates. Curr. Biol. 11, 494-501. 
 
 
